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Introduction
Les protéines intrinsèquement désordonnées (IDPs), qui n’ont pas de structure tridimensionnelle stable, ont
longtemps été considérées comme d’intérêt biologique limité. Depuis une vingtaine d’années, leur propor-
tion élevée dans les protéomes, notamment eucaryotes (Ward et al., 2004), et leur rôle dans de nombreux pro-
cessus physiologiques et pathologiques (Wright and Dyson, 1999) sont reconnus. En particulier, le désordre
est commun dans les processus de signalisation (Iakoucheva et al., 2004). De récents développements mé-
thodologiques, notamment en résonance magnétique nucléaire (RMN), permettent l’étude de ces protéines
désordonnées, en parallèle de l’émergence de nouveaux concepts associés.
Dans les travaux présentés ici, nous nous intéressons à la région C-terminale désordonnée de ErbB2/HER2/neu
(que nous appelons CtErbB2). ErbB2 fait partie de la famille de récepteurs tyrosine kinase des ErbBs, dont
EGFR, ou ErbB1, est le membre le plus étudié et est utilisé comme modèle pour l’étude de leur mécanisme
de transduction du signal (Kovacs et al., 2015b) : la liaison d’un ligand protéique au domaine extracellu-
laire du récepteur permet son homo- ou hétéro-dimérisation, l’activation de son domaine tyrosine kinase
intracellulaire et la phosphorylation de sa région C-terminale. Cette région, par le biais de ses tyrosines
phosphorylées, constitue une plateforme d’interaction avec de nombreuses protéines adaptatrices. Ces in-
teractions activent les voies de signalisation correspondantes, contrôlant la division, la différentiation et
la motilité cellulaires et la résistance à l’apoptose (Yarden and Sliwkowski, 2001). Dans ce modèle, deux
aspects en particulier restent mal compris : les mécanismes spécifiques à chaque ErbB et les mécanismes
d’interaction entre la queue C-terminale et les protéines adaptatrices.
Plus de 20% des cancers du sein sont associés à une surexpression de ErbB2, et cette forme dite HER2 +
est particulièrement agressive (Slamon et al., 1987). Contrairement aux trois autres membres de la famille,
l’activation d’ErbB2 ne nécessite pas l’association d’un ligand à son domaine extracellulaire (Cho et al.,
viii
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2003). La capacité intrinsèque d’ErbB2 à dimériser et l’activation de son domaine kinase n’étant donc pas
contrôlées par un signal extracellulaire, la régulation de la phosphorylation et des interactions de sa queue
C-terminale est d’autant plus cruciale. Plusieurs éléments suggèrent que cette région est globalement désor-
donnée (Keppel et al., 2017), mais aucune étude à haute résolution n’a été menée. Pourtant, son rôle dans
la régulation de la transduction du signal en fait un modèle pour l’étude du lien entre désordre et fonction
ainsi qu’une cible thérapeutique intéressante.
Mon travail de thèse a consisté à étudier dans un premier temps les caractéristiques structurales et dyna-
miques de CtErbB2 isolée et non phosphorylée. Dans un deuxième temps, je me suis intéressée à Grb2,
un partenaire majeur de CtErbB2. Cette protéine adaptatrice contenant trois domaines (SH3-SH2-SH3)
est connue notamment pour interagir avec une tyrosine phosphorylée de CtErbB2 (Dankort et al., 1997)
et la connecter, en interagissant avec d’autres protéines par ses domaines SH3, à la voie de signalisation
Ras/MAPK (Lowenstein et al., 1992). J’ai donc étudié l’organisation modulaire de Grb2 en solution, puis
son interaction avec CtErbB2. Enfin, j’ai mis en place différentes méthodes permettant d’étudier CtErbB2
dans un état plus fonctionnel : dans son état phosphorylé, et dans le contexte de la région intracellulaire
entière (avec le domaine kinase).
Contexte des travaux présentés
Les protéines intrinsèquement désordonnées (IDPs)
Le désordre dans les protéines Contrairement au premier dogme de la biologie structurale, et au concept
de "clé-serrure" de Fischer (1894), toutes les protéines n’ont pas une structure tridimensionnelle unique
déterminant leur fonction spécifique. Un grand nombre de protéines possèdent au moins 30 résidus consé-
cutifs ne présentant pas de structure stable, et de telles régions sont dites intrinsèquement désordonnées.
Chez l’homme, il est estimé que c’est le cas de 44% des protéines (Oates et al., 2013). La longueur des seg-
ments désordonnés, ainsi que leur composition en structures secondaires et leur compacité, sont fortement
variables, et on parle donc de "continuum du désordre" (Uversky et al., 2005; Dyson and Wright, 2005).
Désordre et séquence Comme la structure d’une protéine globulaire, le niveau de désordre d’une IDP est
largement dicté par sa séquence. Les IDPs sont globalement pauvres en résidus hydrophobes, enrichies en
résidus chargés, polaires, en prolines et parfois en glycines et alanines (Habchi et al., 2014). Les séquences
répétées sont aussi fréquentes dans les IDPs. Ces spécificités ont permis le développement de programmes
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de prédiction de désordre à partir de la séquence d’une protéine.
Les prolines sont des acides aminés uniques, jouant un rôle particulier dans les IDPs (Mansiaux et al., 2011).
Leur chaîne latérale cyclique entraine l’absence du proton amide du squelette, empêchant la formation de
liaisons hydrogène nécessaires à la stabilisation d’hélices α ou de feuillets β . De plus, les contraintes gé-
nérées par le cycle sont fortes. La proportion d’isomère cis de la liaison peptidique X-Pro (plusieurs %)
est bien plus élevée que pour les autres acides aminés (moins de 1%) (Alderson et al., 2018). La cinétique
d’interconversion avec la forme trans est très lente, souvent plusieurs minutes voire plusieurs heures (Rei-
mer et al., 1998). De plus, les prolines favorisent un type particulier d’hélices auxquelles elles donnent leur
nom : les hélices polyproline II (PPII). Ces hélices triangulaires de 3 résidus par tour, présentées en figure 3,
sont étendues (3.1 Å par résidu) et bloquent les liaisons peptidiques en conformation trans. Elles sont fré-
quemment formées lors d’interactions de motifs riches en prolines avec des domaines SH3 ou WW (Macias
et al., 2002).
Fonctions de IDPs Les spécificités physico-chimiques des IDPs sont liées à des spécificités fonction-
nelles : elles sont sur-représentées lorsqu’une grande flexibilité est avantageuse (rôle de chaîne entropique),
ou lorsque qu’une grande accessibilité et adaptabilité dans les interactions sont requises. Les complexes
impliquant des IDPs peuvent eux-même présenter différents niveaux de désordre et différentes multiplicités
de sites. Dans le cas le plus couramment décrit, la liaison est couplée au repliement local du partenaire
désordonné au niveau d’un motif en interaction avec un site spécifique d’un partenaire ordonné. À l’autre
extrême, un partenaire (ou les deux) peut conserver un grand niveau de désordre (on parle alors de "fuzzy
complex"), et adopter de multiples conformations en échange entre plusieurs sites d’interaction. La notion
d’allostérie, soit la régulation de l’activité d’un site par liaison d’un ligand à un autre site éloigné, liée ori-
ginellement à l’observation de changements structuraux propagés d’un site structuré à l’autre, a aujourd’hui
été étendue afin de prendre en compte l’allostérie liée à des changements de dynamique et à des transitions
ordre/désordre. En lien avec ces caractéristiques de liaison des IDPs, leurs interactions sont souvent d’affi-
nité modérée, tout en conservant une grande spécificité. L’association et la dissociation étant généralement
rapides, les interactions impliquant des IDPs permettent une grande adaptabilité. Il n’est donc pas étonnant
que les protéines désordonnées soient courantes dans les mécanismes de signalisation (Iakoucheva et al.,
2004), et notamment dans les récepteurs comme ErbB2 (Kjaergaard and Kragelund, 2017).
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Étude structurale du désordre La méthode expérimentale de choix pour étudier les IDPs avec une ré-
solution atomique est la résonance magnétique nucléaire (RMN). Elle permet d’obtenir des informations à
la fois structurales et dynamiques (de la centaine de ps à la s ou plus), ce qui revient à sonder l’ensemble
conformationnel exploré par la protéine. Elle peut être combinée à des informations plus globales sur la
forme et la taille moyenne de l’ensemble, obtenues par SAXS, et à des informations à l’échelle de la molé-
cule unique (par FRET, spectroscopie de force ou nanopores uniques par exemple). Enfin, les données ex-
périmentales peuvent être complétées par des études in silico, en générant (et sélectionnant) des ensembles
conformationnels ou des trajectoires de dynamique moléculaire cohérents avec ces données, pour explorer
des mécanismes possibles.
La queue C-terminale intrinsèquement désordonnée de ErbB2 (CtErbB2)
Les ErbBs Les quatre protéines ErbB (ErbB1/HER1/EGFR, ErbB2/HER2/neu, ErbB3/HER3 and ErbB4/HER4)
sont des récepteurs tyrosine kinase (RTKs), présentés en figure 10. ErbB1 a été le premier RTK découvert,
et sert classiquement de modèle pour comprendre le mécanisme de transduction du signal par les ErbBs. Les
quatre ErbBs ont une structure globale commune : une région extracellulaire divisée en quatre domaines, une
hélice transmembranaire, une région intracellulaire juxtamembranaire, un domaine tyrosine kinase et une
queue C-terminale contenant des sites de phosphorylation tyrosines. Les voies de signalisation activées par
les ErbBs comprennent notamment : la voie Ras/MAPK, la voie Akt/PI3K, la voie des Src kinases, la voie
des STAT et la voie de MEMO (Yarden and Sliwkowski, 2001; Marone et al., 2004). Ces voies contrôlent la
division, la différentiation, l’adhésion et la motilité cellulaire, ainsi que la résistance à l’apoptose (Pinkas-
Kramarski et al., 1996; Jeon et al., 2015; Chausovsky et al., 2000; Zaoui et al., 2008; Giani et al., 1998). Les
ErbBs sont toutes impliquées dans des processus physiologiques tels que le développement et la fonction de
différents organes (Sebastian et al., 1998; Lee et al., 1995) et dans des processus pathologiques, en particu-
lier l’apparition de cancers (Yarden and Sliwkowski, 2001; Yarden and Pines, 2012). Cependant, les ErbBs
ont des spécificités fonctionnelles : leurs ligands, de la famille des facteurs de croissance épidermiques,
diffèrent et ErbB2 n’a pas de ligand endogène identifié ; leur activité kinase varie et celle d’ErbB3 est très
faible ; les processus physiologiques et pathologiques, notamment les types de cancers, dans lesquels elles
sont impliquées sont différents (Yarden and Sliwkowski, 2001).
Le mécanisme général de signalisation par les ErbBs, déterminé principalement grâce aux études sur EGFR,
se décompose en cinq étapes impliquant différentes parties des récepteurs (Kovacs et al., 2015b; Purba et al.,
2017) et est récapitulé en figure 19 :
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• La liaison d’un ligand à la région extracellulaire du récepteur entraine un changement structural dans
l’organisation de ses quatre domaines (Ferguson et al., 2003). Alors que la forme libre inhibe la for-
mation de dimères actifs pour la signalisation, la forme liée rend accessible la zone extracellulaire
de dimérisation. Des dimères d’ErbBs sans ligands ont par ailleurs été observés (Tao and Maruyama,
2008), mais n’impliquent pas la dimérisation de la région extracellulaire et n’entrainent pas de signa-
lisation.
• Dans le dimère actif ainsi formé, les hélices transmembranaires dimérisent dans une conformation
où leurs extrémités intracellulaires sont éloignées et où l’hélice juxtamembranaire immédiatement
adjacente (JMA) forme un dimère antiparallèle (Bragin et al., 2016).
• Le domaine tyrosine kinase est activé par contacts intermoléculaires dans un dimère asymétrique, où
une kinase inactive dite "activatrice" active l’autre, appelée "réceptrice" (Zhang et al., 2006). Dans
ce dimère asymétrique le segment juxtamembranaire le plus proche de la kinase (JMB) réceptrice
stabilise l’interaction en interagissant avec la kinase activatrice (Red Brewer et al., 2009; Jura et al.,
2009). Ce mécanisme est très différent de l’activation "classique" des RTKs par transphosphorylation
du domaine kinase.
• Le domaine kinase ainsi activé phosphoryle la queue C-terminale en trans (Qian et al., 1994) et/ou en
cis, par un mécanisme inconnu.
• Les tyrosines phosphorylées recrutent des protéines adaptatrices contenant majoritairement des do-
maines SH2 ou PTB, et ce recrutement active les voies de signalisation associées. La queue C-
terminale et sa phosphorylation ont aussi été montrées comme étant impliquées dans la régulation
de l’activité des domaines kinases (Gill et al., 2017). Cette observation est cohérente avec l’interac-
tion observée entre ces deux régions dans les structures cristallographiques des domaines kinases,
qui contiennent le début de la queue C-terminale (Lemmon et al., 2014). Une hélice, appelée AP-2
chez EGFR, située au début de la queue C-terminale, est notamment observée dans les structures de
la kinase non activée. Elle interagit de façon intramoléculaire et intermoléculaire avec les domaines
kinases, stabilisant un dimère symétrique inactif.
Ces régions structurées dans les cristaux de domaines kinases sont les seules informations à haute
résolution connues sur la queue C-terminale des récepteurs ErbBs. Le reste de la queue a été montré
comme étant globalement désordonné (Keppel et al., 2017) et dynamique (Lee and Koland, 2005;
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Lee et al., 2006), avec un comportement dépendant de l’état de phosphorylation (Lee et al., 2006;
Bishayee et al., 1999).
ErbB2 et sa queue C-terminale (CtErbB2) ErbB2 a plusieurs particularités fonctionnelles dans la fa-
mille : elle n’a pas de ligand endogène connu et est capable d’activer des voies de signalisation de façon
ligand-indépendante (Di Fiore et al., 1987; Brennan et al., 2000). Elle est surexprimée dans plus de 20% des
cancers du sein, dits HER2 + (Slamon et al., 1987). Ces cancers sont particulièrement agressifs (Press et al.,
1993). Ces particularités fonctionnelles sont associées à des particularités structurales, et notamment l’exis-
tence d’une unique conformation de sa région extracellulaire, celle permettant la dimérisation (Cho et al.,
2003). Il manque donc à ErbB2 un mécanisme de régulation par rapport aux autres ErbBs, et la régulation
de sa phosphorylation et de ses interactions est donc particulièrement importante.
La queue C-terminale d’ErbB2 contient 5 sites d’autophosphorylation connus (Hazan et al., 1990; Segatto
et al., 1990), appelés YA, YB, YC, YD and YE, dont le rôle dans la transduction du signal a été étudié par
Dankort et al. (1997, 2001a,b). La phosphorylation de YA a été montrée comme ayant un rôle inhibiteur
de la transduction du signal, levé seulement par la phosphorylation de YD. La phosphorylation des quatre
autres sites est activatrice de la signalisation, grâce à l’interaction avec différents partenaires, dont : Grb2
pour YB, Crk pour YC, Shc et MEMO pour YD, Dok-R pour YE.
En dehors de la possible formation de structures locales lors d’interactions, et de l’hélice AP-2 visible dans la
structure cristallographique du domaine kinase de ErbB2 comme chez EGFR, on s’attend à ce que CtErbB2
soit globalement désordonnée, comme suggéré par l’étude de Keppel et al. (2017). Le but de notre étude
est de caractériser à haute résolution la structure et la dynamique de CtErbB2, afin de comprendre comment
sont régulées les interactions avec ses partenaires dans le cadre de l’activation des voies de signalisation.
Nous avons en particulier étudié le partenaire Grb2.
Grb2, une protéine adaptatrice essentielle des voies de signalisation de ErbB2
Grb2 est une protéine modulaire purement adaptatrice, sans rôle catalytique, et dont la fonction repose ex-
clusivement sur les interactions protéine-protéine. Elle a une organisation de type SH3-SH2-SH3. Elle lie
différents RTKs (dont ErbB2) sur leurs phosphotyrosines par son domaine SH2 et fait le pont principa-
lement avec la voie Ras/MAPK en recrutant d’autres protéines via ses domaines SH3 N- et C-terminaux
(notés respectivement NSH3 et CSH3) (Lowenstein et al., 1992; Cheng et al., 1998). Grb2 est essentielle
pour l’embryogenèse et est impliquée dans la tumorigenèse, notamment celle médiée par ErbB2 (Cheng
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et al., 1998; Xie et al., 1995; Gril et al., 2007).
Les trois domaines de Grb2 Les domaines SH2 sont des domaines d’une centaine de résidus, ayant une
structure canonique constituée d’un feuillet β central et de deux hélices, positionnées de chaque côté. Une
telle structure est présentée en figure 25. Les domaines SH2 sont des domaines de liaison aux phosphoty-
rosines (pY, en contact avec une des faces du feuillet), et leur spécificité dépend des résidus positionnés en
N-terminal de pY (en contact avec l’autre face du feuillet) (Liu et al., 2012). Le domaine SH2 de Grb2 a une
structure globale canonique (Thornton et al., 1996), avec une spécificité pour les ligands de type pYxNx. La
position de la chaîne latérale d’un tryptophane de Grb2 (W121) contraint la conformation de la chaîne de
ses ligands en N-terminal de pY. Ce tryptophan force la formation d’un coude β (Marengere et al., 1994;
Rahuel et al., 1996; Papaioannou et al., 2016) montré en figure 31, alors que les ligands des domaines SH2
adoptent classiquement une structure étendue.
Les domaines SH3 sont plus petits, généralement entre 50 et 75 résidus, et sont constitués de deux feuillets
β antiparallèles (voir figure 26). Ils lient différents types de motifs, le plus couramment riches en prolines
formant des hélices polyproline PPII, et notamment les motifs RxxPxxP (classe I) et PxxPxR (classe II)
(Musacchio, 2002). Ces deux classes de peptides se lient avec des orientations opposées, permettant l’inter-
action des motifs xP (ou Px) avec des résidus aromatiques et une proline du SH3, et de l’arginine avec un
résidu acide (E ou D) du SH3. Les interactions secondaires (en dehors de ces deux interactions principales)
sont aussi courantes et participent à la spécificité de chaque SH3. Les deux SH3 de Grb2 ont une structure
globale canonique (Goudreau et al., 1994; Kohda et al., 1994), présentée en figure 32c et 32d. Cependant, le
domaine NSH3 a été montré comme échangeant entre sa forme repliée et une forme largement dépliée dans
des conditions physiologiques (Goudreau et al., 1994). Les deux domaines SH3 ont une préférence pour les
ligands de classe II plutôt que de classe I, mais le CSH3 peut aussi interagir avec des ligands de type RxxK
contenant des prolines (Musacchio, 2002; Lewitzky et al., 2001; Harkiolaki et al., 2009). Sos, le facteur
d’échange nucléotidique de Ras, peut se lier aux deux SH3, avec une préférence pour le NSH3 (McDonald
et al., 2009). Les protéines Gab, elles, se lient au domaine CSH3 (Lewitzky et al., 2001; Harkiolaki et al.,
2009).
xiv
Résumé en français
Grb2 entière La seule structure de Grb2 entière est une structure cristallographique, sans ligand, donnée
en figure 29 (Maignan et al., 1995). Dans cette structure, les deux domaines SH3 de Grb2 sont en inter-
action électrostatique, mais leurs sites d’interaction restent accessibles. La seule étude de Grb2 entière en
solution a été effectuée avec des ligands peptidiques à la fois pour les domaines SH3 et le domaine SH2
(peptides extraits de Sos et d’EGFR respectivement) (Yuzawa et al., 2001). Cette étude montre une absence
d’interaction notable entre les domaines, contrairement aux données cristallographiques. Aucune donnée
n’est actuellement publiée sur le comportement de Grb2 en solution en l’absence de ligands.
L’état oligomérique de Grb2 est sujet à controverse. La structure cristallographique de Grb2 (Maignan et al.,
1995) montre un dimère dans lequel les domaines SH2 et CSH3 interagissent (voir figure 30a), alors qu’en
solution avec ligands peptidiques Grb2 est purement monomérique (Yuzawa et al., 2001). D’autres études
conduisent à des constantes de dissociation du dimère de l’ordre du µM (McDonald et al., 2008b; Lin et al.,
2012; Ahmed et al., 2015). Des études du domaine SH2 isolé ont aussi montré un dimère croisé métastable
de ce domaine ("domain-swapping"), où l’hélice C-terminale est échangée entre deux monomères d’un di-
mère (Schiering et al., 2000; Nioche et al., 2002; Benfield et al., 2007; Papaioannou et al., 2016). Cependant,
un tel échange dans la protéine entière ou in vivo n’a jamais été démontré.
Bien que les liaisons des domaines SH2 et SH3 à des peptides différents soient indépendantes les unes des
autres (Cussac et al., 1994; Lemmon et al., 1994), la situation semble différente lorsque les ligands sont
protéiques et non simplement peptidiques (Ravichandran et al., 1995). De plus, la liaison à un partenaire
contenant à la fois un motif phosphotyrosine et un motif polyproline n’a jamais été étudiée structuralement,
bien que la liaison de Grb2 à EGFR et ErbB2 in cellulo semble requérir à la fois les domaines SH2 et SH3
(Gill et al., 2017; Xie et al., 1995). De nombreuses informations sont donc nécessaires pour mieux com-
prendre l’interaction de Grb2 avec ErbB2 : l’arrangement des domaines en solution dans l’état libre, ainsi
que la structure et la dynamique des complexes Grb2-ErbB2.
Méthodes expérimentales
Production et purification des protéines recombinantes étudiées
Expression dans E. coli et purification CtErbB2 (résidus 988-1255 de ErbB2) et Grb2 (domaines SH2,
NSH3 et CSH3 respectivement isolés, bidomaines NSH3SH2 et SH2CSH3, et protéine entière) ont été pro-
duits de manière recombinante dans E. coli, selon des protocoles classiques. Selon les expériences, CtErbB2
était non marquée, marquée [U-15N] ou marquée [U-15N; U-13C], tout comme les constructions NSH3,
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SH2, CSH3 et SH2CSH3 de Grb2. Le bidomaine NSH3SH2 ainsi que Grb2 entière ont été produits mar-
qués [U-15N; U-13C; U-80% 2H].
CtErbB2 a été exprimée sous la forme d’une protéine de fusion contenant en N-terminal une étiquette his-
tidine pour faciliter la purification, suivie d’un domaine lipoyl permettant d’éviter les phénomènes d’agré-
gation et d’un site de clivage à la protéase TEV pour pouvoir obtenir la protéine sans étiquette. La protéine
finale contenait seulement quatre résidus (GSHM) supplémentaires par rapport à la séquence native. Toutes
les constructions de Grb2 ont été produites avec une étiquette histidine N-terminale suivie d’un site de cli-
vage à la TEV. Après clivage, chaque construction contenait deux résidus (GA) supplémentaires par rapport
à la séquence native des domaines correspondants.
Pour CtErbB2 comme Grb2, la purification a été effectuée par lyse à haute pression, chromatographie d’af-
finité sur colonne de nickel puis clivage à la TEV. La protéase utilisée contenait elle-même une étiquette
histidine. Une seconde chromatographie d’affinité sur nickel a permis d’éliminer la TEV, les étiquettes cli-
vées et les protéines non clivées. Une chromatographie d’exclusion stérique (SEC) finale a permis d’obtenir
des protéines d’une pureté (estimée par SDS-PAGE) supérieure à 95 %, et d’intégrité vérifiée par spec-
trométrie de masse. Pour les constructions de Grb2 dans lesquelles l’étiquette histidine a été conservée, le
protocole était le même en supprimant l’étape de clivage et la seconde chromatographie d’affinité.
Expression en cellules d’insectes La région intracellulaire entière d’ErbB2 (résidus 676-1255) a été pro-
duite en utilisant le système d’expression baculovirus Bac-to-bac R©, en suivant les recommandations du pro-
tocole fourni par Invitrogen. Ce système d’expression est basé sur l’infection de cellules d’insectes (SF9)
par un baculovirus, le gène d’intérêt ayant préalablement été inséré dans l’ADN viral par transposition de-
puis un plasmide bactérien. Le titre des stocks viraux obtenus a été déterminé par infection de cellules SF9,
reconnaissance des cellules infectées par un anticorps anti-gp64 (protéine d’enveloppe virale) fluorescent, et
détermination du pourcentage de cellules infectées par cytométrie de flux. La multiplicité d’infection (MOI,
le ratio du nombre de virus sur le nombre de cellules), et donc le titre viral initial, a pu être retrouvée en
considérant que le pourcentage de cellules effectivement infectées suit une loi de Poisson. Nous avons ob-
tenu des titres viraux usuels de l’ordre de 108 PFU/mL.
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Résonance magnétique nucléaire (RMN)
Les études par RMN de CtErbB2 ont été effectuées dans un tampon MES (40 mM MES pH 5.6, 200 mM
NaCl, 2 mM TCEP) à 298 K, majoritairement à 950 MHz pour avoir la meilleure résolution possible. Les
études de Grb2 ont été principalement effectuées dans un tampon PIPES (40 mM PIPES pH 7.2, 150 mM
NaCl, 2 mM TCEP) à 308 K, majoritairement à 600 MHz, champ auquel le plus de pics sont observables
à cause de phénomènes d’échange. Les études d’interaction par RMN ont été effectuées à 298 K dans le
tampon PIPES.
Attributions L’attribution du squelette de CtErbB2 et Grb2 a été principalement effectuée à l’aide d’expé-
riences tridimensionnelles d’attribution séquentielle basées sur les couples N-H amides. Les prolines n’ayant
pas de proton amide, des expériences de type HCAN et CON (cette dernière en détection carbone), ainsi
que le spectre HSQC du mutant Q161A, ont été utilisés pour l’attribution des régions riches en prolines
de CtErbB2. Des expériences HADAMAC (Lescop et al., 2008) ont permis le transfert de l’attribution des
HSQC 1H-15N de CtErbB2 entre différentes conditions (mutations, pH, température...). L’attribution des
chaines latérales de CtErbB2 a été effectuée grâce à des expériences H(C)C(CO)NH, (H)CC(CO)NH, HB-
HANH et HBHA(CO)NH.
Études des déplacements chimiques Les déplacements chimiques sont informatifs de l’environnement
local du noyau observé. Pour CtErbB2, ils ont été utilisés pour calculer des propensions de structures secon-
daires formées, grâce au programme SSP (Marsh et al., 2006). Pour Grb2, les structures secondaires ont été
déterminées grâce à TALOS+ (Shen et al., 2009) et comparées aux structures secondaires attendues d’après
les structures déjà publiées.
Relaxation des azotes amides du squelette Les paramètres de relaxation 15N (vitesses de relaxation lon-
gitudinale R1 et transverse R2, et effet Overhauser hétéronucléaire {1H}-15N nOe) permettent d’étudier la
dynamique des protéines dans une gamme allant de la centaine de ps ({1H}-15N nOes) à quelques ns (R1 et
R2). Les valeurs de R2 sont aussi sensibles aux phénomènes d’échange à l’échelle de la µs-ms. Ces para-
mètres ont été utilisés pour déterminer le comportement dynamique local des résidus le long de la chaîne de
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CtErbB2, ainsi que la dynamique de chaque domaine dans Grb2 entière.
Couplages scalaires Les couplages scalaires (à travers les liaisons) entre protons amides et α (3JHNHα )
donnent des informations sur les angles dièdres dans une protéine. Ils ont ici été utilisés pour différencier
des structures de type polyproline (PPII) et des structures de type brin β dans CtErbB2.
Couplages dipolaires résiduels (RDCs) Les couplages dipolaires, qui résultent en RMN d’une interac-
tion anisotrope entre spins nucléaires à travers l’espace, donnent des informations d’orientation, notamment
des liaisons N-H dans une protéine. Ils peuvent être utilisés pour obtenir des informations de structure se-
condaire ou d’orientation globale ou relative de domaines structurés. Ils sont moyennés à zéro en solution,
mais peuvent être partiellement réintroduits (on parle alors de couplages dipolaires résiduels ou RDCs) par
utilisation d’un milieu anisotrope. Ici, les RDCs de CtErbB2 ont été mesurés dans un gel d’acrylamide étiré
(Chou et al., 2001), afin de compléter les données de structures secondaires données par les déplacements
chimiques et les couplages scalaires.
Augmentation de relaxation par effet paramagnétique (PRE) Afin de compléter les données de struc-
ture locale par des informations sur les contacts à longue distance dans CtErbB2, le phénomène d’aug-
mentation de relaxation par effet paramagnétique (PRE) a été exploité : une sonde paramagnétique (ici un
nitroxide, le MTSL) est couplée à la protéine en une position choisie (une cystéine). Les signaux des atomes
proches de cette sonde dans l’espace subissent une diminution d’intensité. Ainsi, en répétant l’expérience
avec différentes cystéines (différents mutants, ici quatre permettant de coupler la sonde en position 45, 146,
227 et 248 respectivement), on peut sonder les contacts tout le long de la chaîne.
Autres méthodes biophysiques
Dichroïsme circulaire (CD) Le dichroïsme circulaire (CD) est basé sur la différence d’absorption de la
lumière polarisée circulairement droite ou gauche par une molécule chirale. En particulier, dans l’UV loin-
tain, les hélices α , feuillets β et les régions désordonnées ont des spectres CD très différents. Cela permet
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donc l’analyse du contenu en structures secondaires d’une protéine, ici CtErbB2.
Diffusion des rayons X aux petits angles (SAXS) Le SAXS permet d’obtenir des informations à basse ré-
solution en solution, typiquement sur la taille et la forme d’une macromolécule. Les paramètres qui peuvent
en être extraits sont le rayon de giration (Rg), une estimation de la masse moléculaire, ainsi qu’une courbe de
distribution des distances interatomiques. Ces paramètres, ainsi que la représentation de Kratky des données
de SAXS, sont très différents selon le degré de globularité de la protéine étudiée, et sont donc un indicateur
de repliement (Kikhney and Svergun, 2015; Receveur-Brechot and Durand, 2012). Les données expérimen-
tales de SAXS peuvent être comparées à des courbes attendues pour un modèle donné (une structure déjà
déterminée, un modèle de type polymère, etc). Nous avons utilisé le SAXS pour estimer le degré de structure
de CtErbB2, et comparer son comportement à celui d’une chaîne dite "wormlike", flexible avec une longueur
de persistance. Le SAXS a aussi été utilisé pour l’analyse de l’organisation des domaines de Grb2, et notam-
ment sa comparaison avec la structure cristallographique. Nous avons enfin utilisé le programme EOM (Tria
et al., 2015; Bernadó et al., 2007) pour affiner notre vision de l’organisation des domaines de Grb2 : nous
avons généré des ensembles de structures à partir de la structure cristallographique dans laquelle les linkers
ont été laissés flexibles, puis sélectionné des sous-ensembles récapitulant les données expérimentales. Nous
avons ainsi pu obtenir une distribution des rayons de giration des structures dans ces sous-ensembles.
Résultats
Caractérisation de CtErbB2 isolée non phosphorylée
CtErbB2 présente un haut niveau de désordre CtErbB2 est très riche en prolines (44 prolines sur 268
résidus) et est prédite, de par sa séquence, comme très majoritairement désordonnée. Sa nature désordon-
née est confirmée expérimentalement par l’absence de structure secondaire détectée par CD et sa migration
ralentie sur gel SDS-PAGE par rapport à la migration attendue de par sa masse moléculaire. De plus, l’al-
lure de sa courbe de Kratky et le bon ajustement de l’intensité de SAXS expérimentale par un modèle de
type polymère "worm-like chain" avec une longueur de persistance d’environ 7 résidus confirment la na-
ture hautement désordonnée de CtErbB2. Enfin, le spectre HSQC 1H-15N de CtErbB2 présente une très
faible dispersion des signaux dans la dimension proton, confirmant l’absence de repliement. Le caractère
désordonné de CtErbB2 a été observé par HDX-MS par Keppel et al. (2017) dans le contexte de la partie
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intracellulaire entière de ErbB2, confirmant que ce n’est pas un artefact de notre construction. Il est aussi
cohérent avec le rôle de la queue C-terminale dans la transduction du signal par ErbB2, requérant une haute
accessibilité des sites de phosphorylation et d’interaction et la possibilité d’interactions multiples et adap-
tables selon le contexte.
Structures locales transitoires de CtErbB2 Malgré les difficultés liées au grand nombre de prolines dans
CtErbB2 et à la faible dispersion des signaux, nous avons pu obtenir l’attribution de près de 99% des réso-
nances du squelette, de 93% des azotes des prolines, et de 75 et 68% des protons et carbones des chaines
latérales, respectivement. L’analyse des déplacements chimiques des carbones β et γ des prolines nous a per-
mis de montrer qu’à part deux prolines (148 et 259), les populations d’isomères cis de chacune des prolines
est inférieure à 10%. De nombreuses prolines étant précédées d’une sérine ou thréonine, une modification
de l’état d’isomérisation selon la phosphorylation de ces résidus, ou la reconnaissance de motifs pS-P ou
pT-P par des prolyl isomérases, sont envisageables. L’ensemble des déplacements chimiques le long de la
séquence nous a aussi permis, grâce à l’algorithme SSP (Marsh et al., 2006) de détecter la présence de struc-
tures secondaires transitoires, dont une hélice α proche de l’extrémité N-terminale (résidus14-22) peuplée
à environ 25% et des structures secondaires étendues de quelques acides aminés réparties tout le long de
la séquence. Ces structures étendues, dont la position est corrélée à la densité de prolines le long de la sé-
quence, ont été confirmées comme étant des hélices PPII (et non des brins β ) grâce à l’analyse des couplages
scalaires 3JHNHα . La conservation d’une haute densité de prolines dans ces régions de CtErbB2, que nous
avons constatée chez les mammifères, renforce l’hypothèse de leur importance fonctionnelle. Les valeurs
de RDCs mesurées sur CtErbB2 présentent des écarts significatifs par rapport à celles calculées pour un
ensemble conformationnel de CtErbB2 qui se comporterait comme une chaîne statistique pure, généré par
Flexible Meccano (Ozenne et al., 2012). Nous avons donc généré un ensemble conformationnel de CtErbB2
présentant des populations locales de structures secondaires issues de l’analyse des déplacements chimiques
par SSP. Les RDCs calculés pour cet ensemble sont cohérents avec les valeurs expérimentales, confirmant
la présence de ces structures secondaires.
Ces dernières sont probablement fonctionnellement importantes, notamment en tant que structures préfor-
mées pour des interactions intra- ou inter-moléculaires : l’hélice α correspond à l’hélice interagissant avec
le domaine kinase dans les structures cristallographiques de ce dernier, et est possiblement impliquée dans
la régulation de l’activité kinase selon l’état de phosphorylation de la protéine ; les hélices PPII sont des
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structures connues pour interagir avec les domaines SH3 et WW. L’une d’elle contient notamment un motif
de classe I (RxxPxxP, résidus 159-165) d’interaction avec des domaines SH3.
Dynamique locale de CtErbB2 Comme les propensions de structures secondaires, les paramètres de
relaxation des azotes du squelette le long de la chaîne de CtErbB2 sont hétérogènes. Les parties les plus dy-
namiques à l’échelle de la ns sont les extrémités de la protéine, et les régions riches en glycines. Les régions
riches en prolines, et partiellement structurées en hélices PPII, apparaissent légèrement moins flexibles, mais
proches d’un comportement d’une chaîne statistique, ce qui confirme le caractère dynamique des courtes hé-
lices PPII. Une région riche en histidines (résidus 56-61) montre elle la plus grande rigidité le long de la
chaîne (visible sur les trois paramètres de relaxation). La région de l’hélice α présente un comportement
dynamique complexe, qui ne peut pas être décrit par un temps de corrélation rotationnel unique, ce qui est
cohérent avec une structuration transitoire. Enfin, deux autres régions présentent un comportement similaire
mais ne présentent pas de structure secondaire notable : la région des résidus 23-49 et 225-244. L’origine de
cette dynamique complexe pourrait être la présence de contacts transitoires à longue distance.
Il existe un contact à longue distance transitoire dans CtErbB2 Pour vérifier cette hypothèse, et déceler
la présence de contacts longue distance dans CtErbB2, quatre expériences de PRE ont été effectuées. Elles
montrent un effet significatif et réciproque entre les régions autour des résidus 30 et 230. La présence d’un
contact transitoire est aussi suggérée par le rayon de giration mesuré par SAXS, qui est inférieur au rayon
de giration prédit en tenant compte des structures secondaires observées. Ce contact longue distance dans
CtErbB2 pourrait réguler l’accessibilité des sites de phosphorylation pour les domaines kinases du dimère
actif, ou pour les protéines adaptatrices des différentes voies de signalisation.
La figure 50 récapitule les éléments structuraux caractérisés lors de notre étude, et leurs rôles potentiels
dans les interactions intra- ou inter-moléculaires de ErbB2.
Comportement de Grb2 en solution
Stabilité du domaine NSH3 et influence de l’étiquette histidine Lors de l’attribution des spectres des
différentes constructions de Grb2, des différences ont été constatées dans les constructions contenant le do-
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maine NSH3 entre les formes avec étiquette histidine et celles où l’étiquette a été clivée à la TEV. Comme
suggéré par de précédentes études, le domaine NSH3 seul est en équilibre entre une forme repliée et une
forme dépliée. Nous avons observé que la forme dépliée est favorisée par la présence de l’étiquette histidine
dans le domaine SH3 seul. Cependant, dans le bidomaine NSH3SH2 et Grb2 entière, la forme dépliée n’est
pas visible lorsque l’étiquette histidine est présente, et apparait seulement lorsque l’étiquette est clivée. L’éti-
quette semble interagir à la fois avec le domaine NSH3 et le domaine SH2 dans ces constructions et stabilise
la forme repliée du NSH3. De manière cohérente, les paramètres de relaxation azote de Grb2 entière in-
diquent que lorsque l’étiquette est présente, les domaines NSH3 et SH2 ont une dynamique très similaire, et
distincte de celle du CSH3. Pour la suite de l’étude, la forme où l’étiquette histidine a été clivée a été utilisée.
Organisation des domaines et dynamique de Grb2 entière Le spectre HSQC 1H-15N de Grb2 entière
est quasiment parfaitement superposable à la somme des spectres des trois domaines isolés, indiquant l’ab-
sence d’interaction notable entre les domaines dans la protéine entière. Ceci est en contradiction avec la
structure cristallographique de Grb2, indiquant des contacts intramoléculaires entre les domaines NSH3 et
CSH3, et intermoléculaires entre les domaines SH2 et CSH3 (dans le dimère). De plus, le comportement
dynamique de Grb2, déterminé par les paramètres de relaxation 15N, est différent de celui de la protéine avec
étiquette, et n’indique pas de mouvement corrélé entre les différents domaines. De plus, ces paramètres de
relaxation indiquent un monomère majoritaire en solution. Le comportement de Grb2 libre en solution est
donc similaire à ce qui a précédemment été observé pour Grb2 en présence de ligands peptidiques d’EGFR
et de Sos (Yuzawa et al., 2001).
Afin de confirmer cette interprétation, nous avons utilisé le SAXS, suivant directement une colonne SEC
pour s’assurer de la monodispersité des échantillons, notamment en termes d’état oligomérique (Pérez and
Vachette, 2017). Le bidomaine NSH3SH2 génère deux pics en SEC, indiquant la présence d’un dimère.
L’analyse SAXS du pic correspondant au monomère indique que sa courbe SAXS est compatible avec
la structure du bidomaine dans la structure cristallographique de Grb2 entière. À l’inverse, le bidomaine
SH2CSH3 est très majoritairement monomérique, et la comparaison avec la courbe de SAXS prédite à par-
tir de la structure cristallographique montre des divergences. En utilisant EOM et en définissant le linker
SH2-CSH3 comme flexible, nous avons montré que les données de SAXS ne sont reproduites qu’en consi-
dérant plusieurs populations de Rg différents, certains plus petits et d’autres plus grands que celui de la
structure cristallographique. La courbe SAXS de Grb2 entière n’est pas non plus compatible avec la struc-
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ture cristallographique, et son ajustement nécessite de prendre en compte des populations de même Rg que
la structure cristallographique, mais aussi des structures de plus grand Rg.
Nous avons donc défini un nouveau modèle, dans lequel Grb2 est monomérique, et ses trois domaines ne
sont pas en interaction. Ce modèle est donné en figure 60. Une flexibilité plus grande du linker entre le
domaine SH2 et le domaine CSH3 par rapport au linker entre les domaines NSH3 et SH2 est observée. Ce
comportement asymétrique, tout en conservant une relative indépendance structurale et dynamique des trois
domaines de Grb2, pourrait avoir des conséquences dans les interactions et la transduction du signal.
Interaction entre CtErbB2 et Grb2
Dans le modèle actuel de l’interaction ErbB2-Grb2, le domaine SH2 de Grb2 interagit avec la tyrosine YB
de ErbB2 phosphorylée. Cette interaction n’a jamais été étudiée à haute résolution. De plus, nous avons
montré que CtErbB2 contient des hélices PPII transitoirement formées et des motifs PxxP, avec lesquels les
domaines SH3 de Grb2 pourraient interagir. Nous avons donc effectué l’étude de l’interaction entre Grb2
entière et CtErbB2 par RMN.
Interaction entre Grb2 et CtErbB2 non phosphorylée Nous avons d’abord étudié l’interaction entre
Grb2 et CtErbB2 non phosphorylée. L’interaction est faible, mais les perturbations de déplacement chi-
mique et d’intensité des signaux lors des expériences de titrage ont permis de mettre en évidence des zones
d’interaction spécifiques. La plus affectée est celle contenant la tyrosine YB (résidu 152), ainsi qu’un seg-
ment riche en prolines 159RPQPPSPR165. Ce segment contient deux motifs PxxP susceptibles d’interagir
avec des domaines SH3, et notamment un motif de classe I (RxxPxxP). Du côté de Grb2, le domaine NSH3
est le plus perturbé par l’interaction, au niveau du site connu de liaison à des peptides polyprolines, et
quelques résidus du domaine SH2 sont impliqués. Ces résidus correspondent à la poche du SH2 liant non
pas les phosphotyrosines, mais l’asparagine en position +2 conférant la spécificité pour Grb2. Cette aspara-
gine est bien présente dans le motif contenant YB. Le domaine CSH3 n’est que peu perturbé par l’interaction.
Interaction entre Grb2 et des peptides de CtErbB2 non phosphorylés ou phosphorylés Pour aller
plus loin dans la caractérisation de l’interaction, et en parallèle de l’optimisation de la phosphorylation des
tyrosines dans CtErbB2 entière, nous nous sommes concentrées sur l’interaction de Grb2 avec des peptides
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synthétiques de CtErbB2 contenant YB et le segment riche en prolines (résidus 141 à 176). L’interaction de
Grb2 avec la forme non phosphorylée de ce peptide est similaire à celle observée avec CtErbB2 entière non
phosphorylée. Elle implique majoritairement le site de liaison du domaine NSH3, avec une affinité faible
(une constante de dissociation KD de l’ordre de la centaine de micromolaire au millimolaire). L’échange
entre la forme libre et liée de ce domaine est rapide à l’échelle des déplacements chimiques. Lorsque la
tyrosine B du peptide de CtErbB2 est phosphorylée, la perturbation du domaine NSH3 de Grb2 est inchan-
gée (en termes de vitesse d’échange et d’affinité). Cependant, la phosphorylation de la tyrosine permet le
recrutement du domaine SH2 pour une interaction de plus grande affinité. L’échange de ce domaine entre la
forme libre et liée est lent à l’échelle des déplacements chimiques, et avec un KD plus faible que le NSH3,
de l’ordre du micromolaire. Les résidus du SH2 impliqués dans l’interaction sont ceux du site de fixation de
la phosphotyrosine et du site de reconnaissance de l’asparagine.
Conséquences fonctionnelles possibles L’implication de deux domaines de Grb2 dans l’interaction avec
CtErbB2 change notre vision de la transduction du signal par cette protéine adaptatrice, comme présenté
en figure 66. La spécificité du motif riche en proline de CtErbB2 pour le domaine NSH3 de Grb2 suggère
une possible compétition pour la liaison de Grb2 avec Sos. L’interaction simultanée SH2-pY et NSH3-PxxP
nécessiterait un rapprochement des domaines NSH3 et SH2 dans la forme liée en comparaison avec la forme
libre, et l’organisation des domaines de Grb2 dans le complexe serait donc intéressante à étudier.
Du côté de ErbB2, mieux comprendre le mécanisme de liaison de CtErbB2 à Grb2 nécessite d’obtenir et
d’étudier CtErbB2 phosphorylée. C’est un travail en cours, dont les enjeux, les défis et les méthodes ont été
étudiés pendant ce travail de thèse.
Vers la caractérisation d’états fonctionnels de CtErbB2 : le défi des études structurales et
fonctionnelles de la phosphorylation de tyrosines
La phosphorylation des tyrosines comme mécanisme de régulation dans la cellule a été découverte plus de
vingt ans après celle des sérines et thréonines (Burnett and Kennedy, 1954; Eckhart et al., 1979). Les phos-
photyrosines (pY) sont très largement moins abondantes que les phosphosérines (pS) et phosphothréonines
(pT) à l’échelle d’un organisme (Hunter and Sefton, 1980). Les mécanismes moléculaires de phosphoryla-
tion des tyrosines sont souvent complexes, la majorité des tyrosine kinases étant des RTKs (Manning, 2002)
requérant des phénomènes d’autophosphorylation. Leur étude est donc relativement récente et peu docu-
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mentée.
Le défi de la détection des sites de phosphorylation La détection par des anticorps est longue, et ne
permet pas un suivi en temps réel. La spectrométrie de masse est très employée, mais pose plusieurs pro-
blèmes : la faible sensibilité de détection des espèces phosphorylée (Thingholm et al., 2009), et la difficulté
de résolution du site de phosphorylation, notamment lorsque la protéine est riche en prolines empêchant le
clivage protéolytique complet, ou lorsque des séquences sont répétées, comme c’est le cas pour CtErbB2. La
RMN est une technique adaptée, et déjà utilisée dans plusieurs études de phosphorylation de sérines et/ou
théronines (Selenko et al., 2008; Liokatis et al., 2010; Theillet et al., 2012; Cordier et al., 2012, 2015; Lan-
drieu et al., 2006; Sólyom et al., 2015). Elle permet un suivi cinétique et une résolution précise des sites de
phosphorylation. Cependant, pour l’étude des tyrosines phosphorylées (particulièrement dans les protéines
désordonnées), des problèmes de superposition des signaux se posent plus fréquemment que pour les sérines
et thréonines. Plusieurs méthodes nécessitent donc d’être utilisées en parallèle.
Produire des échantillons de protéine phosphorylée pour des études structurales La production d’échan-
tillons de protéines phosphorylées est aussi un défi majeur. Plusieurs techniques d’incorporation d’acides
aminés phosphorylés à des positions choisies existent (phosphomimétiques, synthèse chimique, acides ami-
nés non-naturels). Cependant, elles ne fournissent pas le(s) motif(s) de phosphorylation biologiquement
pertinents. D’autres méthodes permettent de s’en approcher, en phosphorylant la protéine d’intérêt (in vivo
ou in vitro) directement par une kinase (idéalement, la kinase endogène). Dans notre cas, le système le plus
pertinent serait la reconstitution de dimères d’ErbBs, dans lesquels la phosphorylation a lieu in vivo.
Stratégies mises en place dans le cadre de ces travaux Ici nous avons choisi de développer trois ap-
proches, répondant à différentes questions sur la phosphorylation d’ErbB2 :
• La coexpression de CtErbB2 avec une tyrosine kinase dans E. coli, en utilisant une souche commer-
ciale (TKB1, Agilent). Cette approche permet de produire, avec un protocole a priori relativement
classique et permettant un marquage isotopique, des quantités de protéine phosphorylée suffisantes
pour des études RMN complètes de l’état phosphorylé de CtErbB2. Cependant, le motif de phos-
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phorylation engendré n’est pas contrôlé ni connu car la kinase coexprimée n’est pas indiquée. Le
peu d’informations données par le fournisseur sur la souche rend aussi l’optimisation du protocole
difficile. Pour l’instant, nous avons réussi à obtenir un échantillon phosphorylé non isotopiquement
marqué et l’optimisation de la production en milieu marqué est en cours.
• La phosphorylation in vitro de CtErbB2 par la kinase ErbB2 (Life technologies). La phosphorylation
peut ainsi être suivie en temps réel dans le tube RMN, avec une spécificité de séquence de la kinase
respectée, mais sans la spécificité due à la topologie des dimères dans lesquels ont lieu la phosphory-
lation in vivo. Des problèmes ont été rencontrés, dus à la faible efficacité catalytique de la kinase, et
sa contamination constatée par une sérine/thréonine kinase.
• La production en cellules d’insectes de la partie intracellulaire entière du récepteur ErbB2. Cette
approche permettrait à la fois d’étudier le comportement de la queue C-terminale attachée au domaine
kinase, et son auto-phosphorylation dans un contexte relativement proche du contexte biologique. En
utilisant le système baculovirus Bac-to-Bac R©, nous avons réussi à exprimer la portion intracellulaire
d’ErbB2. La production à grande échelle pour la RMN et le marquage isotopique restent à réaliser.
Ces trois approches ont pour inconvénient de produire des protéines avec des motifs de phosphorylation a
priori complexes et hétérogènes. Une approche serait de phosphoryler des sites uniques pour commencer
par l’étude de l’effet des phosphorylations individuelles. Dans ce but, des mutants monotyrosines, dans les-
quels toutes les tyrosines ont été mutées en phénylalanine sauf une, ont été produits. La phénylalanine a été
choisie pour sa ressemblance structurale avec la tyrosine, combinée à l’impossibilité de sa phosphorylation
due à l’absence du groupe hydroxyle. Nous avons effectué l’étude RMN du mutant où toutes les tyrosines
ont été remplacées par des phénylalanines, et montré que ces mutations ne perturbent pas significativement
le comportement de CtErbB2, validant cette approche. Elle nous permettra d’étudier notamment trois phos-
phorylations intéressantes, en s’appuyant sur l’étude de Dankort et al. (1997) : la phosphorylation de YA,
qui a été montrée comme inhibant la signalisation, la phosphorylation de YB, cruciale pour l’interaction
avec Grb2, et celle de YD, qui peut lever l’inhibition due à YA . La phosphorylation de YA et YD pourrait
aussi modifier le contact longue distance entre ces deux régions que nous avons mis en évidence grâce aux
expériences de PRE.
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Résumé en français
Conclusions et perspectives
Nous avons caractérisé en termes structuraux et dynamiques l’ensemble conformationnel de CtErbB2, et
l’organisation des domaines de son partenaire Grb2. Nous avons aussi montré que l’interaction entre ces
deux protéines met en jeu deux interactions locales : celle du domaine SH2 de Grb2 avec la tyrosine B
phosphorylée de CtErbB2 et celle entre le domaine NSH3 de Grb2 et un motif polyproline de CtErbB2.
La caractérisation structurale et dynamique complète des deux partenaires en complexe reste à effectuer,
afin de déterminer notamment si et comment CtErbB2 se structure en interaction, et si l’organisation et
la dynamique inter-domaine de Grb2 est modifiée. De plus, l’étude de l’effet du domaine kinase et de la
phosphorylation sur CtErbB2 et ses interactions est fondamentale dans le but de comprendre ses mécanismes
fonctionnels. Cette étude, avec notamment la production du domaine intracellulaire entier de ErbB2 pour
la RMN, est en cours. Ces travaux sont un élément de plus vers la compréhension du comportement des
protéines et régions intrinsèquement désordonnées et de leurs rôles.
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INTRODUCTION
Intrinsically disordered proteins (IDPs) or regions (IDRs), that lack stable three-dimensional structure, have
attracted much attention in the last twenty years. Previously often considered as artefacts or thought to have
no physiological function, these proteins are now known to be widely spread in all organisms and especially
eukaryotes (Ward et al., 2004), and to be involved in crucial processes in the cell. In particular, a high
proportion of disorder is observed in signaling and regulatory pathways (Iakoucheva et al., 2002). Addition-
ally, many post-translational modifications, and especially phosphorylation, occur preferably in disordered
regions (Iakoucheva et al., 2004). Disordered regions are often found in receptors (Minezaki et al., 2007;
Kjaergaard and Kragelund, 2017), and serve as linkers between folded domains and/or the membrane, reg-
ulatory domains, localization signals, hubs for signaling protein-protein interaction or post-translational
modification platforms, or a combination of these roles (Kjaergaard and Kragelund, 2017). The C-terminal
tail of the ErbB2, further noted CtErbB2 in the manuscript, is a good example of the role of such regions,
and a typical illustration of how disordered regions have often been overlooked in mechanistic studies. With
recognition of IDPs prevalence, the emergence of new associated concepts, and the development of cus-
tomized experimental methods, especially in nuclear magnetic resonance (NMR), neglecting them is no
longer conceivable.
ErbB2, also called HER2 (Human epidermal growth factor receptor 2) or neu, is part of the ErbB family of
receptor tyrosine kinases that contains four members. The first member of this family to be discovered, the
epidermal growth factor receptor (EGFR or ErbB1), is the most studied one and represents a model to under-
stand how the ErbBs transduct signal from the extracellular space to signaling pathways. ErbB-dependent
pathways are critical for cell division, motility and differentiation, and control of apoptosis. They include the
Ras/MAPK pathway, the MEMO-RhoA-mDia1 pathway, the Akt/PI3K pathway, the STAT pathway, and the
Src kinase pathway (Yarden and Sliwkowski, 2001; Marone et al., 2004). The studies carried out on EGFR
led to the following model of the mode of action of ErbBs (Kovacs et al., 2015b): ligand binding triggers
a conformational change in the extracellular domain, enabling homo- or hetero- dimerization of the recep-
tors, and dimerization-induced activation of their intracellular tyrosine kinase domain (TKD). This domain
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is then able to phosphorylate the C-terminal tail of the receptors, assumed to be a trans-phosphorylation.
The tyrosine-phosphorylation of the C-terminal tails triggers interaction with adaptor proteins, activating
the corresponding signaling pathways. This well-established model has two issues: it does not take into
account the specificities of each ErbB, and lacks a description of the C-terminal tail and its mechanisms of
interaction with the kinase domain(s) for phosphorylation and with the adaptor proteins for signal transduc-
tion.
In the case of ErbB2, no biologically relevant ligand has been identified for the extracellular domain, that
has been found only in a dimerization-potent conformation (Cho et al., 2003). Physiologically, ErbB2 has
been shown to be the preferred hetero-dimerization partner of other ErbBs (Graus-Porta et al., 1997). Patho-
logically, overexpression of ErbB2 is observed in more than 20% of breast cancers, and this HER2 + form of
the disease is very aggressive (Slamon et al., 1987). The mechanism of kinase activation is believed to be, as
for EGFR, only dimerization-dependent (Aertgeerts et al., 2011). Thus, no regulation mechanism other than
receptor concentration seems to exist upstream of phosphorylation itself. Regulation of the phosphorylation
and interactions of the C-terminal tail, which is the end of the chain before transducting signal to partners, is
key. The absence of crystal structure for this region has led to the assumption of its lack of a stable structure,
which is consistent with measurement of dynamics of this region, and observation of delayed electrophoretic
migration. Very recently, its has finally been proven that the tail of EGFR and ErbB3 receptors is indeed
disordered (Keppel et al., 2017). However, no residue-resolved information is accessible yet. At the begin-
ning of this work, CtErbB2 was known to have several functions usually associated with structural disorder:
it is a highly-phosphorylated region, and accessibility of these sites is crucial; it is an interaction hub for
signaling, which requires plasticity and adaptability; it is believed to participate in regulation of the kinase
domain, once again requiring adaptability. CtErbB2 is thus both an interesting model system to study the
emerging "disorder-function" paradigm, and a potential target in the context of breast cancer.
To go further into this functional investigation, we chose to study the interaction between CtErbB2 and the
adaptor protein Grb2. Grb2 is the link between ErbB receptors and the Ras/MAPK pathway that had been
missing until the study by Lowenstein et al. (1992) and is crucial for both ErbB2 physiological and patho-
logical roles. Grb2 is made of a central SH2 domain, and two terminal SH3 domains (named NSH3 at the
N-terminus and CSH3 at the C-terminus). It has been shown to bind specifically to one tyrosine of CtErbB2
(numbered Y1139 in full-length ErbB2, Y152 in the tail, and often designated as YB for being the second
auto-phosphorylation site in the tail) (Dankort et al., 1997). The sequence around this tyrosine matches the
determined sequence specificity of the SH2 domain of Grb2 (Marengere et al., 1994), but no atomic model
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of the binding exists. Besides, Grb2 SH3 domains could be involved in the CtErbB2-Grb2 interaction, since
SH3 domains are known to interact with polyproline motifs, and that CtErbB2 is proline-rich. Grb2 is thus
an interesting partner to study CtErbB2 binding modes.
Finally, the phosphorylation itself of CtErbB2 tyrosines is interesting to understand phosphorylation of IDPs.
This system has several specificities that make the study of its phosphorylation both unique and challenging:
it happens on tyrosines, and tyrosine phosphorylation remains poorly characterized compared to serines and
threonines; there are at least 5 phosphorylation sites (Hazan et al., 1990; Segatto et al., 1990), distributed
heterogeneously along CtErbB2 chain, leading to expected heterogeneous phosphorylation patterns; and
the endogenous phosphorylation mechanism is not trivial, since it is autophosphorylation: phosphorylation
happens in the context of ErbB dimers, with the ErbB kinases phosphorylating the tails, in a mechanism that
has never really been elucidated and happens in trans (Qian et al., 1994), but potentially also in cis.
In this PhD work, I studied CtErbB2 both from the structural and functional points of view.
In the first chapter, I describe the context of this study. Section 1 is dedicated to understanding the specific
questions arising from the study of intrinsically disordered proteins, from their sequence to their structural
features and functional specificities, and ways to study them. In section 2, I present interest of studying the
ErbB family of proteins, and why understanding the mechanism of signal transduction in their C-terminal
tail, in particular in ErbB2, is necessary. Finally, section 3 is dedicated to CtErbB2 partner Grb2.
The second chapter presents the experimental approaches used to study this system: from production and
purification of the studied proteins (section 4), to the NMR experiments (section 5) and complementary
characterization techniques (section 6) used.
The third chapter presents the results of this study. In section 7, the unphosphorylated form of CtErbB2 is
described in terms of structure and dynamics, at atomic resolution, and I show how the results can yield
information relevant for ErbB2 function. In section 8, I present the study of Grb2 alone, and how the results
allow a better understand of how it can perform its function as a modular protein. Section 9 is devoted
to the analysis of the interaction between Grb2 and CtErbB2, showing SH2-tyrosine and SH3-polyproline
components. Finally, section 10 presents methods that I implemented to produce and study phosphorylated
samples of CtErbB2, and preliminary results.
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CONTEXT OF THIS WORK
1 Intrinsically disordered proteins (IDPs)
1.1 Discovery and assessment of biological relevance of IDPs
Intrinsically disordered proteins (IDPs) are proteins that lack stable three-dimensional structure under physi-
ological conditions. The idea that these proteins are functional and widely spread in life was slow to emerge,
for it deeply challenged the structure-function paradigm.
1.1.1 Historical perspective
Since Emil Fisher and the concept of "lock and key" established in 1894 (Fischer, 1894), the idea that speci-
ficity of interactions (and therefore function) emerged from complementarity of well-defined, unique con-
formation of the partners had governed structural biology. It was reinforced while the number of elucidated
structures grew from the one of myoglobin, solved by Kendrew et al. (1958), to nearly 11,000 structures at
the end of the XXth century in the Protein Data Bank (PDB). In the 50s, the importance of flexibility was
acknowledged in a few studies, such as the study of "configurational adaptability" of bovine serum albu-
min by Karush (1950), and the one by Koshland and Brooks (1958) introducing the concept of "induced
fit", but the importance of interdomain motion was not deeply investigated before the 60s and 70s (Monod
et al., 1965; Koshland et al., 1966). The concept of intrinsic disorder, and the recognition of its functional
importance, was only possible with the combination of experimental evidence, such as the observation of
missing electron density in a large amount of crystal structures, or high sensitivity to proteases, and bioinfor-
matics predicting high levels of disorder in protein sequences derived from high-throughput sequencing of
genomes. This global shift in paradigm was really initiated at the end of the 90s, with the study by Romero
et al. (1998) predicting that over 15,000 proteins of the SwissProt database have disordered segments of
more than 40 residues, and the insightful review by Wright and Dyson (1999) asserting functionality of
disorder: "The high proportion of these sequences in the genomes of all organisms studied to date argues for
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important, as yet unknown functions, since there could be no other reason for their persistence throughout
evolution.". This argument can be nuanced by the fact that statistically, protein sequences should be biased
towards disorder rather than stable structure, and that in that sense we should rather wonder why structured
proteins have been selected by evolution. But given the paradigm at that time, this was a bold statement.
Since then, the importance of disorder in all kingdoms of life has been further assessed: in 2004, 2.0% of
archaean, 4.2% of eubacterial and 33.0% of eukaryotic proteins were predicted to have disordered segments
of more than 30 residues (Ward et al., 2004), and as of 2013, a proportion as high as 44% is predicted for
human proteins (Oates et al., 2013).
1.1.2 Current questions and challenges
One of the remaining questions concerning the relevance of IDPs was to know to what extent structural
disorder could persist in the crowded intracellular environment. The effect of molecular crowding on fold-
ing or unfolding is complex, difficult to predict, and crowding can have multiple outcomes (Fonin et al.,
2018). Although the number of proteins which behavior has been studied in cell is still limited, molecular
simulations, in-cell NMR, fluorescence studies and Fourier transform infrared spectroscopy have begun to
unveil details of the life of IDPs in such environment, and showed that prokaryotic and eukaryotic cells can
preserve high levels of disorder (Theillet et al., 2014, 2016).
The study of intrinsic disorder is still a developing field, with new systems investigated regularly and con-
tinuous methodological development. Latest reviews mainly focus on methodological aspects: NMR stud-
ies, with focus on in-cell studies (Milles et al., 2018; Sciolino et al., 2019), single-molecule fluorescence
(Leblanc et al., 2018; Nasir et al., 2019), Small-angle X-ray scattering (Cordeiro et al., 2017) and simu-
lations (Huang and MacKerell, 2018; Bhattacharya and Lin, 2019). There is also emerging interest into
applying recently acquired knowledge on IDPs to drug development (Metallo, 2010; Uversky, 2010; Mar-
tinez et al., 2017; Kumar et al., 2017; Ruan et al., 2019).
With this paradigm shift, many systems can be looked at with new eyes. While disordered proteins that
were ignored for a long time are now being deeply studied as model systems, such as α-synuclein or tau,
interest is also growing for disordered parts of structured proteins that have been long disregarded, and for
which atomic-scale description was not considered relevant for mechanistic studies. That is the case for the
terminal tails of receptors such as ErbBs.
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1.2 Diversity of disordered states
Proteins are not either ordered or disordered. A way of describing the diversity of their states is to classify
functional proteins into four major thermodynamic states (Uversky, 2002), any of which possibly being
native. In this Protein Quartet model shown in figure 1a, extended from the Protein Trinity model of Dunker
et al. (2001), "function aris[es] from four specific conformations (ordered forms, molten globules, pre-
molten globules, and random coils) and transitions between any two of the states". While random coils
possess very few to no secondary or tertiary structures, pre-molten globules are a little more compact and
contain residual secondary structures. Secondary structure content and compactness increases even further
in molten globules, and are maximum in the ordered state.
The Protein Quartet is still a simplified view. While proteins that lack both secondary and tertiary structure
all along their sequence represent one extreme case, globular proteins another, (pre-)molten globules are
intermediate states on a spectrum that can be defined as the "continuum of disorder", with different lengths
of intrinsically disordered regions (IDRs) and different levels of flexibility/residual secondary or tertiary
structure in these regions (Uversky et al., 2005; Dyson and Wright, 2005). This continuum and different
states along it are presented in figure 1b.
(a)
(b)
Figure 1 – Depiction of the diversity of disordered states. (a) Model of the Protein Quartet, described by Uversky
(2002). Figure from Van Der Lee et al. (2014). (b) Continuum of disorder, from globular proteins to IDPs. From
Habchi et al. (2014)
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1.3 The sequence-(dis)order relationship
1.3.1 Origin of disorder: composition bias in IDPs
Anfinsen’s dogma (Anfinsen, 1973), stating that the structure of a protein is determined by its amino acid
sequence, can be easily extended to disordered proteins. Folding being mainly driven by the formation
of a hydrophobic core, depletion in hydrophobic and aromatic residues is often the main characteristic of
IDPs. They are instead enriched in polar and charged residues, as well as in secondary-structure disrupting
residues (proline, and to a less extent glycine and alanine). The composition bias of IDPs is shown in
figure 2, together with the resulting distinct area sampled by structured and disordered proteins in a Charge-
Hydropathy plot.
(a)
(b)
Figure 2 – Amino-acid composition features of intrinsically disordered proteins. From Habchi et al. (2014) (a) Bias
of amino acid frequence in IDPs compared to globular proteins. (b) Mean net charge plotted against hydropathy for
IDPs (red) and folded proteins (blue).
Consequently, IDPs are characterized by the absence of collapse (random coils), or by a non-specific,
dynamic collapse (disordered globules).
Although repetitive sequences are not restricted to disordered proteins (for example collagen has Gly-X-X,
and especially Gly-Pro-Hyp repeats, where Hyp is hydroxyproline), it is a characteristic often found in IDPs,
which in addition to their overall composition bias, tend to have low sequence diversity.
Let us have a closer look at the role of prolines, that have a particular role in protein order, disorder, and
dynamics, and that are enriched in CtErbB2.
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1.3.2 The unique role of prolines in disorder
This natural amino acid is unique, for its cyclic side-chain, covalently bound to the backbone nitrogen, re-
stricts its dihedral φ angle, and because it has no amide proton to act as a H-bond donor. These features
often exclude prolines from the core of canonical secondary structures, namely α helices and β sheets, and
explains the high abundance of prolines in disordered proteins as seen in figure 2a.
Another interesting feature of prolines is the relatively high proportion of cis isomer of the X-Pro peptide
bond: 5 to 80% of the cis isomer in short model peptides and up to 10% in unfolded polypeptides or proteins,
exchanging with the trans isomer; in most folded proteins either the cis or trans isomer is populated due to
constraints (Alderson et al., 2018). The exchange between the cis and trans isomers in short peptides is slow
(hundreds to thousands of s) (Reimer et al., 1998). However, in vivo the process can be catalyzed by prolyl
isomerases, leading to an acceleration by several orders of magnitude. An interesting thing to note is that
the important Pin1 isomerase is specific to pSP and pTP motifs (Ranganathan et al., 1997), and that many
Ser/Thr kinases recognize SP or TP motifs, showing an important interplay between prolyl isomerisation
and phosphorylation (Lu et al., 2002).
Despite their enrichment in IDPs and IDRs, prolines have the ability to form specific kinds of structures,
namely polyproline helices, PPI and PPII. While the right-handed PPI helices are only populated in some
organic solvents (often aliphatic alcohols) and require all-cis peptide bonds, all trans PPII helices are quite
abundant in aqueous solvents. PPII helices are left-handed, extended triangular structures of 3 residues per
turn and 3.1 Å rise per residue (Mansiaux et al., 2011), as shown in figure 3a. About 5% of protein residues
are estimated to adopt PPII conformation (not only prolines), but this number might be underestimated
(Mansiaux et al., 2011). Indeed, PPII helices are not always taken into account in structural analyses, and
their extended nature and dihedral angles (φ , ψ) of (-78◦, -149◦) can lead to confusion with β strands (see
figure 3b). They are abundant in disordered proteins, especially (although not exclusively) in proline-rich
ones (Mansiaux et al., 2011). No intra-helix hydrogen bonding is observed in PPII helices, consistent with
their enrichment in prolines. This makes PPII helices good H-acceptors from the solvent or partners, and
frequent interaction motifs, with SH3 or WW domains, or with DNA.
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(a)
(b)
Figure 3 – Polyproline II (PPII) helices. (a) PPII structure, from the top (left) or side (right). (b) Ramachandran plot
showing the region defining PPII helices, close from β sheets. From Narwani et al. (2017).
1.3.3 Predicting disorder
These sequence specificities imply that disorder is, in most cases, rather easy to predict directly from se-
quence (with the Charge-Hydropathy plot introduced by Uversky et al. (2000) and the Hydrophobic Cluster
Analysis developed by Gaboriaud et al. (1987) for example). However, most methods (PONDR R©, found at
www.pondr.com/, DisEMBL (Linding et al., 2003), found at http://dis.embl.de/, DISOPRED (Ward
et al., 2004), found at http://bioinf.cs.ucl.ac.uk/disopred) are now indirect, and use machine
learning, relying on experimental IDPs databases (the largest one being DisProt http://www.disprot.
org, with 803 proteins and 2167 protein regions as of April 8th 2019). IUPRED (Dosztányi et al., 2005;
Mészáros et al., 2018) (https://iupred2a.elte.hu/) is an combined method, using energy calculations
based on contacts in the sequence predicted from databases of contacts in globular proteins. Each predictor
performs differently depending on the characteristics of the considered protein (length, sequence composi-
tion...). The use of these predictors can help to design constructs of proteins, and to orient the choice towards
the structural biology technique(s) that seem most powerful to study them (see section 1.5).
1.4 Functional specificities
IDPs perform a wide range of functions. Their adaptability often allows a single IDP to have multiple, in-
dependent functions; a phenomenon called moonlighting. A redefinition of the structure-function paradigm
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has been proposed over time (Dunker et al., 2001; Uversky, 2017a) to include the disorder-function rela-
tionship and the role of exchange between order and disorder, and is given in figure 4. IDPs are enriched
in some functional mechanisms: molecular assembly, molecular recognition, protein modification and en-
tropic chain functions (Uversky, 2017a). Except when their role relies only on dynamics (entropic chains,
flexible linkers), the functional specificities of IDPs mainly rely on the way they interact with partners, that
is fundamentally different from the canonical lock and key model, and is closer to an intermolecular folding
process.
Figure 4 – The structure/disorder-function paradigm, developed by Dunker et al. (2001). Function can arise from
order, disorder, or exchange processes between those states. Figure from Brucale et al. (2014).
1.4.1 Interaction modes of IDPs
Contrary to structured proteins, where the interaction site is usually defined by a surface, interaction of IDPs
is mediated by short linear motifs (SLiMs) of around 3 to 10 residues, and/or by longer segments that adopt
a secondary structure when bound and are called molecular recognition features (MoRFs) (Oldfield et al.,
2005; Van Der Lee et al., 2014). SLiMs can be recognized for cleavage, post-translational modification, or
as ligands to other, usually structured, proteins. They can be, and often are, embedded in MoRFs.
Hereafter is presented mainly the mechanism of binding of IDPs to structured partners. However, IDP/IDP
interactions exist, for example mediated by strong electrostatic interactions (Borgia et al., 2017), or weak
multiple binding that can lead to liquid-liquid phase transition (Uversky, 2017b).
Coupled folding and binding of IDPs Several types of complexes can be formed by the interaction of
IDPs with their target: the best described one so far is when the interaction site of the IDP, then classified as
a MoRF, folds upon binding (Wright and Dyson, 2009). MoRFs can form any type of secondary structure
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(α-helices, β -sheets, polyproline helices, or even turns). The most commonly found one is the α-MoRF
(Oldfield et al., 2005), since formation of α-helices only requires local interactions, as opposed to β -strands.
MoRFs can either be recognized via conformational selection amongst different conformations preexisting
in the free IDP, or "fold upon binding" (induced fit mechanism), as illustrated in figure 5. Examples of
both processes have been found: while the binding of the IDP PUMA to Mcl-1 is independent on residual
structure in the free state (Rogers et al., 2014), indicating an induced fit, the unbound state of PDEγ exhibits
transiently formed structure resembling its bound state to transducin (Song et al., 2008). However, for many
IDPs, the actual mechanism is a complex mix between these extreme cases (Dogan et al., 2014).
Figure 5 – Schematic representation of the two extreme coupled folding and binding mechanisms. From Wright and
Dyson (2009).
Multiplicity of binding and flexibility in the complex IDP binding offers an additional level of com-
plexity, in a much more common way than globular proteins: multiplicity of binding. Thanks to the relative
independence of multiple interaction sites allowed by flexibility, and to the transient nature of most IDP com-
plexes, IDPs can have a great number of different partners, either simultaneously on different sites, or succes-
sively on one particular site. For example, the CREB-binding protein CBP, can bind different proteins (p160
or IRF3) on the same site, adopting different structures (Waters et al., 2006; Qin et al., 2005). Conversely, a
single structured partner can interact simultaneously with different sites of the IDP, creating a phenomenon
of avidity, and different sites of an IDP can compete for a same interaction site of the partner, a phenomenon
called allovalency that increases overall affinity (Olsen et al., 2017). In the extreme case, multiple sites on
both the IDP and its partner, where the pairwise interactions are not highly specific, lead to a highly dynamic
complex where the IDP remains widely disordered: this is called a "fuzzy complex" (Tompa and Fuxreiter,
2008). A database of fuzzy complexes can now be found at http://protdyn-database.org/ (Miskei
et al., 2017). The different possibilities of binding multiplicity between an IDP and a structured partner are
schematically represented in figure 6.
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Figure 6 – Different binding mechanisms of one IDP to one globular partner. (a) Two-state model, involving one site
on each partner. (b) Avidity, with two specific sites on each partner. (c) Allovalency, with multiple sites of the IDP
competing for a single site of the globular partner. (d) Fuzzy complex, with multiple sites on both partners, without
strong pairwise specificity. From Olsen et al. (2017).
Extension of the concept of allostery Allostery is defined as the regulation of activity at one site of a
protein by binding of a ligand at another, remote, site. The concept of allostery was originally described by
Monod, Jacob and Changeux in the context of a frozen structural description of proteins (Monod and Jacob,
1961; Changeux, 1961; Monod et al., 1965). It was thus restricted to structural changes, and the dynamics
underlying the transition between states was not the focus. Recent works on redefinition of the concept of
allostery, taking into account disorder and dynamics, have led to a more comprehensive view. Allostery can
be defined as ligand-binding triggering changes in the conformational ensemble of the protein, including
not only structural but also dynamic changes (Motlagh et al., 2014; Tompa, 2014; Berlow et al., 2018). New
forms of allostery that are regrouped under the concepts of "ensemble allostery" (Motlagh et al., 2014) or
"multistery" (Tompa, 2014) are presented in figure 7 and can include transitions between relatively rigid
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states, modification of side-chain and/or backbone dynamics of folded domains, local folding or unfolding,
or dynamic coupling between regions of IDPs.
(a)
(b)
Figure 7 – Extension of the concept of allostery (a) taking into account different amounts of dynamics and disorder
induced by ligand binding (Motlagh et al., 2014) and (b) taking into account different disorder-based mechanisms
(Tompa, 2014).
Thermodynamics and kinetics of IDP binding In many cases, IDP binding to their partner is highly
specific, but with a relatively low affinity (high dissociation constant KD, in the order of µM or higher)
(Zhou, 2012). Low affinity of IDPs is often attributed to the entropy cost of folding upon binding. Relatively
high association rates are achieved through the so-called "fly-casting" mechanism, using the great capture
radius allowed by flexibility, and thanks to adaptability of IDPs that reduces the need for "correct" orientation
of the partners to bind. This leads to an increased number of "productive" encounter complexes, effectively
leading to the formation of the final complex (Huang and Liu, 2009). Even in the case of coupled folding
and binding, binding is often not drastically slowed down by folding, thanks to preformed structure in the
free form.
For structured proteins, specificity is often associated to high affinity. How is IDP specificity achieved then?
A first explanation is the usually extended interaction interface of IDPs, using short linear motifs; a second
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feature is the existence, in many cases, of several secondary interaction sites (Didry et al., 2012; Delaforge
et al., 2018). These characteristics facilitate a precise fit of the IDP to its target, and contribute to enhanced
relative affinity, especially in the case of folding upon binding.
Several models exist to explain the peculiar behavior of IDPs regarding binding. Oldfield et al. (2005)
explained the decoupling between affinity and specificity in the model of conformational selection, as shown
in figure 8a. In such a model, the two-step mechanism, with folding first that only affects affinity, and then
the binding step itself, on which depend both affinity and specificity, is the key to separately tune them. To
explain the high association rates of IDPs to folded partners, a "dock-and-coalesce" model was described by
Zhou et al. (2012) and is presented in figure 8b. The docking step is often the rate-limiting step, and is fast
thanks to the low requirement for a specific orientation of the encounter.
There are of course counter-examples to this general model, and IDPs can bind with high affinity. A striking
example is the recent description of the pM fuzzy complex between histone H1 and prothymosin-α , resulting
from strong electrostatic interactions (Borgia et al., 2017).
(a)
(b)
Figure 8 – Binding properties of IDPs (a) How disorder can decouple affinity and specificity, from the extreme case
of conformational selection of an IDP (here Bad, binding to Bcl-xL). As opposed to proportionality between affinity
and specificity expected for two rigid structured partners, with only one binding step, affinity can be independently
tuned by the folding step of an IDP. From Oldfield et al. (2005). (b) The "dock-and-coalesce" mechanism proposed
by Zhou et al. (2012), where the IDP docks to its partner by the interaction of a small segment, and then coalesces in
a second step to form the complete binding interface.
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1.4.2 IDPs in signaling
The low-affinity/high-specificity binding of IDPs is very useful in the context of signaling and regulation:
relatively low affinities favor transient interactions, with high association and/or dissociation rates. More
than globular proteins, IDPs are sensitive to various regulation mechanisms: they are prone to alternative
splicing, experience high numbers of post-translational modifications, can modulate their accessibility to
partners depending on conditions, and can undergo fast degradation and recycling. Consistently with these
two characteristics, IDPs are overrepresented in signaling and regulatory processes: 66% of proteins in cell-
signaling are predicted to contain disordered segments longer than 30 residues (Iakoucheva et al., 2002),
allowing for rapid response to diverse inputs (Uversky et al., 2005).
Intrinsically disordered regions are found in many transmembrane proteins (Kjaergaard and Kragelund,
2017). As in the case of ErbB receptors C-terminal tail, the disordered regions is most often located in the
cytoplasmic region of plasma membrane receptors (Minezaki et al., 2007). As reviewed by Kjaergaard and
Kragelund (2017), the associated functions include formation of signaling complexes and regulation of the
activity of a folded domain. For the first function, disordered segments can provide many short binding sites
(SLiMs), that are adaptable and dynamically independent, in a relatively short sequence. Several examples
are known, amongst which the N-methyl-D-aspartate (NMDA) disordered tail that is able to recruit many
different proteins (CaM, CaMKII, PKC, PP2B, α-actinin), some of them binding to multiple sites (Strack
and Colbran, 1998; Bayer et al., 2001; Leonard et al., 1999; Ehlers et al., 1996; Wyszynski et al., 1997).
For the regulation of folded domain activity by disordered segments in transmembrane proteins, it has been
reported in some channels (Goldin, 2003). In the case of receptor tyrosine kinases, and in particular ErbBs,
the two roles of disordered regions described here can be relevant: the tail acts as a hub for adaptor proteins
triggering signaling, and the tail is suspected to regulate kinase activity.
1.4.3 IDPs and diseases
Thanks to their chemical and structural adaptability and their binding promiscuity, IDPs are key to many
cellular functions. As such, they are tightly regulated. This also implies that failure in such regulation can
have dramatic consequences.
IDP aggregation and amyloidogenesis have been shown to be involved in many diseases, especially neu-
rodegenerative diseases (Uversky, 2015). Amongst the most studied ones are α-synuclein, involved, inter
alia, in Alzheimer’s (AD) and Parkinson’s (PD) diseases, tau, involved in AD , and Aβ , involved in AD
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and Down’s syndrome. Interestingly, the interactions of IDPs that lead to amyloidogenesis are high-affinity
interactions, as opposed to usually observed low-affinity interactions of IDPs, with very stable supramolec-
ular assembly. Disorder has also been shown to be overrepresented in cancer-associated proteins (CAP).
79% of human CAP have predicted disordered regions of 30 residues or more (Iakoucheva et al., 2002)
(as opposed to an estimation of 44 % in all human proteins (Oates et al., 2013)). Such cancer-associated
disorder-containing proteins include p53, BRCA1, PTEN and CBP amongst others. Other diseases often
involving IDPs include cardiovascular diseases and diabetes. IDP-related diseases can originate from muta-
tions, chromosomal translocation, altered levels of expression/degradation, aberrant alternative splicing or
post-translational modifications (Uversky, 2014). Rational drug design approaches have to be adapted to the
specificities of IDPs, and strategies to target them are beginning to emerge (Ruan et al., 2019).
1.5 Structural biology of IDPs
1.5.1 The goal: reconstruction of conformational ensembles
Having no stable structure, IDPs are better described as collections of rapidly interconverting conformers
that we call conformational ensembles. The challenge for structural biology of such objects is therefore to
gain insight into this ensemble from data that are usually an average of virtually an infinite number of states.
This implies building model ensembles with enough structures to recapitulate experimental data. In these
structures, the features that will be of particular interest will be the presence of partially formed secondary
structures (potential MoRFs) and long-range contacts (intramolecular interactions) that can regulate acces-
sibility of different regions of the protein and be critical for interactions and folding.
Even more than for structured proteins, IDP function is largely governed by dynamics. The second aspect
of structural biology of IDPs is therefore to describe the different timescales of interconversion between
these structures, and local dynamics of each of them, and to link these dynamic features to the timescale
of biologically-relevant events. Dynamics will be particularly important to understand entropic chain func-
tions, but also mechanisms of interaction.
Given that regulation mechanisms are numerous and particularly important for IDP function, the confor-
mational ensemble of an IDP can be switched during its life cycle, for example by a post-translational
modification or the binding of a partner. An extreme case of ensemble switching is the folding of the IDP
4E-BP2 into a four-stranded β domain upon multiple phosphorylation, described by Forman-Kay and col-
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leagues (Bah et al., 2015). Comparing structural ensembles from the different potential states of the protein
is thus crucial.
1.5.2 NMR, the choice atomic-resolution method to study flexible objects
Although disordered regions of proteins were historically (and sometimes still are) identified by crystallog-
raphy (absence of crystal obtention or missing electron density), NMR has proven to be the best technique
for atomic-resolution study of intrinsically disordered segments. It allows for both structural and dynamic
description of such proteins, in conditions that are relatively close to physiological compared to other in
vitro methods. Contrary to many other techniques, flexibility is rather favorable in NMR (if the dynamics if
fast enough) as it enhances signal-to-noise ratio thanks to favorable nuclear spins relaxation properties for
an IDP compared to a globular protein of the same size.
Challenges of IDPs NMR and specific requirements NMR for the study of IDPs suffer from the general
lack of sensitivity of the technique, requiring high quantity of proteins of the order of the mg, even though
it is less critical than for globular ones. High purity is important for structural biology, and even more for
IDPs since they are more accessible to proteases and can be degraded rather fast.
On the point of view of spectroscopy itself, several problems are common for IDPs. The most obvious one
is the poor spectral dispersion of proton signals (and especially amide protons), that all experience a similar
environment, dominated by the interaction (and exchange) with the solvent. This phenomenon is increased
by poor sequence diversity commonly encountered in disordered proteins, that can be overcome by specific
labeling strategies (Urbanek et al., 2018). Therefore, (very) high fields are usually required for such studies.
Accessibility to solvent also is an issue when the rate of exchange with water is in the intermediate/fast
regime, and causes line broadening/extinction of the signal. That often prompts spectroscopists to choose
low pH, low temperature conditions, to slow it down, with the risk to get further from physiological con-
ditions. More generally, flexibility in the "wrong" timescales (that is, leading to an intermediate exchange
regime) can lead to troublesome line broadening. That is a problem more commonly observed for (pre-)
molten globules than for random coils. In these cases, adapting the magnetic field can be useful to fall back
into the fast or slow exchange regime.
The last issue that is common to many IDPs for NMR studies is the high occurrence of prolines. Many
routine protein-NMR experiments, starting with the 1H-15N HSQC, are backbone amide-proton based. Pro-
lines lacking those amide protons lead to missing information along the protein sequence. This is partic-
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ularly troublesome for sequential assignment, and "proton-less" NMR experiments (HCAN, CON... see
section 5.1.2) have to be implemented to fill in the gaps and assign proline-rich regions.
Information accessible by NMR Here I describe the possibilities that NMR offers for the description of
IDPs. The detailed description of each type of experiments are given in the experimental section 5.
A number of NMR parameters are rather easily accessible and give structural information. It is not to
be forgotten that these parameters also depend on dynamics, since dynamics controls their averaging (or
non-averaging). Local (secondary) structure of IDPs is mainly probed via chemical shifts, J couplings and
residual dipolar couplings (RDCs). While chemical shifts can directly give access to rather precise estimates
of secondary structure propensities (via different calculation methods such as δ2D (Camilloni et al., 2012)
and SSP (Marsh et al., 2006), see section 5.2), quantitative interpretation of J couplings (see section 5.4)
and RDCs (see section 5.5) is indirect and often requires comparison with simulated ensembles.
RDCs, and to a lesser extent chemical shifts, are also sensitive to transient long-range contacts. It is however
difficult to decouple contribution from tertiary and secondary structure. Once again, comparison with back
calculated values from simulated ensembles or between different conditions is necessary. With nOes being
very weak (and often not detectable) for transient contacts in such flexible proteins, the method of choice
to directly detect long-range intramolecular interactions in IDPs is to use paramagnetic relaxation enhance-
ment (PRE) measurements, probing contacts in different regions of the protein (one by one, see section 5.6).
Dynamics can be probed by a number of different NMR experiments, depending on the timescale of the
movements observed, as shown in figure 9. The most common type of experiments is 15N relaxation mea-
surements (R1, R2 and 1H-15N nOe, see section 5.3) that probe local dynamics, that is motions in the range
of 100 ps-ns. To probe slower motions corresponding to either slow local motions or more global confor-
mational changes, relaxation dispersion (µs to ms), CEST experiments (ms to s), or other magnetization
transfer experiments (ms to dozens of s) can be used. For even slower motions, sequential NMR experi-
ments (from simple 1D spectra to any type of longer experiments depending on the needed timepoints) can
be recorded allowing monitoring of processes slower than the second range.
The NMR community for the study of disordered proteins is very active, and a lot of very good reviews exist
on the topic, amongst which Kosol et al. (2013); Konrat (2014); Milles et al. (2018).
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Figure 9 – Molecular motions in proteins (top) at different timescales, and NMR observables (bottom) allowing to
probe them. From Deville (2015).
1.5.3 Complementary methods
NMR is very powerful to probe local structure and dynamics of flexible proteins, as well as intra- and inter-
molecular interactions. However, it is difficult to get information on the overall dimensions of the objects
in solution by NMR. The dedicated technique to obtain this information is SAXS. By fitting the scattering
curve with different models, size, shape, and compactness parameters can be calculated. More details are
given in section 6.2. The drawback of both NMR and SAXS is that they only give information on the average
over all the conformations in the ensemble that are exchanging fast enough compared to the experimental
sampling. Two types of study of IDPs try to overcome this limit.
Experimentally, single-molecule analysis is rapidly emerging, with single-molecule fluorescence, single-
molecule force spectroscopy, and single-nanopore studies. These techniques enable one to discriminate
between ensemble and dynamic averaging (static vs. dynamic heterogeneity), and follow sequential events,
for they have the best ensemble resolution possible (single particle), and a very broad range of timescales
accessible. A method often used for IDPs is single-molecule FRET, that gives non-ensemble averaged dis-
tance information, contrary to NMR and SAXS. The application of single-molecule methods for the study
of IDPs was recently reviewed by Brucale et al. (2014).
The other approach is to use simulations. Molecular dynamics allow, in combination with experimental
techniques, to gain mechanistic insight at the atomic level. Major progresses have recently been made in the
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development of specific force fields, adapted for disordered proteins, as opposed to force fields developed
for globular proteins that often favor compaction. This implies adjustment of the potentials for backbone
dihedral angles, and/or solvation. Efforts to optimize electrostatic potentials, often more critical for IDPs
than for globular proteins, are also made. The last challenge is to ensure a sufficient sampling of conforma-
tional space. Given the high number of degrees of freedom, short simulations only explore a small portion
of the energy landscape accessible to the IDP. Enhanced sampling methods are needed, and some have been
developed, such as replica-exchange. These developments were very recently reviewed by Kasahara et al.
(2019).
Some insight can also be gained by generating "static" conformational ensembles, to build models. Back
calculation of experimental parameters from these models allows characterization of specific features com-
patible with experimental data. The first step is the generation of atomic models of the disordered protein,
with the possibility to apply structural constraints to this ensemble. This can be done using Flexible Mec-
cano, developed by Blackledge and colleagues (Ozenne et al., 2012). One can directly compare experimental
data with the generated ensemble, or perform a selection step to obtain sub-ensembles fitting them. Two
programs exist, the ENSEMBLE program developed by Forman-Kay and colleagues (Krzeminski et al.,
2013), and the ASTEROIDS program developed by Blackledge and colleagues (Nodet et al., 2009). This
type of approach, using NMR and SAXS data, has been successfully used on several systems, as reviewed
by Sibille and Bernadó (2012).
The present work, studying the disordered tail of a receptor tyrosine kinase, is in line with ongoing
research in the IDP field, and tackles many of the IDP-related issues: the role of a long disordered part in
an overall structured protein; the influence of prolines on disordered states; the mechanism and influence of
post-translational modifications; the role of disorder in protein-protein interactions and signaling; and the
role of disorder in diseases. The main technique used was NMR, to investigate structure, dynamics, and
interactions of CtErbB2, complemented by SAXS measurements, and generation of structural ensembles
with Flexible Meccano.
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2 The C-terminal tail of ErbB2 (CtErbB2)
2.1 The ErbB/EGFR/HER family of receptor tyrosine kinases
Receptor tyrosine kinases (RTKs) are key proteins for regulation of cell proliferation, cell motility, differ-
entiation and apoptosis (Lemmon and Schlessinger, 2010). They are essential for development and several
physiological processes, but are also involved in diseases, especially cancer (Du and Lovly, 2018). There
are 58 RTKs in humans (Robinson et al., 2000), divided into 20 classes defined by phylogeny.
ErbB receptors were the first ones to be identified, and are therefore referred to as class I RTKs. ErbB1
was discovered by O’Keefe et al. (1974) as the epidermal growth factor receptor (EGFR). It was shown
to have tyrosine kinase activity a few years later by Cohen et al. (1982). In 1984, sequencing unveiled its
homology to a viral oncogene, v-erb-B (erythroblastic leukemia viral oncogene B) (Downward et al., 1984),
and the ErbB family was named after it. It is also called the HER (Human Epidermal growth factor Recep-
tor) or EGFR family, and contains four members: ErbB1/EGFR/HER1, ErbB2/neu/HER2, ErbB3/HER3,
ErbB4/HER4, presented in figure 10.
As for all RTKs listed to date (Hubbard, 1999), ErbB receptors are made of a ligand-binding extracellular
domain (ECD), a transmembrane helix (TMH), an intracellular juxtamembrane region (JM, composed of
two parts JMA and JMB), a tyrosine kinase domain (TKD) and a C-terminal tail (Ct), also called regulatory
domain. The whole receptors are about 140 kDa, and up to 185 kDa when they are glycosylated.
Despite this common domain organization of all four ErbBs, functional differences exist between them and
are shown in figure 10. Most strikingly, no ligand has been found for ErbB2, and ErbB3 kinase has been
shown to be very weakly active (about 1000 fold less active than EGFR) (Brignola et al., 2002a) . From the
evolutionary point of view, it was determined that in invertebrates there is only one ErbB-like protein (called
let-23 in C. elegans), and that the number of ligands is small (only one ligand identified in C. elegans, 4 in
Drosophila). Following three steps of gene duplication (separating ErbB1/2 from ErbB3/4 first, with then
another gene duplication of each), the four distinct ErbBs appeared in vertebrates, in which ligand diversity
was also increased (Stein and Staros, 2006). Although EGFR and ErbB2 have different functional specifici-
ties, ErbB2 is therefore the closest homolog of EGFR on the family.
Hereafter I describe the physiological functions of ErbB proteins, the molecular origin of these func-
tions, and their implication in diseases. Most of the conclusions were drawn from studies of EGFR, which
is the model ErbB receptor. Their validity for ErbB2, the focus of this work, are discussed in section 2.2.
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Figure 10 – The four ErbBs. (top) Crystal structures of the three main structured domains (each domain crystallized
independently) of the four ErbB proteins. The extracellular domain (ECD) structures are in the tethered (ligand-free,
inactive) state, except for ErbB2, which only exists in the dimerization-prone conformation (see section 2.1.3). Do-
mains IV of the ECD for ErbB1/3/4 are not shown for clarity, but mask the dimerization loop. Black arrows: ligand-
binding cleft. Dashed circle: dimerization loops. White arrow: ATP-binding cleft. The C-terminal tails are omitted
in this figure, for no structure is known. Figure from Yarden and Pines (2012). (bottom) Main characteristics of each
ErbB in terms of interaction partner, kinase activity, ligand binding and aberrations observed in cancer.
2.1.1 Cellular function (and disfunction) of ErbBs
ErbB receptors ensure a wide range of roles in development and adult organ function (Burden and Yarden,
1997; Chan et al., 2002), and null mutation of any of them is lethal at an early stage of embryogenesis. More
specifically, ErbBs are involved in development of mammary glands (Sebastian et al., 1998), peripheral ner-
vous system and Swann cells (Lee et al., 1995; Gassmann et al., 1995; Britsch et al., 1998; Riethmacher
et al., 1997), and in cardiac development and function (Lee et al., 1995; Gassmann et al., 1995). At the
cellular level, ErbBs are mitogenic (Pinkas-Kramarski et al., 1996; Vaskovsky et al., 2000), but are also
involved in cell adhesion (Jeon et al., 2015), motility (Chausovsky et al., 2000; Marone et al., 2004), and
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differentiation (Vaskovsky et al., 2000; Giani et al., 1998). They were shown to perform these functions by
activating (mainly) the MAP-kinase, PI3K/Akt, Src kinase and STAT5 pathways (see figure 11), and more
recently the MEMO pathway, described by Badache and colleagues (Marone et al., 2004), that controls cell
motility.
Misregulation and mutations of ErbB proteins have been linked very early to cancer (Downward et al.,
1984; Schechter et al., 1984). Different receptors, or receptor combinations, are involved in different types
of cancer (Yarden and Sliwkowski, 2001; Yarden and Pines, 2012), as detailed in figure 10. Additionally,
ErbBs are associated with neurodegeneration, and especially Alzheimer’s disease (Chaudhury et al., 2003),
cardiovascular diseases (Nakata et al., 1996) and psoriasis (Ben-Bassat and Klein, 2000). The nature of the
ErbB-related diseases is consistent with their physiological tissue localization.
Figure 11 – Main ErbB signaling pathways, from the example of the EGFR/EGFR and ErbB2/ErbB3 dimers. Figure
from Yarden and Sliwkowski (2001). The MEMO pathway, discovered more recently (Marone et al., 2004), is not
shown here.
2.1.2 Overall mechanism of signal transduction
Given their implication in both important physiological functions and cancer, a lot of effort was put into
understanding the mechanism of signal transduction by ErbBs. Structural studies were key to this under-
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standing. Briefly, ligand binding to ErbB1, ErbB3 or ErbB4 ECD is followed by a conformational change
that enables formation of active homo- or hetero-dimers of the receptors. ErbB2, on the contrary, does not
bind any known ligand and is constitutively poised to dimerize. Dimerization enables the activation of the
intracellular TKD of a least one monomer of the dimer and then leads to tyrosine phosphorylation of the
C-terminal tail. Finally, the phosphorylated tails serve as anchors for interaction with adaptor proteins that
trigger signaling. A very schematic view of the steps is given in figure 12, and the role of each domain is
detailed in the following sections.
Understanding the general mechanism of signal transduction by ErbB receptors is crucial to understand the
role of their C-terminal tails, their different states (signaling potent or not), their direct or indirect interac-
tions with the other domains, and the relevance of the constructs to use for their study.
The numbering used in these sections is given in figure 12b for EGFR, the most studied ErbB, and ErbB2,
the focus of our work.
2.1.3 The extracellular domain (ECD), ligand binding, and dimerization
ErbBs ECD is composed of about 630 residues divided into four domains (see figure 12b). Domains I and III
are also called L1 and L2 domains, respectively, while domains II and IV are called cysteine-rich domains
CR1 and CR2, respectively. The historical ligand EGF, that only binds ErbB1, has been joined by 10 other
EGF-family ligands binding ErbB receptors (see figure 10).
Crystal structures of EGF-bound (Ogiso et al., 2002) and free (Ferguson et al., 2003) ECD of EGFR re-
vealed the first step in ErbB dimerization (figure 13): in the free, autoinhibited state, the dimerization site
in domain II is masked by interaction with domain IV. Upon ligand binding, mainly to domains I and III, a
large conformational change frees domain II from intramolecular interaction with domain IV, and permits
dimerization of the ECD. This conformational change for activation was confirmed in vivo using mutational
studies and antibody-binding (Arndt-Jovin et al., 2014). Contrary to the dimerization mechanism of some
other RTKs, the ligand itself does not dimerize. For each of the ErbB1/ErbB3/ErbB4 receptors, binding of
different ligands leads to different types of dimers and different dimer association constants, with different
signaling specificities (different pathways activated, different signaling intensities and signal lifetimes...)
(Wilson et al., 2012; Macdonald-Obermann and Pike, 2014; Freed et al., 2017).
24
2. The C-terminal tail of ErbB2 (CtErbB2)
(a)
EGFR
0 25                                                                       645    706                             979                                             1210
   0                                                                       621    682                             955                       1186
0 24                                                                        653    714                             987                                                      1255
 19                                                                         648    709                             982                            1251
ERBB2
Signal peptide
Extracellular domain (ECD)
Transmembrane helix (TMH)
C-terminal tail (Ct)
Tyrosine kinase domain (TKD)
Juxtamembrane domain (JM)
Uniprot numbering
alternative numberings 
found in the literature
645   664   682
JMA   JMB
669   688   706
676    696   714
671    691   709
I II III IV
I II III IV
987                                                             1255
979                                                      1210
JMA    JMB   1005 1023*     1112  1127  1139*  1196* 1221/1222*   1248*
  998 1016* 1069* 1092* 1110* 1125 1138 1172*  1197*
(b)
Figure 12 – ErbBs domains function (a) Schematic representation of the role of each domain in ErbB signaling.
Adapted from Iwakura and Nawa (2013). Only some of the signaling pathways are represented here. (b) Overall
structure of EGFR and ErbB2 with numbering. The Uniprot numbering is used (unless otherwise stated) in this
manuscript. For EGFR, the alternative numbering sometimes used excludes the signal peptide in the N-terminus.
For ErbB2, the alternative numbering is that of rat ErbB2 (neu). In the C-terminal tail, all tyrosine positions are
indicated, with * on the ones that are known autophosphorylation sites.
In addition to this ligand-induced dimerization model, a ligand-induced activation of inactive dimers
was also proposed. Indeed, preformed, ligand-free inactive dimers were shown to exist in vitro and in vivo
(Moriki et al., 2001; Tao and Maruyama, 2008). In this model, the described ligand-triggered conformational
change of the ECD happens in the preformed dimer. The subsequent conformational changes in the trans-
membrane and intracellular domain (described bellow) activate the kinase domain in the so-called "rotation
model", reviewed by Purba et al. (2017). Between the two models, only the starting points really differ, but
the activation mechanism itself is the same. Whether the monomers or inactive dimers predominate might
actually depend on the nature of the receptor, level of expression, and localization in the membrane, since
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membrane composition is not homogeneous (Arndt-Jovin et al., 2014).
Structural studies of the ECD were performed on monomers or homodimers. No structure of het-
erodimeric ECD of ErbB receptors has ever been described. It has been suggested that dimerization of
the ECD only drives homo- but not hetero-dimer formation, that would be driven by other regions of the
receptor (Ferguson, 2000).
Figure 13 – EGFR auto-inhibition by its extracellular domain is released by binding of a ligand (here EGF, blue).
Contacts in the dimer are made through the dimerization loop, and two other sites of domain II marked by asterisks.
Figure from Burgess et al. (2003).
2.1.4 The transmembrane helix (TMH) and N-terminal end of the juxtamembrane region (JMA)
It has been shown that dimerization of the ECD itself is not sufficient for ErbB receptors signal transduction,
but that other intermolecular interactions allowed by the more global conformational change are required
(Yarden and Schlessinger, 1987). Consistently, truncated forms of ErbBs lacking the ECD are active (Down-
ward et al., 1984), suggesting that the (ligand-free) ECD is auto-inhibitory. In particular, the TMH has been
shown to enhance ligand-induced homodimerization of the ECD (Tzahar et al., 1996), and isolated TMH
homo- and hetero-dimerize (Mendrola et al., 2002; Sharpe et al., 2002; Duneau et al., 2007). Furthermore,
mutations in the TMH are involved in overactivation of ErbBs and diseases. For example, the Val to Glu
mutation in position 659 (664 in another numbering in use, see figure 12b) of neu/ErbB2 is activating, and
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is found in rat neuroglioblastoma (Bargmann and Weinberg, 1988).
The effect of this mutation, and the origin of activation of the receptor, has been suggested to be due to
rotation of the TMH to form a hydrogen bond with the other TMH of the dimer (Bell et al., 2000). A re-
cent NMR study by Bragin et al. (2016), using a ErbB2 construct containing the TMH and beginning of
the juxtamembrane region (juxtamembrane region A, JMA), supports the importance of the rotation of the
TMHs. This rotation, stabilized by a GxxxG motif, enables the C-termini of the helices to "open" in the acti-
vated state (see figure 14). Consistently with previous studies (Red Brewer et al., 2009; Endres et al., 2013;
Zhang et al., 2006), in this "open" conformation JMA regions dimerize and are antiparallel. Conversely,
the suggested model for the inactive state shows a membrane embedded, parallel, JMA dimer. Interaction
of the intracellular part of ErbBs with the plasma membrane had already been suggested to be inhibitory
(Arkhipov et al., 2013).
Even though the conformation and dimerization states of the transmembrane helix of ErbB receptors seem
to link the effects of ligand binding to the ECD to conformational changes in the intracellular domains, the
link has been suggested to be quite loose (Lu et al., 2010; Mi et al., 2011), with both active and inactive
kinase dimers found in ligand-bound receptors. Reality is most probably way more complex than duality
between all-active and all-inactive states.
Figure 14 – Model of the conformation of the TMH and JMA of ErbB2 in the "inactive" and "active" states. From
Bragin et al. (2016)
2.1.5 The tyrosine kinase domain and its activation
A non-canonical activation In many RTKs, monomeric kinase activity is low but non-zero. Dimeriza-
tion of the receptors causes trans-tyrosine phosphorylation of the kinase or juxtamembrane domains, which
dramatically increases kinase activity by changing the conformation of the activation loop (Hubbard, 2004).
Such a mechanism was initially expected for ErbBs, and the expected trans-phosphorylation site in the ki-
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nase is the conserved tyrosine Y869 in EGFR. However, Tyr to Phe mutagenesis studies (Gotoh et al., 1992)
showed that optimal kinase activity in the dimers does not require phosphorylation of Y869. In accordance
with that observation, the crystal structure of EGFR unphosphorylated kinase domain, solved by Stamos
et al. (2002), showed a conformation typical of the active state of a tyrosine kinase. A structure resembling
the inactive, unphosphorylated state of other kinases was described two years later, with a tyrosine kinase
inhibitor (Lapatinib) bound (Wood et al., 2004).
Activation by asymmetric dimerization Without Tyr trans-phosphorylation as a mean to activate the
kinase, the activation mechanism and necessity for dimerization was not understood. A closer look at the
crystal lattice of the active EGFR from (Stamos et al., 2002) showed two main possible dimers: a symmetric
one, and an asymmetric one, shown schematically in figure 15. Zhang et al. (2006) showed by mutagenesis
of the interface residues and concentration-dependent activity assays that the active form is the asymmetric
dimer. This dimer is similar to the CDK/cyclin complex, and one kinase monomer plays the role of an
activator, promoting via intermolecular interactions the activation of the other, receiver kinase. The N-lobe
of the receiver contacts the C-lobe of the activator with mainly hydrophobic interactions, and their relative
position is characterized by a 3-fold screw rotation (120◦ rotation, 43 Å translation).
The mechanisms determining the relative position of each kinase (receiver/acceptor) is not clear. It has
been proposed that it is dependent on the binding of ligand to each monomer (Macdonald-Obermann et al.,
2012), but other studies suggested that it is intrinsic to the composition of the dimer, each receptor having a
certain propensity to be the receiver (and EGFR being the "best receiver") (Ward and Leahy, 2015).
Symmetric dimer Asymmetric dimer V948R mutation
Figure 15 – Schematic representation of EGFR kinase symmetric dimer (left), asymmetric dimer (middle) and V948R
mutation that allowed to determine that the asymmetric dimer is the functional one. From Zhang et al. (2006)
28
2. The C-terminal tail of ErbB2 (CtErbB2)
Role of the C-terminal juxtamembrane region (JMB) The asymmetric dimer supposes asymmetric po-
sitions of the juxtamembrane regions (JM), and especially their C-terminal moiety (JMB) which are not
present in Zhang’s construct. This JMB region was shown by Thiel and Carpenter (2007) to be important
for kinase activity. Red Brewer et al. (2009) crystallized a construct containing JMA, JMB and the kinase
domain. At the same time, Jura et al. (2009) compared the juxtamembrane-containing crystal structure of
the kinase domain of ErbB4 (Wood et al., 2008) and the symmetric, inactive dimer structure of the V948R
mutant to understand the role of this region. Both studies converged in saying that interaction of the JMB
segment of the receiver with the C-lobe of the activator is necessary for activation, by acting as a "latch"
thats locks the active dimeric conformation.
Model of activation in the whole transmembrane and intracellular domain A model recapitulating
activation the mechanism of the kinase domain from the most recent studies is given in figure 16. From the
observation that ErbB3 tail can be phosphorylated even though it is kinase dead, and other experiments with
kinase-dead constructs (Qian et al., 1994), it is known that trans-autophosphorylation (phosphorylation of
the tail of one ErbB monomer by the kinase of the other ErbB of the dimer) is efficient. The co-existence
of trans-autophosphorylation with cis-autophosphorylation (phosphorylation by its very own kinase) has
however never really been ruled out.
In the symmetric inactive dimer stabilized by the V948R mutation (see figure 15), described by Jura
et al. (2009), the contact between the two kinases is mainly mediated by the beginning of the C-terminal tail
of the receptor. This may explain regulation mechanism of the kinase activity of EGFR by the C-terminal
tail, discussed in section 2.1.6 below.
2.1.6 The C-terminal tail (Ct), regulation and signal transduction
Tyrosine phosphorylation sites The C-terminal tail primary role in ErbB receptors is to ensure signal
transduction via interactions of phosphorylated tyrosines with signaling proteins (via SH2 and PTB do-
mains mainly). These tyrosines are called autophosphorylation sites when they are phosphorylated by ErbB
kinases in the dimer, as opposed to tyrosines phosphorylated only by other tyrosine kinases in the cell. There
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C-ter
Figure 16 – Model of the active state of the transmembrane, juxtamembrane and kinase domains of EGFR, from
Lemmon et al. (2014). The extreme C-terminal helix of each kinase, from where the C-terminal tail would start, is
indicated.
are 9 tyrosines in EGFR C-terminal tail, amongst which six can be autophosphorylated. Four of them have
been shown to be highly autophosphorylated sites (Y1092, Y1110, Y1172 and Y1197), and two have lower
levels of phosphorylation (Y1016 and Y1069) (Bertics et al., 1985; Margolis et al., 1989; Walton et al.,
1990). Phosphorylation studies of EGFR have been reviewed by Koland (2014), and a recapitulative table
is shown in figure 17a. It was suggested that phosphorylation does not happen at many sites at once (Kim
et al., 2016), but phosphorylation mechanism and patterns are widely unknown.
Partners of phosphorylated tyrosines of ErbBs Partners of ErbB phosphotyrosines include Grb2 and
Shc (MAP kinase pathway), PI3K (Akt pathway), Src and STAT5 (Yarden and Sliwkowski, 2001; Schulze
et al., 2005) (see figure 17b). Some partners are common between different ErbBs and some are not. We
will focus of CtErbB2 partners in section 15. The C-terminal tail also includes motifs signaling for endo-
cytosis and degradation/recycling, but these phenomena are not completely understood yet, and no direct
interaction was shown (Sorkin and Goh, 2009).
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P-site in vitro studies Studies in cultured cells
1016 + -/+++
1069 ++ +/++/+++
1092 +++ +/++/+++
1110 ++/+++ ++/+++
1125 ND ND
1138 ND +++
1172 +++ +/++/+++
1197 +++ +*/+++
(a)
(b)
Figure 17 – Phosphorylated tyrosines of EGFR. (a) Review of different studies of the relative levels of phosphoryla-
tion of 8 (out of 9) tyrosines of EGFR C-terminal tail. *: greatly enhanced by ErbB2 expression. "/" indicates differ-
ent results in different studies. Adapted from Koland (2014). (b) Phosphotyrosine interactome of the C-terminal tails
of ErbB receptors. Adapted from Schulze et al. (2005).
The C-terminal tail as a regulatory domain Additionally, the C-terminal tail is believed to participate
in the regulation of the activity of the kinase domain, since it has been shown that deletion of some parts
of the C-terminal tail modulates kinase activity. However, the results of the different studies (Walton et al.,
1990; Sorkin et al., 1992; Alvarez et al., 1995; Cheng and Koland, 1996; Pines et al., 2010) diverge on the
nature and precise regions of the tail involved in this regulation. This regulation could be phosphorylation-
dependent, creating feedback loops. Indeed, C-terminal tyrosine to phenylalanine mutants of activated
EGFR showed different kinase activities (Gill et al., 2017). Crystal structures (shown in figure 18) show the
implication of the C-terminal tail in the kinase domain conformational state, supporting a regulatory func-
tion. In the inactive state, a helix is structured at the beginning of the C-terminal tail: this helix (995-1004) is
sometimes called the AP-2 helix because it is responsible for binding to the AP-2 clathrin adaptor protein. It
interacts with parts of the kinase N-lobe close to the N-lobe-C-lobe hinge region, which could alter activity.
In the inactive, symmetric dimer of the V948R mutant (Jura et al., 2009), this helix also interacts with the
N-lobe of the other monomer, and is followed by an extended part (1006-1014) interacting with the C-lobe
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in a similar manner as the JMB in the active asymmetric dimer. This extended part instead forms another
helix (1010-1018) in some other inactive and active structures (with varying length and position) interacting
with the N-lobe. Molecular dynamics studies support the interplay between the C-terminal tail and JMB
for kinase regulation (Mustafa et al., 2011). The C-terminal tail, at least its beginning, is even suspected to
participate in the stabilization of the kinase core, since when the whole C-terminal tail removed, no crystals
were obtained (Gajiwala, 2013).
(a)
(b)
Figure 18 – Interaction of the C-terminal tail with the kinase domain of EGFR. (a) Inactive (Wood et al., 2004)
and active (in the asymmetric dimer) (Zhang et al., 2006) kinase domain of EGFR showing interactions with the
C-terminal tail. Side chains are shown for tyrosines (Y974, involved in endocytosis, and 992, autophosphorylation
site) for which phosphorylation could disrupt interactions. Figure from Lemmon et al. (2014). (b) Inactive, symmet-
ric dimer with the C-terminal tail preventing interaction of the JMB segment on the C-lobe. From Jura et al. (2009).
Here the numbering is the alternative one (see figure 12b)
A model, as complete as possible today, of ErbB activation (in the "rotation model" supposing preformed
inactive dimers) from ligand binding to phosphorylation of the C-terminal tail, is given in figure 19.
Order and disorder in ErbB C-terminal tails All the crystal structures only contain about 40 residues of
the C-terminal tail of EGFR (out of 231). Flexibility, causing missing electron density even in the segments
present in the crystals, is probably preventing crystallization of longer fragments. This is consistent with a
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Figure 19 – Full model of ErbB activation in the "rotation model", supposing the existence of preformed, inactive
dimers. From Purba et al. (2017).
study by Keppel et al. (2017) studying the C-terminal tails of ErbBs alone and in the context of the whole in-
tracellular fragment, that uses a combination of biophysical techniques (HDX-MS, CD, SEC-MALS, DLS,
AUC, SAXS) to show that they are disordered in EGFR and ErbB3, and at least solvent-accessible in ErbB2.
Structural and dynamic features of the tails, and interaction with the kinase domain, are phosphorylation-
dependent (Lee and Koland, 2005; Lee et al., 2006). However, the phosphorylation does not seem to cause
any dramatic change in the secondary structure content (Lee et al., 2006), and what seems to be modified
is the tertiary structure. For example, the observed contacts in the crystals could be modified by tyrosine
phosphorylation (see figure 18). This is also what was suggested by a study by Bishayee et al. (1999): an
antibody recognizes a conformation of the C-terminal tail of EGFR where two parts of the epitope, far in
the sequence, are close in space. This recognition only happens when three tyrosines are phosphorylated
(Y1016, Y1092 and Y1110) .
2.2 ErbB2/neu/HER2, a singular ErbB
ErbB2 was originally known as neu, since it was identified in rat neuroglioblastomas (Schechter et al.,
1985), and its homology to EGFR/ErbB1 was found via their common similarity with the erythroblastic vi-
ral oncogene (Schechter et al., 1985). For historical reasons, EGFR has always been the most studied ErbB.
However, interest for ErbB2 has been progressively growing, for it is involved in many different types of
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aggressive cancer, and especially in breast cancer. Even though from an evolutionarily point of view ErbB2
is the ErbB closest to EGFR, lack of any known ligand, and peculiarities in its structure, have made it a good
model of structure-function comparative studies.
Special emphasis is put in this section on features that seem specific to ErbB2 compared to mechanisms
described in section 2.1.
2.2.1 ErbB2 and cancer
ErbB2 has been shown to be overexpressed (up to 100-fold, from about 104 to about 106 molecules/cell)
in about 30% of breast cancers (Slamon et al., 1987). These cancers are called HER2-positive, and are
associated with poor prognosis (higher relapse rate, and lower overall survival) (Press et al., 1993). ErbB2
is also overexpressed in some ovarian (Hellström et al., 2001), lung (Ugocsai et al., 2005), endometrial
(Buza et al., 2014), or gastric (Abrahao-Machado and Scapulatempo-Neto, 2016) cancers. Mutations of
ErbB2 have been observed in many cancer patients, especially in the kinase domain (Connell and Doherty,
2017). With these clinical data, knowledge that ErbB2-containing heterodimers are more potent than any
homodimer (Graus-Porta et al., 1997; Lenferink et al., 1998), and that ErbB2 overexpression and/or muta-
tion induces constitutively high ligand-independent activation, ErbB2 is a particularly attractive drug target.
Antibodies targeting ErbB2 Trastuzumab (Herceptin R©, Genentech) was the first HER2-targeted drug on
the market (approved by the FDA in 1998), aimed at breast cancer patients. This monoclonal humanized an-
tibody binds the extracellular domain of ErbB2 (Carter et al., 1992; Cho et al., 2003), and acts by triggering
antibody-dependent cellular cytotoxicity (ADCC), inhibiting dimerization due to steric hindrance, and pre-
venting cleavage of the extracellular region. Trastuzumab was the 5th best-selling drug worldwide in 2018
(Nami et al., 2018). Although it greatly improves survival rates, resistance to trastuzumab is common and
can be due to signaling via other receptors, or truncated forms of ErbB2 (Nahta and Esteva, 2007). Recently,
an antibody-drug conjugate (ADC) where trastuzumab is coupled to the cytotoxic agent emtansine, T-DM1
(Kadcyla R©, Lonza), has been developed, and FDA-approved in 2013. It allows cancer-cell targeted delivery
of emtansine, coupled to the activity of trastuzumab.
Another antibody, pertuzumab or 2C4 (Agus et al., 2002) (Perjeta R©, Genentech, FDA-approved in 2012)
has been developped. Like trastuzumab, it binds to the extracellular domain of HER2 and triggers ADCC,
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but prevents heterodimerization more efficiently (Agus et al., 2002). This is consistent with a binding epi-
tope of pertuzumab on domain II (Franklin et al., 2004), contrary to trastuzumab that binds domain IV
(Cho et al., 2003). Combined treatments with trastuzumab and chemotherapy is now the first-line treatment
(Swain et al., 2015) for HER2-positive metastatic breast cancer.
Tyrosine kinase inhibitors (TKIs) Lapatinib (Tyverb R©, FDA-approved in 2007) is an inhibitor of the
kinase domains of EGFR and ErbB2 (Nelson and Dolder, 2006) that binds to the ATP-binding pocket.
Different TKIs are under development, that target EGFR, ErbB2 and ErbB3 (Neratinib), ErbB2 only (Tuca-
tinib), or all ErbBs (Poziotinib, Pyrotinib).
A recent review of treatment of HER2-positive breast cancer was done by Escrivá-de Romaní et al.
(2018). What comes out of those studies is that combined therapies are the best way to escape resistance.
Targeting new domains of ErbB2 would therefore open new possibilities.
2.2.2 ErbB2 conformation is ligand-independent and dimerization prone
No biologically relevant high-affinity ligand for the extracellular domain of ErbB2 has been found, and its
ligand-dependent activity has been linked to its heterodimerization with other, ligand-binding, ErbBs (Klap-
per et al., 1999). It has actually been shown to be their preferred heterodimerization partner, even in the
presence of ligands for other ErbBs (Graus-Porta et al., 1997; Tzahar et al., 1996), and ErbB2/ErbB3 het-
erodimers have been shown to be the most potent ones, with the highest proliferation index (Holbro et al.,
2003). ErbB2 has also been shown to be able to induce transformation (cells acquiring the properties of
cancer) in a ligand-independent manner when overexpressed (Di Fiore et al., 1987; Brennan et al., 2000),
suggesting signaling potential of homodimers.
Extracellular domain conformation These findings implied that the extracellular conformation of ErbB2
had to be different from the ligand-free, tethered conformation of EGFR (Ferguson et al., 2003), and closer
to its bound, "open" conformation. This was confirmed with the crystal structure of the free rodent ErbB2,
shown in figure 20, and of Herceptin-bound human ErbB2 (Cho et al., 2003). Domain II, which is responsi-
ble for dimerization of EGFR ECD, is exposed in ErbB2, as in ligand-bound EGFR, despite large differences
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in the orientation of domains I/II relative to domains III/IV. This different orientation is due to hydrophobic
interactions of domains I and III of ErbB2 that do not exist in EGFR, but instead are mediated by EGF. The
domains II/IV interface of tethered EGFR do not exist in ErbB2. This explains why ErbB2 does not need a
ligand to be locked in the "open" conformation. This structure was consistent with a quasi-simultaneously
published structure of domains I-II-III of human ErbB2, which superimposes very well (Garrett et al., 2003).
Without control of signaling by ligand-binding, ErbB2 lacks an important regulation mechanism of ErbBs.
This observation makes it all-the-more interesting and important to understand how signal is transmitted
downstream of the extracellular domain.
Figure 20 – Comparison of EGF (red)-bound EGFR (blue) domain I-II-III and ErbB2 (green, PDB 1N8Y) extracellu-
lar domains. On the left, domain II was omitted for clarity. Figure from Cho et al. (2003).
Homodimerization The existence of ErbB2 substancial ligand-independent activity and in cell microscopy
studies revealed that ErbB2 homodimers are more frequently found than homodimers of other ErbBs (Arndt-
Jovin et al., 2014). Surprisingly, the ErbB2 ECD did not crystallize as a dimer, it was shown to be monomeric
by analytical ultracentrifugation (Horan et al., 1995), and mutagenesis suggested that ErbB2 dimerization
did not involve the domain II residues key for EGFR dimerization (Franklin et al., 2004). Whether the ECD
is involved in homodimerization of ErbB2 is unclear. However, other parts of ErbB2 are critical for ho-
modimerization: the V659E (transmembrane) "activating" mutation (Bargmann et al., 1986; Akiyama et al.,
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1991) increases constitutive homodimerization, tyrosine phosphorylation and transforming potency, while
987VVI989/AAA mutation (at the interface between the kinase domain and the C-terminal tail) abolishes
homodimerization and phosphorylation of wild-type and V659E activated mutant (Penuel et al., 2002). The
987VVI989 sequence was shown not to be as critical for heterodimerization and ligand-dependent signaling
as for homodimerization and ligand-independent signaling (Penuel et al., 2002).
Kinase domain structure and activity ErbB2 kinase has been show to have relatively low kinase activity
(a few fold less than EGFR and ErbB4) (Brignola et al., 2002b). Mutation studies linked this low activity
to poor ATP-binding and turnover and to glycine residues located between the αC helix and the β4 of the
kinase domain (Fan et al., 2008). This was confirmed when the crystal structure of ErbB2 kinase domain
with a small kinase inhibitor was solved in 2011 (Aertgeerts et al., 2011) (PDB 3PP0). Although the asym-
metric activated dimer is very similar to the one solved for EGFR, increased flexibility due to the previously
identified glycines seems to destabilize the active site.
2.3 CtErbB2
2.3.1 Role of each phosphotyrosine (pY) in signal transduction
Five autophosphorylation sites have been identified in CtErbB2: Y1023 (called YA), Y1139 (YB), Y1196
(called YC), Y1221/1222 (YD1 and YD2) and Y1248 (YE) (Hazan et al., 1990; Segatto et al., 1990). Sequence
analysis showed that site B has a consensus sequence to bind Grb2 SH2 domain (pYxN) where pY is a
phosphotyrosine, while sites C and E have consensus sequences for binding to PTB domains (NPxpY), and
site D2 a sequence close to that consensus (NLxpY) (Dankort et al., 2001a).
Major studies of CtErbB2 interactome were conducted by Dankort, Muller and colleagues (Dankort et al.,
1997, 2001a,b), who tried to understand the role of each tyrosine in transformation and signal transduction
by the Ras pathway. The authors used tyrosine to phenylalanine mutations to abolish phosphorylation at
specific sites. These mutants were derived from the V659E mutant (noted "NT") that induces transformation
without need of elevated overexpression. Using this mutant enables to easily assess the status of ErbB2
signaling using focus formation assays. The authors made constructs with only one autophosphorylation
site mutated to F (called for example "NT-A" when YA is mutated to F) or with all but one tyrosine mutated
to F (called for example when only site A remains as a tyrosine "NT-YA").
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Phosphorylation of YA inhibits signal transduction, contrary to all other autophosphorylation sites
Main results of focus formations assays of the mutants studied by Dankort et al. (1997) are given in fig-
ure 21. They showed that the phosphorylation of tyrosine A alone inhibited focus formation even more than
when all tyrosines are mutated to phenylalanines. Conversely, all other autophosphorylation sites (B to D)
were individually sufficient for transformation. Besides, mutation of individual tyrosine autophosphoryla-
tion sites to F only slightly reduced foci formation, except for single mutation of YA to F, that enhanced
transformation. Additional phosphorylation of YB, YC, or YE did not reverse YA inhibition, while YD did,
suggesting some connection between those two sites.
Grb2 binds ErbB2 directly via phosphorylated YB, and indirectly via Shc on phosphorylated YD The
authors showed in following studies (Dankort et al., 2001a,b) that signaling by YB and YD correlated with
Grb2 binding to ErbB2 directly (YB, consistently with Grb2 sequence specificity) or indirectly (YD). Shc
PTB domain was shown to bind to YD and Grb2 to bind to Shc phosphorylated SH2 domain. These interac-
tions with Grb2 and Shc were shown to couple ErbB2 to the Ras/MAPK pathway, and to be responsible for
the transformation induced by phosphorylation at these sites.
An interaction between the site B phosphotyrosine and the protein Grb7 SH2 domain has also been charac-
terized by co-immunoprecipitation (Stein et al., 1994) and by NMR (Ivancic et al., 2003). The role of this
interaction in vivo is less characterized than the one between Grb2 and ErbB2, but is believed to be involved
in breast cancer (Stein et al., 1994).
Several PTB- and SH2-containing proteins bind phosphosites YC and YE Although Shc PTB domain
was mainly shown to bind to site D, it was also shown to bind to site C (Marone et al., 2004). Crk adaptor
protein, as well as PLCγ were also shown to bind to this site, although they contain SH2 domains and not
PTB domains (Dankort et al., 2001b; Marone et al., 2004). Site E was shown to bind the PTB domain of
Dok-R (Dankort et al., 2001a). Although the role of these interactions have not been investigated in details,
all those proteins are involved in the MAPK pathway.
The main SH2- and PTB-containing proteins binding to each site of CtErbB2 are recapitulated in fig-
ure 22.
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Figure 21 – Role of the different autophosphorylation sites of ErbB2. Transfection with different mutants of activated
(NT) ErbB2/neu, of which schematic examples of constructs are given, and observation of foci formation (transfor-
mation). Restoration of any of four autophosphorylation sites (YB to YE) compared to an all-phenylalanine mutant
(NYPD) restores significant transformation, while tyrosine A phosphorylation inhibits transformation. Inhibition by
YA is lost only when YD is phosphorylated. Tyrosine phosphorylation in all but the NYPD mutant was verified. From
Dankort et al. (1997). Here the numbering is the alternative (rat neu) one (see figure 12b)
Phosphorylated YD binds MEMO to control cell motility A strategy similar to that of Dankort et al.
(1997) was used in the group of Ali Badache (Marone et al., 2004) to identify proteins interacting with
autophosphorylation sites YD. They identified a new protein that they called MEMO (mediator of ErbB2-
driven cell motility), binding on the second tyrosine of this site (Y1222, also numbered Y1227 or YD2). This
protein is structurally related to bacterial dioxygenases and does not contain any SH2 or PTB domain, so it
was first thought to interact indirectly with ErbB2. However, it was shown by pull-down experiments that
the interaction was direct (Qiu et al., 2008), and the interaction between MEMO and a YD-derived peptide
was described by NMR (Feracci et al., 2011). In the docking model, the phosphotyrosine binds in the
large cleft of MEMO via three histidines and a cysteine making hydrogen bonds with the phosphate group.
The minimal sequence for binding was shown to be 1217FDNLYpYWDQD1226. MEMO has been shown
to control cell motility by regulating microtubule dynamics, formation of adhesion sites, and formation of
actin-binding complexes (Zaoui et al., 2008).
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Figure 22 – Main SH2 and PTB domains interacting with CtErbB2 autophosphorylation sites. Figure from Dankort
et al. (2001a). Here the numbering is the alternative (rat neu) one (see figure 12b)
2.3.2 Regulation of kinase activity
The effect of the C-terminal tail, and of its phosphorylation, on the activity of the kinase is unclear. Mech-
anisms similar to EGFR may be at stake but were not really investigated. From ErbB2 kinase domain
structures (bound to inhibitors), both published in 2011 (Aertgeerts et al., 2011; Ishikawa et al., 2011), the
AP-2 helix observed in EGFR is positioned in a similar fashion in ErbB2, next to the hinge between the
kinase N and C lobes (see figure 23). This position could suggest a similar role in kinase activity regulation.
2.3.3 Known structural features of CtErbB2
In the free state CtErbB2 is expected to be highly disordered Except for the helix (Pro999-Leu1009)
seen in the crystal structure of the kinase domain, there is no atomic-resolution data on the structure and
dynamics of free CtErbB2. Although Keppel et al. (2017) focused on EGFR and ErbB3, they also showed
by HDX-MS that CtErbB2 is highly solvent-accessible and probably disordered in the context of the whole
intracellular region. In this study, the helix seen in the crystal structure also seems more protected than the
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tail
kinase 
domain
ɑ-C helix
Figure 23 – Structure of the ErbB2 kinase domain, in complex with the SYR127063 inhibitor not shown (PDB 3PP0)
(Aertgeerts et al., 2011).
rest of the tail, which suggests that there is more structuration in this region in solution, consistently with
the kinase domain crystal structure.
Expected conformation of the phosphotyrosine binding sites in the bound state A phosphopeptide
(from the receptor TrkA) bound to Shc PTB domain was shown to adopt a complex structure, completing
a β -strand of the protein and forming a β -turn N-terminal to the pY (Zhou et al., 1995). Whether a similar
structure is formed when CtErbB2 binds Shc PTB domain is unknown. In the MEMO-YD structure, the
peptide adopts a helical structure in the region FDNLYpYW (Feracci et al., 2011). Phosphotyrosine peptides
usually adopt an extended conformation when binding to SH2 domains (Liu et al., 2012). However, peptides
binding to Grb2 SH2 have been shown to adopt a β -turn involving the phosphotyrosine and the residue in
position +3 (Rahuel et al., 1996), and a peptide from ErbB2 YB site complexed with the Grb7 SH2 domain
exhibits such a turn (Ivancic et al., 2003). Different kinds of local structure can thus be expected in different
bound forms of CtErbB2.
Aims and strategies of this work CtErbB2 is expected to interact with many different partners, in an
intramolecular manner (with its kinase domain for regulation), in the ErbB dimers (for potential trans phos-
phorylation), and with signaling proteins. To understand how these different interactions are regulated, we
chose to adopt two complementary approaches:
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• Study the structure and dynamics of free CtErbB2. The expected disordered nature of this tail indi-
cates that both the existence of local prestructured motifs (or MoRFs), and the overall structure and
dynamics of the region might allow regulation of multiple binding events, as described in the first
section of this manuscript for IDPs.
• Study of individual interaction events. In parallel to the first approach, it is crucial to understand at
the atomic level how CtErbB2 interacts with its partners. Each interaction will then be replaced in
the general context of signaling. In this work, we chose to focus on one particular partner, Grb2,
presented below.
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3 Grb2, a major adaptor protein in ErbB2-dependent pathways
Grb2 (for Growth factor receptor-bound 2) was discovered in human as the protein ensuring signal trans-
duction between RTKs and the Ras/MAPK pathway (Lowenstein et al., 1992). It is known as Sem-5 (Sex
muscle abnormal protein 5, for its role in vulval development) in C. elegans and Drk (downstream of re-
ceptor kinase) in Drosphila. It is a typical example of adaptor protein, a protein that links different parts of
signaling pathways, with no catalytic activity. It is entirely made of two protein-binding modules: a cen-
tral SH2 domain flanked by two SH3 domains (called NSH3 at the N-terminus and CSH3 at the C-terminus).
3.1 Grb2 in ErbB2 signaling
Grb2 in signaling pathways Grb2 was originally shown to bind to phosphorylated RTKs via its SH2 do-
main, and to the Son of sevenless guanine nucleotide exchange factor (Sos) via its SH3 domains, triggering
Ras/MAPK pathway signaling (Lowenstein et al., 1992; Gale et al., 1993; Buday and Downward, 1993).
Grb2 has been shown to bind both directly and indirectly to ErbB2: it binds directly to phosphorylated YB
and indirectly to phosphorylated YD via Shc (Dankort et al., 1997, 2001b). Shc binds YD via its PTB domain
and phosphorylated Shc is recognized by Grb2 SH2 domain. Sos, by interacting with RTK-bound Grb2, lo-
calizes at the plasma membrane, getting closer to the Ras GTPase. Sos then exchanges the nucleotide bound
to Ras from GDP to GTP.
Although the MAP kinase pathway is the RTK/Grb2-related pathway that is best described (see figure 24),
Grb2 also interacts with other proteins determining the fate of receptor tyrosine kinase signaling: via binding
to Gab1 (for Grb2-associated-binding protein 1), it links RTKs to the PI3K pathway controlling apoptosis
and to Shp2 phosphatase reinforcing Ras-dependent signaling (Gu and Neel, 2003); binding to ubiquitin
ligase Cbl controls ubiquitination of EGFR (Ravid et al., 2004); and binding to dynamin1 controls EGFR
endocytosis (Yamazaki et al., 2002).
Physiological and pathological roles of Grb2 Grb2 role as an adaptor has been shown to be essential for
early steps of embryogenesis, especially differentiation. This role has been directly correlated to the role of
Grb2 in Ras pathway, connecting RTKs by its SH2 domain to Sos. Indeed, replacing Sos proline-rich motifs
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Figure 24 – Simplified scheme of the two main Grb2-dependent signaling pathways: PI3K/Akt and Ras/MAPK.
with Grb2 SH2 domain, thus allowing direct connection between RTKs and Sos, rescued differentiation in
the Grb2-null cells (Cheng et al., 1998). The same study showed that Grb2 is also rate-limiting for mammary
carcinoma induction in mice. Moreover, it has been shown to be upregulated in some breast cancers (Daly
et al., 1994). Grb2 has been shown to be essential for ErbB2-induced transformation (Xie et al., 1995), and
the efficacy of targeting Grb2 in HER-2 positive cancer cells has been proven (Gril et al., 2007).
3.2 General description of SH2 and SH3 domains
Src Homology 2 and 3 (SH2 and SH3) domains were discovered in proteins related to the cytoplasmic
tyrosine kinase Src. Since then, they have been shown to be highly abundant in signaling pathways, and
to often work together. Many proteins contain tandem SH2 and SH3 domains (Fyn, Grb2, Abl, Lck, GAP,
PI3K, phospholipase Cγ ...).
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3.2.1 SH2 domains and phosphotyrosines
SH2 domains were discovered in 1986 in Pawson’s lab (Sadowski et al., 1986), and are domains of about
100 residues that specifically recognize phosphorylated tyrosines. It was the first protein interaction domain
to be identified. 111 human genes code for at least one SH2 domain, for a total of 121 human SH2 domains
described so far (Liu et al., 2011). SH2 domains can be found in enzymes or non-catalytic proteins, and
often participate in signaling pathways of receptor tyrosine kinases.
SH2 binding to a phosphopeptide do not trigger large conformational changes. The phosphotyrosine binds
in a conserved pocket (see figure 25), with a conserved arginine residue in a FLVR motif. Specificity of
SH2 domains for their substrate is given mainly by another pocket, formed by loops on the other face of
the central β sheet. That pocket accommodates residues C-terminal compared to the phosphotyrosine (up
to position +6). Residues N-terminal to the phosphotyrosine, or further in the sequence, can also participate
in the interaction in some cases. The location of the two pockets requires, in most cases, the ligand peptide
to be in an extended conformation perpendicular to the central β sheet. The specific, secondary interactions
allow for dissociation constants that can be as low as nM (Felder et al., 1993), but are more usually in the
µM range. SH2 domains can, in some cases, bind non-phosphorylated peptides but with significantly higher
KD, except for some SH2 domains such as SAP (Poy et al., 1999) and Shc (Charest et al., 1996) that can
also quite specifically recognize non-phosphorylated peptides.
A website gathering comprehensive information about SH2 domains is accessible at www.sh2domain.org.
3.2.2 SH3 domains and polyproline motifs
SH3 domains are small domains of about 50 to 75 residues. Even though sequence conservation of SH3
domains is not very high (about 27% (Larson et al., 2000)), they have a conserved fold. They are made
of two perpendicular antiparallel β sheets, with their termini close to each other and located on the side
opposite to the binding site, as seen in figure 26a. SH3 domain-containing proteins are involved in recog-
nition and assembly of other proteins (for example with recognition of dynamin by amphiphysin (Hinshaw,
2000)), membrane localization (of Sos thanks to binding to Grb2 (Buday and Downward, 1993)), and kinase
regulation (in Crk (Sriram and Birge, 2012)).
SH3 domains mainly bind peptides containing the PxxP motif in a PPII conformation, with affinities usually
in the µM range (Musacchio, 2002). Ligand-binding does not trigger any large conformational change. Two
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Figure 25 – Canonical structure of SH2 domains (A, here Src, PDB 1SPS) and binding to a phosphotyrosine peptide
(red sticks). Here, the phosphotyrosine-binding pocket is on the right of the central β sheet, and the specificity pocket
is on the left. Residues important in the phosphotyrosine-binding pocket are given in B, and alignment of different
SH2 domains is given in C. From Liu et al. (2012)
main classes of ligands, that bind in opposite orientations, have been identified: class I ligands with con-
sensus sequence RxxPxxP (said to bind in the plus orientation) and class II ligands with PxxPxR sequence
(said to bind in the minus orientation) (Musacchio, 2002). Details of the two binding modes are given in fig-
ure 26b. In both cases, two pockets (named S1 and S2) bind one xP motif each, using aromatic residues and
a proline. A third pocket (S3), located between the RT (β1-β2) and N-Src (β2-β3) loops, accommodates
the positive charge of the arginine (sometimes a lysine) with a negatively charged residue, often a glutamate.
The existence of two different binding orientations of polyproline motifs to SH3 domains is allowed by the
symmetry of the PPII structure.
Many examples can be found of binding of SH3 domains to non-canonical motifs, with varying positions
of the prolines or even absence of prolines in the ligand. Regions quite far from the canonical binding motif
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S2
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S3
(b)
Figure 26 – Structure and binding of SH3 domains to polyproline motifs. (a) Structure of Sem-5 C-terminal SH3
domain and alignment of different SH3 domains. β1, β2 and β5 form one sheet, while β3 and β4 form the second
one (which sometimes also contains the end of β2). Sticks of key residues for xP binding (blue background in the
alignment) and the acidic pocket (red background) are shown. On the alignment, in blue are conserved residues, and
in red are residues that confer binding specificity to each SH3. From Saksela and Permi (2012). (b) Binding of the
canonical classes of polyproline ligands to SH3 domain. Left: β -PIX SH3/AIP-4 peptide complex as an exemple of
class I ligand binding. Right: p40phox SH3/p47phox peptide complex as an example of class II ligand binding. From
Kaneko (2008).
can also play an important role.
3.3 Previous structural descriptions of Grb2
Sequence analysis of Grb2 was sufficient to identify its SH2 and SH3 domains (Lowenstein et al., 1992).
The first direct structural descriptions of Grb2 were the NMR solution structures of its NSH3 domain bound
to Sos proline-rich peptides (PDB 1GBR)(Goudreau et al., 1994; Wittekind et al., 1994), and of its CSH3
domains (PDB 1GFC) (Kohda et al., 1994). These monodomain structure determinations were shortly
followed by the crystal structure of the full-length, apo-Grb2 (PDB 1GRI) (Maignan et al., 1995), and then
the isolated SH2 domain (PDB 1GHU) (Thornton et al., 1996). Although the folding of each individual
domain is consistent with other domains of the same nature, interesting features appear in each of them and
in their organization in the full-length adaptor.
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3.3.1 Individual domains
SH3 domains There are only 3 structures of the NSH3 domain of Grb2 in the PDB. As suggested by
its first structural study (by solution NMR) by Goudreau et al. (1994), the domain exhibits unfolding in
several different conditions, even if its overall folding resembles that of other SH3 domains. It was said to
be "degraded" and to dimerize (depending on the presence of DTT, as observed by mass spectrometry) at
pH 6.5, and to be stabilized at pH 3.5. At this low pH, however, an equilibrium between a folded and an
unfolded form was observed. The C32S mutant of the protein was not "degraded" and did not dimerize, but
underwent the same folded/unfolded equilibrium at pH 3.5. Moreover, it had almost the same 3D structure
as the wild type protein at pH 3.5. This indicates that cysteine oxidation only has an effect on dimerization,
while pH controls folding stability. Later, the group of Mueller did not report stability issues working at pH
6.0 with 10mM DTT (Wittekind et al., 1994, 1997), consistent with this analysis.
Analysis of mutant structures also gives insight into this domain (un)stability. The C32S-P49L mutant was
shown to be unfolded, although this proline is not essential in folding of other SH3 domain; The C32S-
Y7V and C32S-E40T mutants exhibited slow folded/unfolded exchange with about 1:1 ratio, similar to the
observed effect of low pH (Vidal et al., 1999). These particular residues do not seem to have a role more
important than others for folding, and the unfolding induced by their mutation highlights the overall unsta-
bility of the domain. In other SH3 domains, pH, ionic strength, temperature, or even addition of proline-rich
ligands, has been shown to have similar destabilizing effects. The control of folded/unfolded equilibrium
depending on conditions may be a mechanism of regulation of interactions in the cell (Vidal et al., 1999).
No ligand-free structure of the NSH3 was deposited in the PDB. One of the two ligand-bound structure of
the wild-type domain is presented in figure 27b.
The first structure of the CSH3 was solved by solution-state NMR by Kohda et al. (1994). It also has the
canonical fold of an SH3 domain, with an additional small two-strand antiparallel β sheet in the RT loop
compared to the canonical structure presented in figure 26. This sheet is found in many SH3 domains (Src,
spectrin, PI3K, Fyn, PLCγ (Kohda et al., 1994)) but not in the NSH3. The cysteine that seems responsible
for the NSH3 dimerization is deleted in the CSH3, even though a cysteine is also present at another position.
For a comparison of NSH3 and CSH3 domains sequence and structure of Grb2, see figure 27.
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(a)
β1β5
β2
β2’
β3
β4
RT loop
N-Src loop
distal loop
(b)
Figure 27 – Comparison of Grb2 NSH3 and CSH3 domains (a) Sequence alignment of Grb2 NSH3 and CSH3 and
comparison of peptide binding. From McDonald et al. (2008a) adapted to fit strands numbering of figure 26. (b)
Alignment of NSH3 (PDB 1GBQ, ligand bound, blue) and CSH3 (PDB 1GFC, free, green) domain structures of
Grb2 in solution.
SH2 The first structure of Grb2 SH2 domain is the crystal structure of full-length, dimeric Grb2, at rather
low resolution (3.1 Å) (Maignan et al., 1995) (see figure 29a). The SH2 domain shows canonical fold-
ing, but with a position of W121 that would prevent binding of extended peptides as seen in other SH2-
phosphotyrosine peptide complexes. The solution structure of Grb2 SH2 domain by Thornton et al. (1996)
shortly after confirmed the unusual pocket closed by W121, as shown in figure 28. Mutation of Src at the
equivalent position to introduce tryptophan suggested that it is responsible for Grb2 selectivity for an as-
paragine in position +2 relative to the phosphotyrosine (Marengere et al., 1994).
Small differences between solution structures of the domain in phosphate compared to phosphate-free buffer,
consistant with binding of phosphate in the phosphotyrosine-binding pocket, were found, especially in the
loop around residues 87-94 (βB-βC) (Senior et al., 1998).
3.3.2 Domain organization in full-length Grb2
Only one structure of full-length Grb2 exists. This crystal structure solved by Maignan et al. (1995) is
a dimer, with no ligand bound. Here we focus on the domain organization in each monomer (the two
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αA
βB
βC
βD
αB
Figure 28 – Solution structure of Grb2 SH2 domain (Thornton et al., 1996) (PDB 1GHU). Compared to a canonical
SH2 fold (figure 25), the position of W121 (red) would prevent an extended phosphotyrosine peptide to bind.
monomers are similar in the dimer), dimerization being discussed below in 3.3.3. Solution structures of
all three individual domains of Grb2 superimpose well to this full-length structure (see figure 29a). The
two SH3 domains are in contact but with a buried interface of moderate surface (1000 Å2) and 5 hydrogen
bonds. The authors suggest that this contact may not be present in solution, and that domains may be flexible
relative to one another to facilitate binding to different partners. It is to be noted that even in this structure
with inter-SH3 interactions, the binding sites for all three domains remain accessible and are not buried.
The hypothesis of flexible linkers between the domains was tested in solution by Yuzawa et al. (2001),
but only in the ligand-bound state. Indeed, the authors studied full-length Grb2 with an EGFR peptide
(EpYINSQV) and a Sos peptide (VPPPVPPRRR) at ratio Grb2:EGFR:Sos of 1:1.2:5. The results, presented
in figure 29b, show that the 1H-15N HSQC spectrum of Grb2 is almost exactly the sum of the HSQC spectra
of individual domains, and that each domain has independent dynamics in the full-length protein. Therefore,
the three domains are expected to have independent behaviors when bound to different, non-connected
peptides. However, it is to be noted that slightly higher chemical shifts differences between full-length Grb2
and the free NSH3 and SH2 are observed than for the CSH3, even though the values are still quite small.
The CSH3 is also more freely rotating than the first two domains, and especially than the NSH3 even though
it is very similar in size and structure. Weak interaction between the two first domains could be at stake.
Whether these observations hold true for the ligand-free protein remains to be investigated.
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SH2 (in full-length)
SH2 (isolated)
NSH3 (in full-length)
NSH3 (isolated)
CSH3 (in full-length)
CSH3 (isolated)
(a)
1
2
3
4
(b)
Figure 29 – Comparison of full-length Grb2 and individual domains. (a) Solution structures of individual domains
of Grb2 (NSH3: light blue, PDB 1GBQ; SH2: pink, PDB 1GHU; CSH3: light green, PDB 1GFC) compared to the
crystal structure of full-length Grb2 (NSH3: dark blue, SH2: red, CSH3: dark green, PDB 1GRI). (b) Compari-
son of proton (1) and nitrogen (2) chemical shifts of full-length Grb2 and individual domains, and 15N relaxation of
full-length Grb2 (3: heteronuclear nOe and 4: rotational correlation time calculated from T1 and T2 values). From
Yuzawa et al. (2001).
3.3.3 Oligomerization
Full-length Grb2 dimer In the literature, data about Grb2 oligomeric state seem contradictory. The crys-
tal structure of the full-length is a dimer, with SH2 domain of one monomer contacting quite extensively
the CSH3 of the other (as shown in figure 30a). This dimer interface is still leaving canonical SH2 and SH3
binding interfaces exposed for interaction.
Moreover, dimerization or higher-order oligomers have been observed during preparation of NSH3 (Goudreau
et al., 1994) or SH2 (Thornton et al., 1996) samples. However, when trying to characterize those dimers or
measure dimerization constants of Grb2 or its domains, no clear picture emerges. Different studies of Grb2
oligomeric state are recapitulated in figure 30c. Results diverge on the formation of non-covalent dimers,
from almost all-monomeric Grb2 to low-µM dimer. The problem also resides in the absence of study of
full-length Grb2 without any purification tag and without ligand. However, it is to be noted for all constructs
that cysteins present in the SH3 domains (one in each) have to be reduced in order to prevent formation of
51
3. Grb2, a major adaptor protein in ErbB2-dependent pathways
covalent dimers when working with constructs containing one or both of them.
Concerning the structure of the individual domains in the dimer, all studies suggest it is unchanged (as
seen in the comparison of the individual domain structures to the crystallographic dimer of the full-length
protein in figure 29a), except in the hypothesis of a domain-swapped SH2 domain, presented below. How-
ever, arrangement of domains relative to one another might be modified by dimerization (McDonald et al.,
2008b).
SH2 (A)
NSH3 (A)
CSH3 (A)
SH2 (B)
NSH3 (B)
CSH3 (B)
(a)
SH2 (A)
SH2 (B)
(b)
Ref Construct Ligand peptide Dimeric state Dimer interface Affinity Method
Guilloteau et al. (1996) FL None unstable monomer ND ND SEC, AUC, light scattering
Maignan et al. (1995) FL None dimer SH2-CSH3 ND X-ray (PDB 1GRI)
Yuzawa et al. (2001) FL EGFR and Sos monomer None >mM NMR and SAXS
McDonald et al. (2008b) Trx-FL-His None equilibrium Assumed NSH3/CSH3 5 µM AUC20-30 µM ITC
Lin et al. (2012) His-FL None equilibrium ND 0.7 µM MST
Ahmed et al. (2015) His-FL None equilibrium ND 0.7 µM MST
(c)
Figure 30 – Grb2 dimerization. (a) Grb2 crystal dimer (PDB 1GRI). The two monomers are labeled A and B. (b)
SH2 domain-swapped dimer structure (PDB 1FYR). (c) Literature data on Grb2 oligomeric state. SEC = Size Exclu-
sion Chromatography; AUC = Analytical Ultracentrifugation; MST = Microscale Thermophoresis; ITC = Isother-
mal Titration Calorimetry. FL = full-length Grb2. Trx = Thioredoxin.
Domain-swapped SH2 dimer All studies until 2000 showed the SH2 domain of Grb2 to have canonical
fold and to be monomeric. However, Schiering et al. (2000) crystallized a dimeric conformation of the SH2
in which the EF loop is extended, and the remaining C-terminal segment is swapped with another monomer
(shown in figure 30b). Such domain-swapping had never been observed for a SH2 domain, and this structure
is still unique today. The domain-swapped dimer reconstitutes two hybrid domains with overall canonical
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SH2 fold. The dimeric form could be separated from monomer by SEC (with a ratio 8:2), without return
to an equilibrium of any of the two peaks in standard conditions. The dimeric form could be returned to
monomer by heating, chemical denaturation and refolding, low pH, or addition of organic solvent, show-
ing that the domain-swapped dimer is a metastable form. This domain-swapped dimer of the isolated SH2
domain has been observed by several groups since this study (Nioche et al., 2002; Benfield et al., 2007; Pa-
paioannou et al., 2016). Domain-swapped dimer conformation has been shown to be independent on ligand
binding (Nioche et al., 2002; Benfield et al., 2007; Papaioannou et al., 2016).
Presence of such swapping in full-length Grb2, and its biological relevance, have not been proven, even
though Schiering et al. (2000) proposed a model of full-length, SH2-swapped Grb2 dimer.
3.4 Known interaction modes of Grb2
3.4.1 SH2-phosphotyrosine (pY) interaction
Grb2 is known to have specificity for pY-x-N-x substrates, with for example a KD of about 0.3 µM for
the SpYVNVQ peptide from Shc compared to 167.8 µM for the PQpYEEIPI peptide (typical substrate for
Src SH2 domain), as measured by ITC (Papaioannou et al., 2016). This specificity has been shown to be
associated with the presence of a tryptophan in the EF loop (W121) (Marengere et al., 1994), that would
block the usually extended structure of the substrate peptide C-terminus of the phosphotyrosine (Maignan
et al., 1995; Thornton et al., 1996). The peptide-bound structure of Grb2 SH2 (figure 31) showed that indeed
the bound phosphotyrosine peptide (KPFpYVNV from BCR-Abl) adopts an unusual conformation with a β
turn formed right after (C-terminus) the phosphotyrosine (Rahuel et al., 1996).
The role of W121 is mitigated in a more recent study (Papaioannou et al., 2016) that shows that Grb2 SH2
W121G substrates also bind in a β turn conformation, only slightly distorted. The mutation only lowered
Grb2 specificity for N in position +2 but did not reverse it (the ratio of affinity for SpYVNVQ compared to
PQpYEEIPI peptides as measured by ITC is still 10). The reverse T to W mutation in Src increased affin-
ity for N+2 less drastically (42 fold increased affinity ratio) than previously measured by SPR (1200 fold
increased affinity ratio) (Marengere et al., 1994) and led to comparable KDs for the two types of peptides.
W121 is therefore not the only determinant for Grb2 SH2 specificity and the peculiar complex structure.
Peptides for which the structure of the complex with Grb2 SH2 have been solved include peptides derived
from EGFR (EpYINQ, PDB 1ZFP), BCR-Abl (FpYVNV, PDB 1BMB), HGFR (TpYVNV, PDB 1FYR),
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Shc (SpYVNV, PDB 1QG1) and CD28 (DpYMNM, PDB 3WA4). There is no structure of a complex be-
tween a peptide from ErbB2 (for which the known interaction site is EpYVNQ (tyrosine B) (Dankort et al.,
1997)) and Grb2 SH2. However, there is a crystal structure of the Grb7 SH2 domain in complex with this
ErbB2 peptide (PDB 1MW4), showing a similar β -turn conformation, even though this conformation is not
due to a tryptophan in the EF loop but to a extension of this loop in Grb7.
(a)
(b)
(c)
Figure 31 – Binding of Grb2 SH2 domain to a pY-V-N-V peptide. (a) Cartoon representation (PDB 1BMB). Figure
from Liu et al. (2012). (b) Surface representation (PDB 1BMB). Figure from Wagner et al. (2013) and (c) Sticks rep-
resentation (PDB 1TZE) of the "specificity site" with W121 forcing the β turn conformation (top) and of the canoni-
cal phosphotyrosine binding site (bottom). Figure from Rahuel et al. (1996).
The effect of SH2 domain swapping on ligand binding is controversial, as affinities were the same be-
tween the monomeric and dimeric forms as measured by Schiering et al. (2000), and KD increased 4 to
13-fold in the dimer as measured by Benfield et al. (2007). The latter observation is compatible with con-
formational change of the 121-123 region to an extended form in the swapped dimer, inducing reorientation
of the W121 side chain and preventing stabilisation of the N+2 residue by W121 indole ring.
3.4.2 SH3 domains interactions
Musacchio (2002) made a review of peptides binding to both NSH3 and CSH3 domains. The result is
reproduced in figure 32a. Even though several other peptides have been tested since, it gives an idea about
the interaction motifs for these SH3 domains. They both bind preferentially to class II peptides (expectedly
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in the minus orientation), as was observed by Kaneko (2008), with estimated preferences for class II vs class
I of about 70% vs 30% for both domains.
Despite this common preference, the NSH3 and CSH3 domains do not have the same specificity, and do
not bind the same proteins in vivo. It was shown that both NSH3 and CSH3 bind to Sos, although there is
a preference of all Sos polyproline motifs for the NSH3 (Kohda et al., 1994; Wittekind et al., 1994; Vidal
et al., 1999; McDonald et al., 2009). Conversely, Gab1 and Gab2 show specificity for the CSH3 domain,
thanks to binding to non-PxxP motifs, RxxK motifs, which was not observed for the NSH3 (Lewitzky
et al., 2001; Harkiolaki et al., 2009). In the structures of the Grb2-Gab2 peptides complexes (PDB 2VWF,
2W0Z), the peptides do not always adopt PPII structure, and make different contacts with Grb2 (residues
Q170, E171 and E174). Additional hydrophobic contacts with prolines adjacent to the RxxK motif resemble
the canonical binding of PxxP motifs. KD is in the µM range, a common range of affinity for SH3 domains.
For both SH3 domains, the presence of multiple PxxP binding sites on their target (Sos and Gab1 for
the NSH3 and CSH3 respectively) was suggested to lead to multivalent binding increasing overall affinity,
involving Grb2 dimerization (McDonald et al., 2012a,b). Moreover, non-PxxP regions may provide multiple
secondary interactions also increasing affinity and specificity, since a Sos construct with scrambled sequence
outside of the 4 PxxP motifs failed to tightly bind Grb2 (Bartelt et al., 2015). While it was suggested that
different specificities of the two SH3 domains of Grb2 may lead to the formation of ternary Sos-Grb2-Gab1
complexes (McDonald et al., 2010), stoichiometry and steric hindrance prevent formation of such complex
in the full-length Grb2 protein (McDonald et al., 2013).
Despite common model of Grb2 interacting with receptors via a SH2-pY interaction, Lin et al. (2012)
showed that Grb2 CSH3 was able to bind to a polyproline motif of the FGFR2 unphosphorylated C-terminal
tail. This binding is believed to promote FGFR2 dimerization via Grb2 dimerization, promoting basal phos-
phorylation. In this model, Grb2 prevents extensive signaling by sterically blocking extensive phosphory-
lation and interaction with other proteins. Upon ligand binding and phosphorylation of Grb2 by FGFR2,
the interaction is thought to be released for signaling via pY residues. Such possible mechanism was never
investigated for ErbB receptors, but resemblance with FGFR receptors suggests it could exist.
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(a)
Domain mutation(s) PDB ligand origin ligand sequence ligand class ligand orientation
NSH3 None
1GBR
Sos
SPLLPKLPPKTYKRE
II minus1GBQ VPPPVPPRRRC32S Y7V 1AZE
CSH3 None
1IO6 designed RHYRPLPPLP I plus
2VWF Gab2 IQPPPVNRNLKPDRK non-canonical minus2W0Z APPPRPPKP
(b)
(c) (d)
Figure 32 – Ligand binding to Grb2 SH3 domains. (a) Characterized Grb2 SH3 ligands as of 2002 (Musacchio,
2002). (b) PDB structures of bound Grb2 SH3 domains. (c) NSH3 (green) bound to a Sos peptide (red), from PDB
1GBQ. Residues interacting with the PxxP motifs are in blue, and residues interacting with the arginine are in cyan.
Sticks are shown for the prolines and arginine of the PxxPxR motif of the peptide. (d) CSH3 (green) bound to a RxxK
peptide, from PDB 2VWF. Residues interacting with the R0xxK3 motif are in cyan, and residues interacting with pro-
lines outside of the motif are in blue. Sticks are shown for R0 and K3, as well as for P-4 and P-5.
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3.4.3 Interdependence of binding of SH2 and SH3 domains
In a modular protein such as Grb2, one could wonder how binding of the SH2 and binding of the SH3
domains interfere.
It was shown by fluorescence and ITC that when the SH2 domain interacts with a phosphotyrosine peptide,
the affinity of the SH3 domains for polyproline peptides is not changed, showing the absence of allosteric
mechanism from the SH2 to the SH3 domains (Cussac et al., 1994; Lemmon et al., 1994). However, when
using full-length proteins, interaction of Shc with the SH2 domain enhances binding of Sos to Grb2 SH3
domains in vivo (Ravichandran et al., 1995). Whether this is due to indirect effect via other proteins or to
direct effects of complex conformation is not known.
When SH2-binding motifs and SH3-binding motifs coexist in the same protein, the problem is even more
complex. Several examples exist where there seemed to be cooperativity of SH2 and SH3 domains to bind
to a single partner in vivo. But once again, the direct or indirect nature of the effect is unknown. Even
though RPTPα binding to Grb2 is known to occur via SH2-pY interaction, the CSH3 domain is required for
the interaction in vivo (den Hertog and Hunter, 1996; Su et al., 1996). Gill et al. (2017) showed that both
the SH2 and SH3 domains are required for Grb2 binding to EGFR single-tyrosine mutants. A similar phe-
nomenon was observed for ErbB2 binding, for which binding to Grb2 is drastically reduced upon deletion
of the NSH3 (Xie et al., 1995). Molecular details remain to be investigated.
Even though Grb2 is essential for ErbB2 signaling and is involved in ErbB2-related pathologies, a lot is
still unknown about its behavior in solution, for it has mostly been studied domain-by-domain. The same
observation can be made about Grb2 interactions: despite relatively abundant data on Grb2 individual do-
mains interactions with peptides, very little is known about interactions in the context of the full-length
protein. Thus, a lot of information is missing on how interaction of the different domains with different
proteins allow signal transduction. Since we suspect Grb2 to interact with ErbB2 through both its SH2 and
SH3 domains, this aspect is crucial.
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4 Protein expression and purification
4.1 Grb2 and CtErbB2 expressed in E. coli
4.1.1 Constructs and mutants
CtErbB2 Constructs For the study of CtErbB2, the C-terminal tail was defined according to the litera-
ture as the portion of the protein following the kinase domain, and encompasses residues 988-1255, that
we number 1 to 268 in this study. For purification purposes, a N-terminal His6 tag was added, as well as
a lipoyl domain tag that increases solubility. Lipoyl is a 12 kDa domain from B. stearothermophilus E2p
that is acidic (pI = 4.53), like CtErbB2, and prevents aggregation by electrostatic repulsion (Lebendiker and
Danieli, 2014). The His6-lipoyl tag is followed by a TEV cleavage site, leaving 4 additional N-terminal
residues (GSHM) when the tag is cleaved. The expressed construct and the final sequence after TEV cleav-
age are presented in figure 33. The gene coding for CtErbB2 was inserted in a YP304 vector also presented
in figure 33, which also contains a gene conferring resistance to the antibiotic kanamycin.
CtErbB2 Mutants Different mutants of CtErbB2 were designed by site-directed mutagenesis:
• Q161A: for help in assignment.
• Four single-cysteine mutants for paramagnetic relaxation enhancement (PRE) experiments: C146S,
C45S, (C45S, C146S, S227C) and (C45S, C146S, S248C). Each mutant was designed to have a single
cysteine for coupling of the paramagnetic probe. How these mutants were used to site-specifically
introduce a paramagnetic probe in CtErbB2 is described in section 5.6.
• Tyr-Phe mutants for selective phosphorylation: mutants "YA" (Y18F, Y125F, Y140F, Y152F, Y209F,
Y234F, Y235F, Y261F), "YB" (Y18F, Y36F, Y125F, Y140F, Y209F, Y234F, Y235F, Y261F), "YC"
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Tyrosine kinase domain 
(TKD) 715-987
C-terminal tail
(CtErbB2) 988-1255
Extracellular domain
(ECD) 1-653
Transmembrane helix 
(TMH) 654-676
Juxtamembrane region
(JM) 677-714
ErbB2 Constructs
GSHM
CtErbB2 (28.711 kDa)
=Tev cleavage consensus sequence ENLYFQG
FL ErbB2 (137.910 kDa)
His6
lipoyl SHM
His6-lipoyl-CtErbB2 (40.227 kDa)Expressed in E.coli
After Tev cleavage
(a)
 GSHMVIQNEDLGPASPLDSTFYRSLLEDDDMGDLVDAEEYLVPQQGFFCPDPAPGAGGMVHHRHRSSSTRSGGGDLTLGLEPSEEEAPRSPLA
     
1
        10        20        30        40        50        60        70        80  
    PSEGAGSDVFDGDLGMGAAKGLQSLPTHDPSPLQRYSEDPTVPLPSETDGYVAPLTCSPQPEYVNQPDVRPQPPSPREGPLPAARPAGAT
    90        100       110       120       130       140       150       160       170   
    LERPKTLSPGKNGVVKDVFAFGGAVENPEYLTPQGGAAPQPHPPPAFSPAFDNLYYWDQDPPERGAPPSTFKGTPTAENPEYLGLDVPV
    180       190       200       210       220       230       240       250       260  
(b)
Figure 33 – Construct of CtErbB2 expressed in E. coli and final CtErbB2 construct after His6-lipoyl tag cleavage by
the TEV protease, compared to the full-length protein. (a) Constructs and vector. The molecular weights are given
for non-isotopically labeled proteins. (b) Sequence of the CtErbB2 protein produced, after TEV cleavage, with the
numbering used in this work.
(Y18F, Y36F, Y125F, Y140F, Y152F, Y234F, Y235F, Y261F), "YD1" (Y18F, Y36F, Y125F, Y140F,
Y152F, Y209F, Y235F, Y261F), "YD2" (Y18F, Y36F, Y125F, Y140F, Y152F, Y209F, Y234F, Y261F)
and "YE" (Y18F, Y36F, Y125F, Y140F, Y152F, Y209F, Y234F, Y235F). The reasons for designing
such single-tyrosine mutants are given in section 10. The "0Y" mutant (Y18F, Y36F, Y125F, Y140F,
Y152F, Y209F, Y234F, Y235F, Y261F), mutating all tyrosines to phenylalanines was also designed
as a control.
All mutants had already been cloned in the lab before my thesis, except for the (C45S, C146S, S227C)
mutant. It was made from the template (C45S, C146S) mutant with the following primers:
forward primer 5’-cgaaggctgggcagaaggcaggagg-3’
59
4. Protein expression and purification
reverse primer: 5’-cctcctgccttctgcccagccttcg-3’
For cloning, the recommendations from the QuickChange II XL kit (Agilent Technologies) were followed.
Subsequent amplification and purification of the plasmid were done following the recommendations from
the NucleoBond R© Xtra Midi kit (Macherey-Nagel), and sequencing was performed by Eurofins Genomics.
Grb2 The domain organization of Grb2 is schematically presented in figure 34a. Each combination of do-
mains of Grb2 was cloned into a pETM11 vector also containing the gene conferring resistance to kanamycin
(shown in figure 34b for full-length Grb2): the three individual domains (NSH3, SH2 and CSH3), the
two bidomains (NSH3SH2 and SH2CSH3) and the full-length protein (FL). Each construct contains a N-
terminal His6 tag for purification purposes, followed by a TEV cleavage site. After cleavage, two additional
N-terminal residues (GA) remain compared to the native sequence, as shown in figure 34c. The definition
of all the constructs after TEV cleavage is given in figure 34d.
NSH3 SH2 CSH3
1                                 58 60                                                    152   156                                      
(a)
(b)
GAMEAIAKYDFKATADDELSFKRGDILKVLNEECDQNWYKAELNGKDGFIPKNYIEMKPHPWFFGKIPRAKAEEMLSKQRH
  1        10        20        30        40        50        60        70
 DGAFLIRESESAPGDFSLSVKFGNDVQHFKVLRDGAGKYFLWVVKFNSLNELVDYHRSTSVSRNQQIFLRDIEQVPQQPT
 80        90        100       110       120       130       140       150
 YVQALFDFDPQEDGELGFRRGDFIHVMDNSDPNWWKGACHGQTGMFPRNYVTPVNRNV
 160       170       180       190       200       210   
(c)
Construct Numbering in the full-length protein (tag-cleaved protein) MW (tag-cleaved, unlabeled protein)
Grb2 FL (GA)1-217 25.334 kDa
NSH3 (GA)1-56 6.677 kDa
SH2 (GA)53-152 11.798 kDa
CSH3 (GA)153-217 7.653 kDa
NSH3-SH2 (GA)1-152 17.827 kDa
SH2-CSH3 (GA)53-217 19.306 kDa
(d)
Figure 34 – Grb2 constructs. (a) Domain structure of Grb2 (as defined in Uniprot). (b) pETM11 vector used for the
expression of Grb2. (c) Sequence of the FL Grb2 construct produced after TEV cleavage, with the numbering used in
this work. (d) Constructs of Grb2 studied in this work.
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4.1.2 Expression in E. coli
Selective pressure was maintained on plates for transformation and in precultures and cultures using 30
µg/mL of kanamycin.
Transformation The CtErbB2 or Grb2 plasmid was transformed into BL21 Star (DE3) E. coli cells with
the following protocol: 50 µL of chemically competent cells were thawed on ice for 20-30 minutes. 1 µL of
DNA (50 to 500 ng/µL) was added to the cells which were then gently swirled and kept on ice for another
20 to 30 minutes. The heat shock was performed in a water bath for 45 s at 42 ◦C. After cooling on ice for 2
min, 250 µL of SOC medium was added, and cells were incubated for 1 h at 37 ◦C with shaking (200 rpm).
50 µL of this culture was plated on LB/agar plates and incubated overnight at 37 ◦C.
Culture in unlabeled medium The next day, one colony from the plate was added to 50 mL of 2xYT
medium and incubated overnight (37 ◦C, 200 rpm) as a preculture. This preculture was then transferred to
1L of 2xYT and grown until OD600nm (optical density measured at 600 nm) reached 0.6 to 0.8. Protein ex-
pression was induced following the conditions given in table 1. Cells were then harvested by centrifugation
at 6000 g for 20 min at 4 ◦C, and the pellet was flash frozen in liquid nitrogen for storage at -80 ◦C until
protein purification.
Protein Induction OD600nm Inducer Tinduction timeinduction
CtErbB2 0.6-0.8 2 mM IPTG 37◦C 4-5h
Grb2 0.6-0.8 1 mM IPTG 25◦C overnight
Table 1 – Induction conditions for CtErbB2 and Grb2 in E. coli
Culture in 15N or 15N-13C labeled medium The culture protocol in labeled medium was similar to culture
in 2xYT, except that for isotopic labeling the 2xYT preculture was centrifuged at 1200 g for 20 min before
resuspension in the M9 culture medium. M9 medium composition is given in table S1. Compared to the
standard M9 medium composition for isotopic labeling, we added vitamins and trace elements to boost
bacterial growth.
Culture for Grb2 80% deuteration The full-length construct of Grb2, and to a lesser extent the bidomain
constructs, are quite large for folded proteins to be studied by NMR, due to slow tumbling and therefore
high transverse relaxation rates. For the signal lifetime to be long enough to have good signal-to-noise ratio,
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and especially to be able to record 3D spectra, a technique is to deuterate the protein. Thanks to the lower
gyromagnetic ratio of deuterium compared to proton, its incorporation reduces the efficiency of the relax-
ation processes due to the strong dipolar couplings of protons. Since the purification and the experiments
are performed in protonated buffers, the backbone deuteron amides have time to back-exchange to protons,
allowing recording of regular 1H-15N-based NMR experiments. Besides, deuteration creates almost-isolated
1H-15N pairs, creating optimal conditions to record TROSY-based experiments at high magnetic fields (see
section 5.1.3).
All full-length Grb2 samples were 80% deuterated. While the SH2CSH3 bidomain could be studied without
deuteration, deuteration was necessary for the NSH3SH2 bidomain, especially for 3D spectra.
For production of deuterated Grb2, 8 mL of 2xYT preculture was transferred to 500 mL 2xYT and the cul-
ture was grown at 37 ◦C at 200 rpm until OD600nm = 0.6 to 0.8. The culture was then centrifuged at 3500 g at
4 ◦C for 10 min, and the pellet was resuspended in 1 L unlabeled M9 medium and grown at 37 ◦C, 200 rpm
until OD600nm = 0.6 to 0.8 again. This step allowed for adaptation of bacteria to the minimal medium. The
culture was centrifuged again at 3500 g at 4 ◦C for 10 min, the pellet was resuspended in 100 mL 15N13C
deuterated M9 medium, and incubated for 1 h at 37 ◦C. 900 mL of 15N13C deuterated M9 was added and
the culture was incubated for around 30 min before overnight induction as in the unlabeled protocol.
4.1.3 Purification
The composition of all buffers used is given in table 2. For both CtErbB2 and Grb2, that contain free
cysteins, a reducing agent (TCEP) was included at all steps to prevent intra- and inter-molecular disulfide
bond formation.
Buffer name Used in step(s) Composition pH
Buffer A HisTrap column and Ni-NTA resin 50 mM Tris-HCl, 300 mM NaCl, 2 mM TCEP 8
Lysis buffer Lysis buffer A + cOmplete EDTA-free Protease Inhibitor Cocktail (Roche) 8
Buffer B HisTrap column buffer A + 500 mM imidazole 8
MES buffer (CtErbB2) SEC/final buffer 40 mM MES, 200 mM NaCl, 2 mM TCEP 5.6
PIPES buffer (Grb2) SEC/final buffer 40 mM PIPES, 150 mM NaCl, 2 mM TCEP 7.2
PBS buffer (Grb2) SEC/final buffer PBS, 2 mM TCEP 7.2
Table 2 – Buffers used for CtErbB2 and Grb2 purification.
For purification, the pellet was thawed on ice and resuspended in 50 mL of lysis buffer/L of culture. Lysis
was achieved by cell disruption (Constant Systems Ltd.), the lysate was ultracentrifuged at 190,000 g for
1 h at 4 ◦C, and the filtered (0.22 µm) supernatant was loaded on a 5 mL HisTrap FF crude column (GE
Healthcare Life Sciences). After a wash step, the protein was eluted with 150 mM imidazole (CtErbB2)
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or 50 mM imidazole (Grb2). The purification tag was removed by TEV proteolytic cleavage, following
conditions given in figure 35. Unsurprisingly, even at low temperature and with small amounts of TEV, the
cleavage of CtErbB2 was complete, consistently with high accessibility due to disorder. On the contrary,
cleavage of the full-length Grb2 tag was never complete, even with overnight incubation at 34 ◦C. The same
observation was made for the NSH3 and NSH3SH2 constructs, suggesting that the His6 tag interacts with
the NSH3 domain of Grb2. It is consistent with the fact that for these three constructs, the affinity of the
tagged protein for the HisTrap column was low (the elution happened at low imidazole concentration, and
partial elution was observed upon changes of flow rates even with no imidazole in the buffer).
Protein Protein concentration Tev:protein ratio T Duration Gel well
CtErbB2 2.6 mg/mL
1:50
15 ◦C B
1:100 C
1:50 D
1:100
4 ◦C
overnight
E
Grb2
1 mg/mL
1:50
RT
2 h
2
0.5 mg/mL
34 ◦C 3
1:10
RT 4
34 ◦C 5
1 mg/mL
1:50
RT
4 h
7
0.5 mg/mL
34 ◦C 8
1:10
RT 9
34 ◦C 10
1 mg/mL
1:50
RT
overnight 6 and 11
two overnight incubations 12
34 ◦C 13
RT 140.5 mg/mL
1:10
34 ◦C
overnight
15
(a)
  A    B    C   D    E    F
50
37
75
25
20
15
His6-lipoyl-CtErbB2
CtErbB2
His6-lipoyl
Tev
(b)
1       2       3      4      5       6      7      8      9     10    11   12    13    14    15
75
50
37
25
15
20
(c)
Figure 35 – TEV cleavage conditions for CtErbB2 and Grb2. (a) Table of the different tests that were run. Chosen
conditions are highlighted in gray. Each test corresponds to a lane of the 15% SDS-PAGE gels given for CtErbB2 in
(b) and for Grb2 in (c). Chosen conditions are indicated with an arrow.
Since the TEV construct used contained a N-terminal His-tag, the excess of TEV protease and the
cleaved tag were removed using a Ni-NTA resin (Thermo Scientific). The proteins were further purified by
size exclusion chromatography using a Superdex-75 column (GE Healthcare Life Sciences) in MES buffer
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(CtErbB2) or PIPES buffer (Grb2). In some early experiments, PBS buffer was used for Grb2, before it was
changed for PIPES not to interfere with phosphotyrosine binding. The yield of [U-15N; U-13C]-CtErbB2
was about 6 mg for 1 L of M9 medium, while we obtained as much as 40 mg of [U-15N; U-13C; U-80%
2H]-Grb2 for a 1 L culture. For all constructs (CtErbB2 and Grb2), purity of the final samples as assessed
by SDS-PAGE was above 95%, and protein integrity was checked by mass spectrometry.
During all purification steps, great care was taken into keeping CtErbB2 samples at 4 ◦C, for its disordered
nature makes it particularly prone to proteolytic degradation. Even with these precautions, proteolysis
happened slowly over time, as seen from the appearance of numerous bands just below the one for CtErbB2
on SDS-PAGE gels before size exclusion chromatography (see figure 35b). Degradation was slowed down
after the final purification step, but was still visible after typically 1 to 2 weeks in the spectrometer at 25 ◦C,
even when antiprotease cocktails were used.
On the contrary, after the first affinity column, Grb2 was purified and kept at room temperature (except for
long term storage, at -80 ◦C). At temperatures below about 10 ◦C, Grb2 samples looked turbid and viscous
and the phenomenon was reversible. This was observed for the full-length protein, but also for the two
bidomain constructs.
4.2 Generation of viral stocks for protein expression in insects cells using the Bac-to-bac R©
expression system
This expression system was used to produce the whole intracellular region of ErbB2, to study ErbB2 tyrosine
phosphorylation, as exposed in section 10.
4.2.1 Principle of protein expression in Sf9 cells using the baculovirus expression system
The baculovirus expression system relies on the production of a recombinant protein via insertion of the
gene of interest into a viral genome, transfection of cells to produce a viral stock, and finally infection of
insect cells with this stock for protein expression. The time-consuming step of this expression system is the
generation of a viral stock for each construct that needs to be expressed. Once it is done, the transfection is
transient (there is no need to establish stable cell lines), fast and easy, and the protein can be harvested after
only of few days. Infected cells are Sf9 cells, which are relatively easy to grow and passage, since they can
be used both in adherent or suspension cultures.
The principle of the baculovirus Bac-to-bac R© expression system (Invitrogen) is shown in figure 36. The
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gene of interest is inserted in the viral genome in place of the gene coding for polyhedrin, a protein that is
usually expressed at high levels by the virus to form occlusion bodies protecting it from the environment.
Given that the viral plasmid (bacmid) is very large (around 130 kb), direct insertion of the gene of interest is
difficult. In the Bac-to-bac R© system, it is performed using transposition from a bacterial plasmid (pFastBac)
to the bacmid in a specific strain of E. coli optimized for transposition. Once the bacmid contains the gene
of interest, it is transfected into Sf9 cells for viral replication and creation of a viral stock, that can be
further amplified by other cycles of infection/harvest of the virus. Protein production then simply consists
of infection of Sf9 cells by addition of a controlled amount of the viral stock to the cell culture. The quantity
of virus added is usually given in terms of multiplicity of infection (MOI), which is the quantity of virus (in
plaque forming units, PFU) added per insect cell.
Figure 36 – Principle of protein production in insect cells using the baculovirus Bac-to-bac R© expression system
(Invitrogen)
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4.2.2 Generation of the viral stock
We thank Dr. Arnaud Poterszman and Simon Pichard (baculovirus platform, IGBMC, Illkirch) for their
advice and tests to guide us with this expression system. The bacmid was recombinantly generated in
DH10BacTM E. coli bacteria using the Bac-to-Bac R© Baculovirus Expression System protocol (Invitrogen).
The guidelines from the same protocol were followed for transfection and two cycles of virus amplification
(resulting in a viral stock called P3).
Briefly, MAX Efficiency R© DH10BacTM competent cells were transformed with our pFastBac TM construct
by a 42 ◦C heat shock and plated on LB agar plus kanamycin/gentamicin/tetracyclin/X-gal/IPTG plates.
After 48h at 37 ◦C, white colonies (for which both transformation and recombination of the gene of interest
into the bacmid were successful) were picked and restreaked for confirmation. Colony PCR with pUC/M13
Forward and Reverse primers, followed by agarose gel electrophoresis, was performed for confirmation of
successful recombination. Two clones with PCR products around 4 000 bp were selected and purified using
the NucleoBond R© Xtra Midi EF (Macherey-Nagel). Transfection of the bacmid into Sf9 insect cells was
performed in Grace’s medium using Cellfectin R© II reagent. Medium was collected 72 h after transfection
and incubation (27 ◦C, 120 rpm), and after removing cells and debris by centrifugation and filtration (0.22
µm), the first viral stock (P1) + 2% fetal bovine serum was stored at 4◦C in the dark. Two rounds of
amplification were performed: the viral stock to amplify was added to log-phase Sf9 cells at a MOI of 0.05-
0.1 and the medium was collected 3 to 7 days later to generate the new viral stock. This resulted in a final
viral stock (P3) used for protein production.
4.2.3 Determination of the viral stock titer by flow cytometry
Usually, viral titers are obtained using plaque assays. However, these assays take at least one week. An al-
ternative method was used using flow cytometry, and allowed the determination of viral titers in less than 24
hours. We thank Dr. Aurélie Albertini (I2BC, Gif-sur-Yvette) for the initial protocol. The method is based
on recognition of infected cells, that display the baculovirus envelop protein gp64, with a phycoerythrin
(PE)-conjugated anti-gp64 monoclonal antibody (AcV1, eBioscience). Determination of the proportion of
infected cells (single or multiple infection) with flow cytometry allows for estimation of the MOI assuming
a Poisson distribution.
2.106 Sf9 cells were infected with 100 µL of viral stock at different dilutions (from 1 to 1000-fold) in 6-well
plates, and incubated at 27 ◦C for 18 hours with shaking (120 rpm). Cells were washed with 750 µL PBS
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(by centrifugation at 450 g for 4 min and resuspension), centrifuged and resuspended in 100 µL of antibody
solution (diluted 200-fold in PBS). Antibody binding was performed by incubation for 45 min at 4 ◦C on a
rotative wheel. Cells were washed again with cold PBS, and final resuspension was performed in 300 µL
PBS for flow cytometry.
Flow cytometry is a single-cell analysis method. Briefly, cells are discriminated thanks to the measure
of forward-scattered light (FSC) that depends on their size, side-scattered light (SSC, at about 90 ◦) that
depends on their granularity (or internal complexity), and fluorescence. Here, cells were analyzed by in
a CytoFLEX S (Beckman Coulter) cytometer driven by the Cytexpert software. A first gating was made
on FSC-SSC dot plot to focus on cells; doublets were discarded using SSC Area-SSC Height dot plot.
PE fluorescence was excited by a 561-nm laser and collected through a 585/42 nm band pass filter. A
total of 15000-20000 cells was acquired for each condition. The threshold of fluorescence for consider-
ing a cell as a positive event for PE (infected cell) was chosen as the highest level of autofluorescence
observed for non-infected control cells. The present work has benefited from the CYTOMETRY facility
of Imagerie-Gif, (http://www.i2bc.paris-saclay.fr), member of IBiSA (http://www.ibisa.net),
supported by France BioImaging (ANR-10-INBS-04-01), and the Labex Saclay Plant Sciences (ANR-10-
LABX-0040-SPS).
Once the percentage of infected (fluorescent) cells was determined, the MOI was calculated assuming that
viral infection follows a Poisson distribution. That gives MOI = −ln(PNI), PNI being the percentage of
non-infected cells. Since MOI = NcellsNvirus with Ncells the number of infected cells and Nvirus the number of
inoculated viruses (in PFU), the viral titer was easily determined knowing the initial number of cells. For
the P3 viral stocks used, viral titer was between 1.108 and 5.108 PFU/mL, an expected value as provided by
the manufacturer.
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5 Nuclear Magnetic Resonance (NMR)
The typical samples for NMR studies were composed of 200-400 µM of protein, in 200 µL of buffer. We
used 3 mm NMR tubes. Three different spectrometers, each equipped with a TCI cryoprobe (1H, 13C, 15N,
2H) and z-axis pulsed field gradients, were used: a Bruker Avance III 950 MHz spectrometer (22.3 T), a
Bruker Avance III 800 MHz spectrometer (18.8 T), and a Bruker Avance I 600 MHz spectrometer (14.1 T)).
Data were processed using different successive versions of Topspin (from 3.2 to 3.7, Bruker) and analyzed
with CCPNMR (Vranken et al., 2005).
5.1 NMR samples, conditions, and assignments
5.1.1 Principles of heteronuclear sequential assignment of proteins
Thanks to advances in labeling and heteronuclear NMR pulse sequences and instrumentations, most NMR
studies of proteins now begin with the 1H, 15N and 13C backbone assignment of resonances. It relies on
the ability to transfer magnetization between nuclei, thanks to the scalar couplings along the chain. Most
commonly the excitation and observation are done on the proton, the most sensitive of the three nuclei
(γ1H ≈ 4γ13C ≈ −10γ15N). Using experiments transferring magnetization following a specific path, one is
able to link 1H, 15N and 13C resonances either in an intra-residue fashion, between sequential residues in the
sequence, or both. The assignment process then relies on two processes. The first one is the determination
of the nature of certain residues, using mainly 13Cα and 13Cβ chemical shifts: typically, Gly, Ala , Ser and
Thr have very recognizable patterns (see figure 37a). The second one is the identification of sequential links
between them, as described below.
A typical example is the one of the HNCACB (given in figure 37b), which links the amide group of a residue
i to both its 13Cα (green) and 13Cβ (blue) and the 13Cα and 13Cβ of the preceding residue (i-1). The goal is
then to find a HN strip (therefore belonging to another residue) that has its intra-residue 13Cα -13Cβ pattern
matching the i-1 13Cα -13Cβ pattern. This residue will therefore be assigned to i-1. When a sufficiently long
stretch has been sequentially assigned with at least some of its residue types identified, it can be matched to
sequences stretches expected from the known primary sequence of the protein.
This strategy works well in many cases, but others have to be implemented in certain cases, for example
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Figure 37 – Heteronuclear protein assignment. (a) Carbon chemical shift statistics for the 20 natural amino acid
types in a protein, from the Biological Magnetic Resonance Bank (BMRB, http: // www. bmrb. wisc. edu/ ) .
They allow unambiguous recognition of certain residue types (Gly, Ala, Ser and Thr mainly). (b) Principle of the
backbone sequential assignment of a [U-15N; U-13C]-labeled protein, with an HNCACB experiment. The intra-
residue carbon chemical shift pattern of a residue can be matched to the inter-residue carbon chemical shift pattern
of another residue, identifying them as sequentially linked.
when carbon labeling is not feasible, when long experiments such as HNCACB (several hours to days)
cannot be recorded due to limited stability of the sample, or when the protein is proline-rich, lacking many
backbone amide proton and therefore creating too many interruptions in the sequential assignment. We had
to use some of these strategies for CtErbB2, and they are described below.
5.1.2 Backbone and side-chains assignment of CtErbB2
Unless otherwise stated, CtErbB2 was studied in MES buffer pH 5.6 (see table 2) and spectra were recorded
at 298 K. Consistently with reasons stated in 1.5.2, these acidic, low temperature conditions seemed optimal
for this protein. Assignment experiments were performed at proton frequencies of 950 MHz or 800 MHz.
High fields are absolutely necessary for a disordered protein of this size, for better resolution: 227 1H-
15N HSQC backbone cross peaks are expected (228 non-proline residues, minus the N-terminal glycine for
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which unfavorable exchange is expected) in a proton dispersion range of about 1ppm only.
For backbone assignment, 3D HNCO, HN(CA)CO, HNCA, HNCACB, HN(CO)CA, HN(CO)CACB, HN-
CANH and HN(CO)CANH spectra were used. The last two experiments enable one to directly link back-
bone amides of sequential residues, and are particularly convenient and applicable to IDPs, since they re-
quire long signal lifetime for long magnetization transfer. All 3D experiments were recorded as BEST
(band-selective excitation short-transient) experiments (Lescop et al., 2007). This technique allows reduc-
tion of the inter-scan delay (and thus great reduction of the experiment time) by optimizing longitudinal 1H
relaxation. The assignment of residue 161 (between prolines) was performed thanks to an HSQC spectrum
of the Q161A mutant. For quick reassignment of the 1H-15N HSQC spectra upon slight spectral changes
(temperature, pH, single point mutation...), HADAMAC experiments were used (Lescop et al., 2008). These
amino acid-type edited experiments enable to distinguish 7 groups of residues, depending on side-chain C-
C and C-H multiplicity, presence and chemical shift range of 13Cβ , and number of carbonyl and aliphatic
13Cγ . The output spectrum is a pseudo-3D in which each 1H-15N HSQC plane contains the amide peaks of
all residues following a particular amino acid type. For example, one plane will contain the amide peaks of
all residues following a glycine. A superimposition of all the planes of an HADAMAC experiment used for
assignment confirmation of the C146S mutant is shown in figure 38.
The side chains were assigned with 3D H(C)C(CO)NH, (H)CC(CO)NH, HBHANH and HBHA(CO)NH
experiments.
To assign the particularly challenging proline-rich regions (CtErbB2 contains 44 prolines), we recorded:
• proton-detected HCAN, HCANi and HACA(CO)N 3D spectra, correlating 1Hα and 13Cα of residue i
to 15N of residue i and/or i+1
• a 13C-detected 2D CON spectrum, correlating 15N of residue i to 13C’ residues i and i-1
5.1.3 Backbone assignment of Grb2
Due to difficulties in removing the His6 purification tag, some His-tagged constructs were assigned and
studied, in addition to the tag-cleaved constructs. Therefore the following constructs have been assigned:
His-NSH3, NSH3, SH2, CSH3, His-NSH3SH2, NSH3SH2, SH2CSH3, His-Grb2 and Grb2 (Grb2 refers
to the full-length construct). Unless otherwise stated, they were assigned and studied in PIPES buffer at
pH 7.2 (see table 2). Assignment in PBS buffer was also initially performed, but left largely unused due to
70
5. Nuclear Magnetic Resonance (NMR)
δ(1H) (ppm)
Residues i with i-1 being:
D or N
T
A, V or I
C, Y, F, W or H
G
S
Any residue
Any residue except P
δ
(15
N
) (
pp
m
)
Figure 38 – HADAMAC experiment for quick confirmation of the assignment of the C146S mutant of CtErbB2. Here
is shown the superposition of the 8 planes of the pseudo-3D.
observed interaction of the SH2 domain with phosphate that could interfere with the observation of SH2-
phosphotyrosine interactions. The only construct for which the assignment was not transferred from PBS to
PIPES buffer was the His-tagged NSH3 domain. Spectra were recorded at 308 K. Assignment experiments
were mostly recorded at 600 MHz, for it gave the narrowest peaks due to the exchange processes at stake in
the NSH3, but some experiments were also recorded at 800 or 950 MHz.
Backbone and 13Cβ assignments of all three individual domain constructs were performed on [U-15N;
U-13C]-labeled samples, using different combinations of 3D experiments: HNCO, HN(CA)CO, HNCA,
HN(CO)CA, HNCACB, HN(CO)CACB and HNCANH in their BEST versions (Lescop et al., 2007). Back-
bone 1H-15N assignment of the SH2CSH3 bidomain was performed on a [U-15N; U-13C]-labeled sample
mainly from transfer of the assignments of the SH2 and CSH3 monodomains thanks to good superimposi-
tion, and confirmed with HNCACB and HN(CO)CACB spectra. Assignments of the NSH3SH2 bidomain
and of full-length Grb2 were performed on [U-15N; U-13C; U-80% 2H]-labeled samples using the same
types of experiments as for monodomains, occasionally transferring assignments from the isolated domains
when necessary and possible. For the bidomains and FL Grb2, the 3D experiments were recorded in the
BEST-TROSY version. TROSY (transverse relaxation-optimized spectroscopy)-based experiments (Per-
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vushin et al., 1997) take advantage of the different widths of the components of a J-coupling multiplet. The
component for which chemical shift anisotropy and dipole-dipole coupling effects on transverse relaxation
cancel most efficiently is selected. This cancellation is best achieved at high fields. The technique gives nar-
rower peaks than common experiments, increasing sensitivity and resolution, and is particularly interesting
for large proteins with fast transverse relaxation.
5.2 Chemical shift analysis
Chemical shifts of protein residues depend on a variety of parameters, mainly amino acid type and neighbors,
experimental conditions such as buffer composition, pH and temperature, but also, and most interestingly
for us, on local structure. The nuclei most commonly used for prediction, because their chemical shifts are
mostly influenced by secondary structure, are 13Cα , 13Cβ and 13CO. Amide proton and nitrogen chemical
shifts are too strongly dependent on experimental conditions (pH, temperature), and are therefore more dif-
ficult to relate to secondary structure. It is to be noted that chemical shifts are also dependent on tertiary
structure, but the effects are more subtle and less easy to predict.
Secondary structure calculations For Grb2, structural integrity of the individual domains (which struc-
tures are known) was verified using chemical shifts and TALOS + (https://spin.niddk.nih.gov/bax/
nmrserver/talos/) (Shen et al., 2009). TALOS+ uses a set of 200 proteins which extensive chemical shift
information have been deposited to the BMRB and for which a crystal structure is known. A neural network
algorithm trained on this database then allows for prediction of backbone dihedral angles and secondary
structure from chemical shifts and residue types.
For disordered proteins or regions, for which we look for structural propensities rather than stable structures,
propensities are most often quantified using secondary chemical shifts (Wishart and Sykes, 1994) defined as
∆δ = δ −δRC
where δRC is the expected chemical shift for a random coil. Different calculation methods exist, using
different random coil chemical shifts databases. We used one of the most common ones, the SSP method
(Marsh et al., 2006). This method takes into account several chemical shifts, weighted by the sensitivity of
the corresponding nucleus to secondary structures, and returns a score that is expected to be a quantitative
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estimate of the propensity for secondary structure. SSP scores are often simplified saying that a positive
score indicates α helices and that negative scores indicate β -strands. However, this interpretation ignores the
other types of structures, that can be important. More precisely, compact structures, which we can define as
structures with a translation per residue typically below 2 Å, have a positive score. Most commonly, positive
SSPs therefore indicate the presence of a α-helix, but can also point to 310 helices. Although PPI helices,
which are right-handed polyproline helices with only cis peptide bonds, are compact structures and could
theoretically also be included in positive SSP types of structure, they have never been observed in water so
far. Regions folding into extended structures, β -sheets but also PPII helices, with a typical translation per
residue above 3 Å, have negative SSP scores. With default settings (that we used), the scores are averaged
over 5 residues to smooth the profile. As recommended for disordered proteins, only 13Cα , 13Cβ and 1Hα
chemical shifts were used. The residues preceding prolines were removed from the calculation, since their
chemical shifts are often extreme outliers.
Combined chemical shift perturbations (CCSP) When comparing spectra from different constructs or
between different conditions (temperature, pH, presence of an interaction partner...) its is convenient to
combine the chemical shift differences of several nuclei into a single value. To do so, the contributions from
the different nuclei need to be weighted either by their gyromagnetic ratio or by the relative width of their
chemical shift range. Therefore, to combine 1H and 15N chemical shift perturbation information, we used
CCSP =
√
(∆δ1H)2+(0.15∆δ15N)2.
5.3 15N relaxation studies
5.3.1 Dynamic information given by 15N relaxation parameters. Expectations for globular proteins
and IDPs.
Longitudinal (R1) and transverse (R2) 15N relaxation rates, as well as steady-state heteronuclear {1H}-15N
nuclear Overhauser effect values (hereafter simply referred to as {1H}-15N nOes) are routinely recorded to
study protein dynamics. Each of these parameters is sensitive to different reorientation timescales of the
N-H bond. While {1H}-15N nOes, sensitive to frequencies in the range of the proton resonance, account
for dynamics in the sub-ns timescale, R1 and R2 rates are mainly sensitive to the contribution in the range
of the nitrogen frequency (a few ns). The dependence of each parameters on the rotational correlation time
τC of the NH bond, in a model of Brownian motions with a restricted libration (S2 = 0.8, τi = 50ps), is
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given in figure 39. Additionally, R2 is sensitive to slower dynamics, in the µs-ms timescale, and therefore
to exchange processes commonly observed in proteins.
For a denatured or unfolded protein, a simple polymer model described by Schwalbe et al. (1997) suggests
that the relaxation parameters should have bell shapes. The profile should be flat at the center of the protein,
with increased flexibility (decreased R1, R2 and {1H}-15N nOes) at the extremities, governed by the length
of the statistical element of the polymer. For a denatured protein, this length is empirically about 7 residues.
Any difference from this bell-shape therefore indicates deviation from a random coil behavior. The use of
NMR relaxation data for the investigation of intrinsically disordered protein is not trivial and is still being
developed, as reviewed by Salvi et al. (2017).
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Figure 39 – Expected 15N R1, R2 and {1H}-15N nOes for a chain with NH bonds experiencing a single rotational
correlation time τC and libration with an order parameter S2 = 0.8 and internal correlation time τi = 50ps. The
curves are drawn for two magnetic fields, 14.1 T (corresponding to a proton resonance frequency of 600 MHz) and
22.3 T (950 MHz proton frequency).
5.3.2 NMR experiments and analysis
For CtErbB2, the three parameters mentioned above were measured at proton frequencies of 600 and
950 MHz (nitrogen frequencies of about 60 and 95 MHz), on [U-15N] labeled samples to prevent arte-
facts from 13C coupling. The pulse-sequences used were the HSQC-based pulse sequence implemented by
Bruker as interleaved pseudo-3D experiments. 10 to 14 delays were used: from 20 ms to 2 s for R1 mea-
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surements, and from 4 to 450 ms for R2 measurements, with one delay being measured three times for error
estimation. Relaxation rates were extracted fitting the curves to a mono-exponential decay. {1H}-15N nOes
were measured with a TROSY-based Bruker pulse sequence using 120◦ pulses every 5 ms for 4 s for proton
saturation. They were calculated as the intensity ratio of each peak in the experiment with or without proton
saturation.
For Grb2, R1, R2 and {1H}-15N nOes were measured at 800 MHz, on [U-15N; U-13C; U-80% 2H] samples,
with carbon decoupling. Other than that, the pulse sequences were the same as for CtErbB2, with delays
ranging from 17 to 305 ms for R2 measurements, and from 20 ms to 1.8 s for R1 measurements. From
the R1 and R2 rates, in absence of conformational exchange contribution, it is possible to approximate the
rotational correlation time τC using the equation τC ≈ 14piνN
√
6 R2R1 −7 (Fushman et al., 1994). We compared
this value with the value of τC derived from the Stokes-Einstein (SE) equation for an ideal spherical object.
It was shown than τC (SE) found with the Stokes-Einstein equation was overestimated by a factor of two for
globular proteins, giving after correction: τC ≈ τC(SE)2 = 12DR =
4piηr3
kBT
(Halle and Davidovic, 2003), where DR
is the rotational diffusion coefficient, η the viscosity of the buffer and r the radius of the sphere. Considering
a globular, spherical protein with a partial specific volume of 0.73cm3.g−1 and with a viscosity of the buffer
of 0.72 mPa.s at 308 K, it yields an estimated τC at this temperature τC ≈ 0.615∗MW with τC in ns and MW
the molecular weight in kDa.
5.4 Scalar couplings
Proton scalar couplings (or JHH couplings) in a protein depend on dihedral angles, and thus give information
about the local conformation of the polypeptide chain. An empirical formula described by Karplus links
J values to the dihedral angle φ (Karplus, 1959): 3JHH(φ) = Ccos(2φ) + Bcos(φ) + A. However, it is
sometimes difficult to find the most accurate Karplus parameters A, B and C, that depend greatly on the
sequence of the protein and experimental conditions.
Here, homonuclear 3JHNHα coupling constants were measured using the Bruker-implemented version of
the 3D HNHA experiment of Vuister and Bax (Vuister and Bax, 1993). To analyze them more accurately,
without the need to calculate dihedral angles, we compared them to 3JHNHα calculated for our sequence
supposing it is in a random coil conformation, using the server https://spin.niddk.nih.gov/bax/
nmrserver/rc_3Jhnha/ (Shen et al., 2018), that takes into account sample temperature and pressure.
While 3JHNHα higher than random coil indicate propensity for β -sheets, α helices have values lower than
random coil, and PPII helices close or slightly lower than random coil (Smith et al., 1996).
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5.5 Residual dipolar couplings (RDCs)
5.5.1 (Residual) dipolar couplings
Dipolar coupling, in NMR, is an anisotropic interaction between two nuclear spins (that behave as magnetic
dipoles), through space. The strength of this interaction between spin i and j is
Di j(θ ,ri j) =−γiγ jh¯µ04pi2r3i j
<
3cos2(θ)−1
2
>
where θ is the angle between the internuclear ij vector and the static magnetic field B0 (as shown in fig-
ure 40a for the N-H bond of a protein), and ri j is the distance between the nuclei, supposed constant in the
case of nuclei linked by a covalent bond. Even though the magnetic susceptibility tensor of proteins are
not strictly isotropic, because of spatial and time averaging due to tumbling, in solution dipolar couplings
average to 0. However, dipolar couplings can give valuable information on local orientation. It is possible
to reintroduce them partially using slightly anisotropic media, and thus have access to this information in
high resolution solution state NMR. They are then called residual dipolar couplings, or RDCs.
5.5.2 Expected RDCs for an IDP
Here we focus on backbone N-H RDCs, or 1DNH, which are the easiest one to measure for a protein.
Measurement of other types of RDCs often requires longer acquisition times, and increases the risk of
protein degradation and/or dealignment of the medium. As shown in figure 40a, in the most common media
that are aligned parallel to the magnetic field, α helices have their backbone N-H bonds roughly parallel
to the direction of the chain and will give positive RDCs. Extended structures, such as β -sheets or PPII
helices, with their N-H bond roughly perpendicular to the direction of the chain, will give negative RDCs.
For a random coil, even when molecular tumbling is partially suppressed, absence of preferred orientation
of the chain should intuitively result in spatial averaging and absence of measurable RDCs, as shown in
blue in figure 40b. However, excluded volume effects locally constrain the chain, in a manner dependent
on the type of amino-acid (Bernadó et al., 2005). This leads to expected RDC values mainly negative for
disordered proteins (red and green in figure 40b). Deviation from the values determined for a statistical coil
samplings indicates propensities for more extended (lower values) or α helical (higher values) structures.
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(a) (b)
Figure 40 – Expected RDCs (a) θ angles of NH bonds relative to the magnetic field expected for extended (A) and
α helical (B) structures. For extended structures, θ is close to 90◦, while for α helices θ is close to 0. From Jensen
et al. (2009). (b) Expected RDC values calculated with Flexible Meccano (see section 6.3) for a poly-valine chain
sampling the statistical coil populations for this amino-acid (red) and for an arbitrary protein sequence, sampling
statistical coil populations determined for each amino-acid type (green), or with completely random sampling of
dihedral angles (blue). From Milles et al. (2018).
5.5.3 Protocol
Common aligning media include bicelles or bacteriophages, which due to their large anisotropic magnetic
susceptibility align the medium parallel to the magnetic field. Acrylamide gels are also used, and can be
compressed or stretched parallel or perpendicular to the NMR tube and therefore to the magnetic field.
Alignment in bicelles or phages is stronger (dozens of Hz compared to a few Hz in acrylamide gels), result-
ing in more precise measurement of RDCs. However, the choice of the aligning medium must also take into
account its (non) interaction with the protein of interest, that can be verified comparing the spectra in solu-
tion and in the alignment media. In our case, we found that PEG-hexanol mixtures interact with CtErbB2,
resulting in heterogeneous peak broadening, and aberrant measurements of RDCs. We therefore chose the
acrylamide gels, which was another technique that had been tested in the lab, and seemed less prone to yield
specific interactions with proteins.
We used the method described by Chou et al. (2001). 6% acrylamide gels were polymerized in the MES
buffer in a cylindrical chamber of 6mm diameter, cut to a length of 1cm, and then dialyzed in water
overnight. The gels were then allowed to dry for several days at room temperature, and then stocked up
to several months before use.
A BEST-type 1H-15N HSQC-IPAP spectrum of the protein was recorded in the standard buffer and condi-
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tions with 2048 points in the indirect dimension, at 800 MHz. This spectrum allowed measurement of N-H
scalar couplings. A gel was then rehydrated with 300 µL of this same protein solution, in the 6 mm cham-
ber, for two days. It was then transferred carefully into a 5 mm, open-ended, Shigemi tube, which forced it
to stretch, and left to settle overnight. The same BEST-type 1H-15N HSQC-IPAP was recorded, allowing to
measure the sum of scalar and RDCs, and to calculate the RDCs. The whole experiment was repeated with
a new sample, to check reproducibility and estimate errors. Each time, the obtained alignment was verified
using a 1D deuterium spectrum, giving deuterium quadripolar splitting of respectively 4.98 and 5.66 Hz.
5.6 Paramagnetic relaxation enhancements (PREs)
Principle In NMR of globular proteins, distance information is routinely derived from nOe data. In most
cases, the contacts in IDPs are too transient to give rise to a significant nuclear Overhauser effect. PRE
experiments use the very high gyromagnetic ratio of unpaired electrons (more than 600 times higher than the
one of proton) to generate stronger dipolar interactions. If a paramagnetic species is introduced at a specific
position of the IDP sequence, nuclei close in space (as schematized by the red sphere in figure 41a) will relax
faster and their peaks will have decreased intensity. Usually, the introduction of a paramagnetic species is
done by coupling of a nitroxide compound on a cysteine via a disulfide bond. Typically, 1H-15N HSQC
peaks of residues adjacent to the paramagnetic species become invisible, and the peaks of the residues that
are brought close (even transiently) to the probe by long-range contacts will also show decreased intensity.
An example is shown for CtErbB2 in figure 41b: introduction of the paramagnetic probe on position 227
induced decreased intensity of the peaks of residues relatively close in the sequence (e.g. residues 214 and
244), but also of residues that are far in the sequence (e.g. residue 42), revealing a long-range contact.
Protocol Four mutants of CtErbB2 were used to couple a nitroxide probe on four different cysteines in
separate experiments: C146S, C45S, (C45S,C146S,S227C) and (C45S,C146S,S248C) (for respective para-
magnetic tags on C45, C146, C227 and C248). These [U-15N; U-13C]-labeled mutants were reduced with
10 mM TCEP. TCEP was removed (using ZebaSpin Desalting columns, ThermoScientific), and the mutants
were incubated at 15◦C overnight with the paramagnetic probe (1:10 protein:probe molar ratio) in a 20 mM
sodium borate buffer at pH 8.0. The buffer was then exchanged for the MES buffer pH 5.6, removing the
excess of free paramagnetic probe. The 1H-15N HSQC spectrum of this paramagnetic form was recorded at
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Figure 41 – PRE experiments. (a) The paramagnetic probe, coupled on a cysteine residue of the protein, induces
an increase in relaxation for any nucleus nearby (in a radius of about 20 Å represented here as a red sphere). The
closer the nucleus, the faster its relaxation, the lower its resonance intensity. From Kosol et al. (2013). (b) Example
of a PRE experiment on CtErbB2 (where the MTSL probe is coupled on residue 227). In black is the spectrum of the
sample where the probe is reduced (diamagnetic, no effect on relaxation) and in red is the spectrum of the sample
where the probe is in its oxidized state (paramagnetic).
950 MHz. The probe coupling was total, as assessed by MALDI-TOF mass spectrometry (data not shown).
To obtain a reference spectrum of the non-paramagnetic protein, the sample was reduced with ascorbic acid
(1:6 protein:ascorbic acid molar ratio) and a second HSQC spectrum was acquired. The assignment of this
reference spectrum was verified by recording BEST-HNCA, BEST-HNCACB, BEST-HN(CO)CACB and
HADAMAC experiments. Except for the peaks adjacent to the probe-coupled cysteine, no chemical shift
difference was observed compared to the uncoupled protein, which ensured that the probe did not have any
impact other than local on the structural ensemble of CtErbB2.
The probes that were used in this study are 3-(2-Iodoacetamido)-PROXYL (IAP) and S-(1-oxyl-2,2,5,5-
tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl methanesulfonothioate (MTSL). We observed two sets of
peaks for residues close to the IAP-coupled cysteine in the reduced form, indicating that the IAP probe was
actually a racemic mixture. This prevented measurement of accurate intensities. This was not observed for
MTSL, and therefore only the results with this second probe where kept. However, even without quantifica-
tion, we could observe that the perturbed residues were the same with IAP than with MTSL.
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5.7 NMR titrations
All NMR titrations between Grb2 and CtErbB2 (or CtErbB2 peptides) were recorded in the PIPES buffer
(see table 2), at 298 K. The buffer was chosen for the pH to be closer to the physiological pH (compared to
the MES buffer pH 5.6 used for the study of CtErbB2), and the temperature was chosen to be 298 K to avoid
degradation of CtErbB2 over time (even though the optimal temperature for the stability and spectral quality
of Grb2 is 308 K). Spectra were recorded at 950 MHz when studying the effect of binding on CtErbB2, and
600 MHz when studying the effect of binding on Grb2. For each point of a titration, 1H-15N HSQC spectra
with identical parameters were recorded.
Titration of labeled CtErbB2 by unlabeled Grb2 Before titration, backbone assignment of CtErbB2 in
PIPES buffer at 298 K was performed using HNCACB and HN(CO)CACB experiments. The titration was
done on a 50 µM [U-15N; U-13C] unphosphorylated sample of CtErbB2. Addition of a sample of unlabeled
FL Grb2 at 1.2 mM in the same buffer was done progressively to have titration points with CtErbB2:Grb2
ratios of 1:0, 1:1, 1:2, 1:5 and 1:10. Because the addition of Grb2 caused dilution, the final sample was
concentrated back to its initial volume of 200 µL.
Titration of labeled Grb2 by unlabeled CtErbB2 Before titration, backbone assignment of Grb2 at 298
K was performed. The titration was done on a [U-15N; U-13C; U-80% 2H]-labeled sample of Grb2 at
100 µM. Unlabeled, unphosphorylated CtErbB2 at 3.6 mM was added progressively to give Grb2:CtErbB2
ratios of 1:0, 1:1, 1:2, 1:3 and 1:5.
Titration of labeled Grb2 by unlabeled peptides of Grb2 The unphosphorylated P1 (sequence VAPLTC-
SPQPEYVNQPDVRPQPPSPREGPLPAARPA) and phosphorylated P2 (VAPLTCSPQPEpYVNQPDVR-
PQPPSPREGPLPAARPA) peptides were purchased from Schafer-N (Copenhagen), their pH was adjusted
to 7 in water and they were lyophilized for titration experiments. Each titration was done on a [U-15N; U-
13C; U-80% 2H]-labeled sample of Grb2 at 100 µM. Peptides were added to final successive Grb2:peptide
ratios of 1:0, 1:0.25, 1:0.5, 1:1, 1:2, 1:5, 1:10 and 1:20.
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6 Other biochemical, biophysical and bioinformatic techniques
6.1 Circular dichroism (CD)
6.1.1 CD of folded and unfolded proteins
Circular dichroism is based on the principle that optically active solutions have different molar extinction
coefficients ε at a given wavelength for left and right circularly polarized light. This difference is measured
with the ellipticity, θ , which is defined as θ = tan−1(b/a) where b and a are the minor and major axes of
the ellipse formed by the resulting electric field vectors. The results are often normalized with molarity,
using the molar ellipticity in deg.cm2.dmol−1 [θ ] = 100θCl , where C is the molar concentration in M and l
the path length of the cell in cm. For polymers (and especially proteins), it can be further normalized with
the number of monomers. For proteins it gives the molar ellipticity per residue MER = [θ ]n where n is the
number of residues in the protein.
Far-UV CD allows one to distinguish, and roughly quantify, the presence of different secondary structures
in a protein. Spectra of different pure secondary structures are given in figure 42. Usually, PPII helices
are not taken into account in CD studies, and are classified as "random coil". From denaturation studies of
collagen, it has been suggested that the positive peak around 220 nm observed on the spectrum attributed to
random coil actually arises from PPII structures (Lopes et al., 2014).
M
ER
Figure 42 – Circular dichroism spectra of pure α-helix (yellow), pure β -sheet (blue), and pure random coil (red).
From Dodero (2011).
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6.1.2 Protocol
The sample for CD measurements was CtErbB2 at 198µM in the same buffer as the one for NMR. Mea-
surements were performed on a Jasco J-810 spectropolarimeter, in a 0.01 mm path length quartz cell. The
wavelength range was 190-260 nm, with a step of 0.1 nm. Temperature was controlled to 298 K using a
sample cell temperature control unit (PFD 423S/L Peltier). The spectra consist of an average of 10 scans
acquired at 50 nm/min, with buffer substraction and normalization of the signal with protein concentration
and number of residues to yield results in molar ellipticity per residue (MER).
6.2 Small-angle X-ray scattering (SAXS)
6.2.1 Principle of SAXS
SAXS gives structural information at low resolution, such as the size and shape of a macromolecule. It is a
method complementary to high-resolution techniques, and especially solution-state NMR, for the descrip-
tion of proteins in solution. The schematic representation of a SAXS experiment is given in figure 43a. A
quartz capillary containing the solution to analyze is placed in front of a collimated monochromatic X-ray
beam, and the intensity scattered by the sample is measured as a function of the momentum transfer q, also
sometimes noted s, which is equal to 4pisin(θ)λ , where 2θ is the scattering angle. The requirement in terms of
sample quantity and buffer are roughly equivalent to NMR, but the sample has to be monodisperse (typically
a single oligomeric state should be present). The sample should also be diluted enough so that intermolecu-
lar distances do not overlap with intramolecular distances information (the solution needs to be ideal).
The first parameters that can be obtained by SAXS are the radius of gyration Rg of the particle and its
molecular weight. This is usually done using the Guinier approximation
ln(I(q)) = ln(I(0))− q
2R2g
3
which is valid in the region of small angles (the limit is usually set at qRg < 1.0). The linear fitting of the
Guinier plot (ln(I(q)) as a function of q2) in this region gives I(0) and Rg. From I(0), knowing the concen-
tration of the protein and estimating its partial specific volume from its sequence, an estimated molecular
weight can be extracted. For IDPs, for which some conformations can have a very high radius of gyration,
the Guinier region may be too narrow to extract reliable parameters. The distance distribution function P(r)
may then be used.
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P(r) is the autocorrelation function of the scattering curve, and is calculated via an inverse Fourier transform:
P(r) = 2r2
∫ ∞
0
q2I(q)
sin(qr)
qr
dq
It gives an histogram of the interatomic distances of the protein, and thus information on the shape of the
protein. It gives Dmax, the maximum r for which P(r) 6= 0. Rg and I(0) can also be extracted from the P(r)
distribution, allowing to get rid of the Guinier limitations:
R2g =
∫ Dmax
0 r
2P(r)dr
2
∫ Dmax
0 P(r)dr
I(0) = 4pi
∫ Dmax
0
P(r)dr
The Kratky plot is a useful representation of SAXS data. It gives graphical information about the shape
of the protein, and especially about its ordered or disordered nature, as shown in the following section. The
original Kratky plot is a plot of q2I(q) as a function of q. A normalized version was proposed by Durand
et al. (2010), plotting (qRg)2
I(q)
I(0) , and allowing to directly compare proteins.
Examples of simulated scattering curves, P(r) distributions Kratky plots and dimensionless Kratky plots
are given in figure 43b. One can clearly distinguish a globular from a modular or disordered protein. In
particular, the dimensionless Kratky plot has a maximum at coordinates (
√
3,1.1) for globular proteins, and
a plateau or increase at high q for disordered proteins. The use of SAXS for disordered proteins has been
reviewed by Kikhney and Svergun (2015) and Receveur-Brechot and Durand (2012).
6.2.2 Data acquisition
CtErbB2 The samples were similar than those for NMR, except that the protein was not isotopically la-
beled. The sample was extensively dialyzed in the MES buffer before SAXS measurements, and the dialysis
buffer was used for SAXS buffer substraction. Data acquisition was performed by Dr. Dominique Durand.
The sample was placed in a capillary cell of 1.8 mm diameter at 285 K. The curves were recorded on a
Bruker Nanostar instrument equipped with a Microstar rotating anode (λ=1.54 Å). The Vantec bidimen-
sional detector was placed 75 cm away from the sample. Data for the buffer and the sample were recorded
in an interleaved manner (10 one-hour recordings for each), and the buffer curves were averaged and sub-
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(a)
(b)
x
Figure 43 – SAXS of globular or (partially) disordered proteins (a) Schematic principle of a SAXS experiment. (b)
Simulated SAXS scattering curve (A), P(r) distribution (B), Kratky plot (C) and dimensionless Kratky plot (D) for a
60 kDa protein, globular (dark blue), 50% unfolded (light blue) or completely unfolded (grey). From Kikhney and
Svergun (2015).
stracted from the sample curves. The curves were normalized to the intensity of pure water. Absence of
radiation damage was checked comparing curves over time. Several concentrations ranging from 50 to 200
µM were tested, yielding no difference in scattering, indicating the absence of oligomerization effects. The
curves with more signal-to-noise ratio (at 200 µM) were therefore chosen for analysis.
Grb2 The SAXS measurements were done at the SWING beamline at the SOLEIL synchrotron (Saint
Aubin, France) with Dr. Aurélien Thureau. The samples were injected at a flux of 0.3 mL/min into an Ag-
ilent Bio SEC-3-300 size exclusion column pre-equilibrated in the PIPES buffer (see table 2) and mounted
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on an HPLC system, prior to its analysis in the X-ray beam (David and Pérez, 2009). 60 µL at 4.1 mg/mL,
50 µL at 11.4 mg/mL and 80 µL at 2.1 mg/mL for respectively full-length Grb2, the NSH3SH2 bidomain
and the SH2CSH3 bidomain were injected. The X-ray energy was 12 keV (λ = 1.033 Å). The Eiger 4M
pixel detector was used, at a distance of 2 m. Images were measured with 990ms exposure and 10 ms dead
time, before void volume for the buffer (180 images) and after void volume for the sample (810 images).
6.2.3 Data analysis
CtErbB2 Data analysis was performed with Dr. Dominique Durand (Biochemistry, Biophysics and Struc-
tural Biology Department, I2BC, Orsay). The PRIMUS program (Konarev et al., 2003) was used for the
analysis of scattering curves. The P(r) distance distribution was calculated using the GNOM program (Sver-
gun, 1992). The dimensionless Kratky plot calculation was made according to Durand et al. (2010).
Given that CtErbB2 is highly disordered, we tried to fit the scattering curve to a polymer model, the wormlike
chain model, using the Sharp-Bloomfield equation (Sharp and Bloomfield, 1968; Pedersen and Schurten-
berger, 1996). This model from polymer physics assumes continuous flexibility along the chain, with ex-
cluded volume effects. This kind of model had been previously successfully used to analyze the behavior
of intrinsically disordered proteins (Receveur-Brechot and Durand, 2012; Obrien et al., 2015). This model
assumes:
I(q)
I(0)
= ISB(q)e−q
2R2c/2
where
• ISB(q) = gD(x)+ bL
( 4
15 +
7
15x − (1115 + 715x)e−x
)
• gD(x) = 2 e−x+x−1x2 is the Debye function (Pérez et al., 2001)
• x = q2Lb/6
• L is the contour length of the chain
• b is the length of the statistical element
• Rc is the radius of gyration of cross section
The parameters obtained from the SAXS curves and from this model could then be compared to expected
values for random coils. The theoretical value of the contour length for a protein is calculated as L = Nl0 f
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where N is the number of residues, l0 is the distance between two sequential Cα , and f is a geometrical
factor taking into account dihedral angles. For an unstructured protein we took l0 = 3.78 Å and f = 0.95 as
in (Receveur-Brechot and Durand, 2012). The radius of gyration Rg can be estimated using Flory theory
giving Rg = R0Nν , where R0 and ν depend on the behavior of the polymer in solution. While for globular
proteins empirical parameters R0 =
√
3/5 ∗ 4.75 and ν = 0.29 have been found (Wilkins et al., 1999), the
behavior of IDPs is quite different, giving R0 = 2.54 and ν = 0.522 (Bernadó and Blackledge, 2009).
Grb2 Data analysis was performed by Dr. Aurélien Thureau (SWING beamline, SOLEIL synchrotron,
Saint Aubin). The curves were processed using the FOXTROT program (https://www.synchrotron-soleil.
fr/en/beamlines/swing) developed at the SOLEIL synchrotron. The curves derived from buffer mea-
surement were averaged and subtracted from the protein curves. Then the radius of gyration Rg was calcu-
lated using a Guinier plot on the most intense curve and extended to all scattering curves, thus producing
a plot of Rg and scattered intensity, I0, for all images. The curves with a stable Rg value were then aver-
aged to produce the protein scattering curve of scattered intensity as a function of the momentum transfer
q = 4pisin(θ)λ , where 2θ is the diffusion angle and λ is the wavelength. Further analysis (Guinier, Radius of
gyration Rg, intensity at origin I0 calculation, distance distribution function P(r), and MW estimation) were
performed with the ATSAS program suite (Franke et al., 2017). The dimensionless Kratky plots were cal-
culated based on Durand et al. (2010). The generation of the theoretical SAXS curves and their comparison
with the experimental ones were done using Crysol 2.8.2 (Svergun et al., 1995).
For constructs for which the SAXS curves derived from the crystal structure did not fit the experimental
data, we wanted to have an idea of the type of rearrangement of the domains that would fit the data better.
EOM is a program allowing the generation of statistical ensembles of proteins with flexible parts, and select
sub-ensembles that fit the SAXS data. EOM 2.0 (Tria et al., 2015; Bernadó et al., 2007) was used to gener-
ate 10,000 structures based on the crystal structure (PDB 1GRI) as the template. The 2 N-terminal residues
from the experimental constructs, and flexible parts missing in the crystal were added to the template. Three
structural pools were generated for each combination (either full-length Grb2 or NSH3SH2, or SH2CSH3).
The 2 linkers (residues 57-65, 154-160) and the C-terminal part (residues 215-219) were considered as flex-
ible regions. Five runs of 100 independent cycles of the EOM2.0 Genetic Algorithm (Gajoe) were run on
each structural pool to estimate the variability in the distribution of the Rg values.
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6.3 Generation of conformational ensembles: Flexible Meccano
We used Flexible Meccano (Ozenne et al., 2012) to generate conformational ensembles of CtErbB2. Flexible
Meccano generates multiple random conformations of a given protein chain using a minimization algorithm.
It takes into account residue-specific dihedral angles distribution restraints (from a X-ray crystallography
database) and volume exclusion effects. We used Flexible Meccano to generate two ensembles. The number
of conformations (10 000 for each ensemble) was set after testing different sizes and verifying convergence.
• First ensemble: a random coil ensemble with no local or long-range constraints.
• Second ensemble: an ensemble with constrained secondary structure propensities derived from the
SSP scores and slightly adjusted to best fit the RDC data. In this ensemble, the α-helix was imple-
mented between residues 15 and 20, with a 20% propensity. PPII helices were constrained using
the dihedral angles (-78◦, 149◦), with propensities of 20% (residues 76-93, 178-191, 216-226 and
238-261), 30% (residues 111-122, 141-151 and 168-175) or 40% (residues 156-165).
6.4 Sequence alignments and distance trees of mammalian CtErbB2
This part of the work was done with Dr. François Bontems (ICSN, Gif-sur-Yvette). 3 iterations of PSI
BLAST (blast.ncbi.nlm.nih.gov) were used to collect 500 sequences related to human CtErbB2. After
each iteration, non-ErbB2, low-quality or fragment sequences were removed. After the final iteration, only
one isoform per organism was chosen if the isoforms were identical. A first distance tree was built based on
pairwise alignment with BLAST. This tree was used to select mammalian sequences on which a multiple
sequence alignment was performed using Clustal Omega (www.ebi.ac.uk/Tools/msa/). Finally, this
alignment was used as input to built the final tree.
87
RESULTS
7 Characterization of isolated, unphosphorylated CtErbB2
7.1 CtErbB2 is an IDP
7.1.1 CtErbB2 is predicted to be disordered from its sequence
We first sought to confirm that, as suggested by other works, CtErbB2 is indeed disordered. If we look
at CtErbB2 sequence, the amino acid composition (presented in figure 44a) is not very much depleted
in hydrophobic residues. It is acidic, with a theoretical pI of 4.29 (as calculated by Protparam https:
//web.expasy.org/protparam/, pI of 4.33 in our construct with the 4 GSHM N-terminal residues).
Such pI is not unusual, even for globular proteins. Consequently, CtErbB2 is not clearly displaced towards
predicted IDPs in the charge/hydropathy plot (see figure 44b). However, its very high content in prolines
(44 residues out of 268) is expected to prevent formation of stable structure. The overall disorder prediction,
as given by IUPRED and shown in figure 44c, is biased towards disorder all along the sequence of CtErbB2,
with order propensity approaching 50% only in three regions (roughly around residues 10 to 50, 190 to 210
and 225 to 235).
7.1.2 Experimental evidence of overall absence of folding
We combined different experimental approaches that were able to unambiguously show that CtErbB2 has
low levels of secondary and tertiary structure.
During the purification process, one feature was readily notable: the SDS-PAGE gels of CtErbB2 showed a
band at molecular weights of about 45 kDa (see figure 35b), whereas the expected mass of CtErbB2 is 28
kDa, and was confirmed by MALDI-TOF mass spectrometry (data not shown). This is a common feature of
proteins containing high levels of flexibility, which slows down their electrophoretic migration.
One of the first methods that was historically used to show the level of structure of a protein, and more
precisely secondary structure, is circular dichroism. As seen in figure 45a, the CD spectrum of CtErbB2 has
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Amino acid class Average % % in CtErbB2
(UniprotKB/Swiss-Prot)
Hydrophobic 41.0 40.0
(A, F, I, L, M, V, W, Y)
Negatively charged 12.2 14.9
(D, E)
Positively charged 13.6 7.8
(H, K, R)
Polar 19.9 18.7
(N, Q, S, T)
Proline 4.7 16.4
(a)
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Figure 44 – CtErbB2 (ErbB2 residues 988-1255) is predicted to be disordered from its sequence (a) Amino acid
composition of ErbB2 compared to the average amino acid composition in UniprotKB/Swiss-Prot (from ProtScale
https: // web. expasy. org/ protscale/ pscale/ A. A. Swiss-Prot. html ). (b) Charge/Hydropathy plot of
CtErbB2 (calculted with PONDR http: // www. pondr. com/ ). (c) IUPRED2a (https: // iupred2a. elte.
hu/ ) prediction for CtErbB2 (with the long disorder option)
a strong negative band around 200 nm, and no sign of a negative band at 222 nm (indicative of α helices)
or a positive band at 195 nm (indicative of β -sheets). This confirms the absence of significant levels of
secondary folding of CtErbB2. SAXS gives more information on the global shape of the protein in solution,
and the Kratky plot especially is a good visualization of the degree of globularity of a protein. In figure 45c
are presented the SAXS scattering curve and the corresponding Kratky plot and distance distribution for
CtErbB2. As expected for a non-globular, extended chain, the Kratky plot shows an increase at high qRg
values, and the P(r) is non symmetrical and extends towards high distances. We therefore tried to fit the
scattering curve with a polymer model, the Sharp-Bloomfield equation, given in section 6.2.3. This model is
a wormlike chain model that takes into account excluded volume effects (Sharp and Bloomfield, 1968). The
fit is shown in red in figure 45c. The fit is very good, and we were able to extract several parameters: the
length of the statistical element, about 20 Å, which is consistent with the value of 7 residues for a random
coil found by Schwalbe et al. (1997); the radius of gyration of cross section, RC = 2.7 Å, that gives the
thickness of the chain; and the contour length L = 770 Å , which gives the length that we would obtain by
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extending the chain without breaking secondary structure. This contour length is a little shorter than what
would be expected for a random coil with no secondary structure (around 980 Å, see section 6.2 for details
of the calculation), indicating that there is some (low) level of local structure in CtErbB2.
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Figure 45 – CtErbB2 is an IDR. (a) Circular dichroism spectrum of CtErbB2. (b) HSQC spectrum of CtErbB2 at
950 MHz. (c) SAXS experimental (black) curve and model (red) using the Sharp-Bloomfield equation. Small panels:
corresponding Kratky plot and distance distribution (P(r)) of CtErbB2.
These CD and SAXS data on CtErbB2 can be complemented by NMR studies at atomic resolution.
Even without assignment, the 1H-15N HSQC spectrum of CtErbB2 (figure 45b) shows that all amide peaks
are clustered in the central region of the proton dimension, with dispersion as low as 1 ppm. This indicates
high levels of disorder. The only structure compatible with such spectra would be α helices, which also give
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rise to peaks in this region, but stable helices were not seen on the CD spectrum.
Overall, these combined approaches prove that CtErbB2 is not stably structured in solution and is indeed an
intrinsically disordered protein.
7.2 NMR assignment of backbone and side chains
We published the assignment of CtErbB2 in Journal of Biomolecular NMR Assignment (Wang et al., 2018),
and the publication is reproduced in the appendix II. The corresponding BMRB entry is 26740. The details
of the assignment strategy are given in the experimental section 5.1.2.
Almost 99% of backbone atoms of non proline residues were assigned: missing backbone 1H-15N are those
of -3G, and -2S; all 13Cα and C’ are assigned except for those of -3G; 96% of 1Hα were assigned. Among
the 44 prolines, 93% had their 15N assigned, as well as all but one 1Hα and all 13Cα .
75% of side chain protons and 68% of side chain carbons (including 13Cβ ) of CtErbB2 were successfully
assigned. High degree of overlap prevented more extensive assignment. More detailed information on the
results of the assignment are given in table 3, and an assigned 1H-15N HSQC spectrum of CtErbB2 can be
found in the assignment publication in appendix II.
Atom type Non-proline Prolines Total ratio assignednot assigned ratio assigned not assigned ratio assigned
Backbone amide N -3G, -2S 226/228 150P, 241P, 188P 41/44 267/272
Backbone amide H -2S 226/227 X X 226/227
13Cα -3G 227/228 none 44/44 271/272
1Hα -3G, 155Q 254/257 240P 43/44 297/301
C’ -3G 227/228 222P, 223P, 240P, 246P 40/44 267/272
13Cβ none 199/199 162P, 222P, 223P, 240P, 246P 39/44 238/243
Table 3 – Details of the assignment of CtErbB2 backbone and 13Cβ . In the side-chains (including 13Cβ ), 75% of
protons and 68% of carbons were assigned.
7.3 Characterization of proline conformation
In such a proline-rich protein as CtErbB2, one would expect that many forms of the protein coexist, each
being characterized by a different set of proline isomers, exchanging in the slow regime. Here it could give
244 = 1.7592186.1013 possibilities. However, the HSQC spectrum of CtErbB2 recorded in "usual" condi-
tions (around 200 µM protein, 8 scans, 298 K, 950 MHz) shows a single visible form. Only by increasing
the concentration samples (to about 400-500 µM) and/or the number of scans could we see minor peaks
emerging from the noise level. Such a spectrum is shown in figure 46a. These minor peaks are in majority
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too poorly populated to give enough signal in the 3D assignment spectra, and therefore were not assigned.
Moreover, in such a disordered protein, the effect of proline isomerization is expected to impact the chemi-
cal shifts only for the neighboring residues, explaining that even if the dispersion of proline isomeric states
is high, many peaks of different states will superimpose into a so-called "major" peak depending only on
the isomeric state of very close prolines in the sequence.
We used the 13Cβ and 13Cγ chemical shifts (determined thanks to the (H)CC(CO)NH spectrum, shown in
figure 46b) observed in the major form to see what is the predominant conformation of each proline of
CtErbB2. Indeed, X-proline peptide bonds (X being any amino acid) in the trans conformation are expected
to exhibit proline [13Cβ ,13Cγ ] chemical shift couples in the range of [31.8± 1.0, 27.4± 0.9] ppm, while
those of cis prolines should be around [33.8±1.2, 24.4±0.7] ppm (Shen and Bax, 2010). Results are given
in figure 46c. For all but two of the assigned prolines, the X-proline bond is trans. For 148P and 159P, the
form that was found and assigned is cis. The intensities of the corresponding peaks (the following residue
in the HSQC and the carbon peaks in the 3D spectra) are lower than for the other prolines, but higher than
the minor forms detected. This indicates that the detected cis form, even though significantly populated,
may not be highly predominant. A trans form peak might also exist, but could not be found, probably due
to peak overlapping. More specifically, we suspect (from spectra at different temperature or pH) that 149Q
peak in the 1H-15N HSQC corresponding to the 148P trans form might be overlapped with 219Q, since the
sequence around these residues is similar (PQP in both cases); similarly 260E could be superimposed with
208E or 151E (PEY sequence). However, this could not be confirmed.
Overall, our results are compatible with a recent publication stating that the trans conformation is ex-
pected to be populated at about 90% or more at each site in such an unfolded chain (Alderson et al., 2018).
The question that we can then ask is why, in two defined positions in CtErbB2 sequence, the cis population
is higher than expected. Asparagine and serine residues preceding prolines (as it it the case for these two
prolines) do not seem to particularly promote the cis isomer in small peptides compared to other X amino
acids in the XP sequence (Reimer et al., 1998). Aromatic residues preceding prolines do favor the cis iso-
mer, but no such sequence is found in CtErbB2. The significant cis populations that we observe here are
therefore probably due to other sequence or conformational effects in CtErbB2, consistent with the fact that
other NP and SP sequences are present elsewhere and exhibit major trans conformations. We could not find
any obvious determinant of this particular behavior.
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Proline number δ13Cβ (ppm) δ13Cγ (ppm) Deduced isomer
9 32.099±0.054 27.091±0.053 trans
12 32.094±0.029 27.246±0.008 trans
39 32.138±0.007 27.354±0.016 trans
46 32.144±0.030 27.050±0.020 trans
48 32.172±0.077 27.148±0.000 trans
50 31.891±0.010 27.439±0.000 trans
78 32.139±0.022 27.413±0.000 trans
84 32.053±0.046 27.440±0.000 trans
87 32.065±0.045 27.316±0.039 trans
90 32.111±0.010 27.436±0.000 trans
115 32.067±0.013 27.435±0.000 trans
119 32.116±0.011 27.127±0.000 trans
121 32.112±0.022 27.240±0.000 trans
129 32.141±0.016 27.029±0.000 trans
132 32.134±0.029 27.336±0.000 trans
134 32.008±0.020 27.457±0.000 trans
143 32.123±0.005 27.344±0.000 trans
148 (weak) 34.359±0.030 ND cis
150 32.125±0.048 27.449±0.000 trans
156 32.124±0.005 27.276±0.000 trans
160 32.096±0.013 27.363±0.000 trans
162 ND ND ND
163 32.047±0.008 27.420±0.000 trans
165 32.114±0.020 27.352±0.000 trans
169 32.189±0.028 27.144±0.000 trans
171 32.029±0.025 27.419±0.000 trans
175 32.106±0.015 27.438±0.000 trans
183 32.210±0.029 27.433±0.000 trans
188 32.186±0.017 27.280±0.000 trans
207 32.097±0.006 27.163±0.000 trans
212 32.045±0.057 27.470±0.000 trans
218 32.089±0.015 27.342±0.000 trans
220 32.157±0.013 27.301±0.000 trans
222 ND ND ND
223 ND ND ND
224 31.995±0.028 27.365±0.000 trans
228 32.001±0.016 27.234±0.000 trans
240 ND ND ND
241 31.969±0.035 27.318±0.000 trans
246 ND ND ND
247 32.100±0.010 27.433±0.000 trans
254 32.143±0.008 27.447±0.000 trans
259 (weak) 34.379±0.017 24.764±0.000 cis
267 31.973±0.025 27.329±0.000 trans
(c)
Figure 46 – Proline isomeric states in CtErbB2. (a) Proline 13Cβ and 13Cγ chemical shifts of CtErbB2. Standard
deviations calculated from the values in the different recorded spectra are given (0.000 when the chemical shift was
only measured in one spectrum). For residues 148P and 259P, we suspect that the trans conformation also exists
but is superimposed with another peak, preventing assignment. (b) Slices of the (H)CC(CO)NH spectrum showing
prolines 13Cβ and 13Cγ peaks for a trans and a cis isomer. (c) 1H-15N HSQC spectrum of CtErbB2 at 400µM, 8
scans, in the MES buffer pH 5.6. Arrows indicate some examples of minor peaks suspected to correspond to residues
following minor isomeric states of prolines.
7.4 Characterization of transient local structure
Secondary structures are characterized by specific dihedral angles that can be probed using chemical shifts
and scalar couplings. Moreover, different secondary structures have different orientations of their backbone
NH bond, allowing to use NH RDCs as another probe. We used these three parameters to look for secondary
structure elements in CtErbB2, and they are presented in figure 47. From the CD data, which do not show
any strong band for α helices or β -sheets, we expect such secondary structures, if they exist, to be transient.
Do to the absence of dispersed peaks in CtErbB2 HSQC, we do not expect to observe β -strands. MoRFs are
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often made of preformed α helices (Fuxreiter et al., 2004), and proline-rich disordered segments are likely
to get partially structured in polyproline (PPII) helices. We thus expect to find those two types of structures
in CtErbB2.
We firstly used the SSP score by Forman-Kay’s lab, that has the advantages of giving roughly quantita-
tive secondary structure propensities (see figure 47). All along CtErbB2 sequence, no secondary structure
more populated than about 30% can be detected. Overall, SSP scores alternate regularly between low pos-
itive (compact helices) and negative (extended structures) scores. Looking closely, the positive regions are
N-capped by serines or aspartates (14DSTFYRSLL22, 71DLTLGL75, 100DGDLGMG105, 135SETDGY140,
231DNLYY235), which is consistent with the formation of short capped α helices. A similar behavior was
already observed for the measles virus nucleoprotein NTAIL disordered region (Jensen et al., 2011). The
regions exhibiting negative SSP scores are less straightforward to interpret. They indicate extended regions,
but chemical shifts do not allow one to discriminate β -strands from PPII helices. However, these extended
regions correspond to regions of higher proline density (see blue vertical bars in figure 47), pointing to PPII
helices. To confirm, and describe in more details, the most populated secondary structures, we used residual
dipolar couplings, as well as scalar couplings, comparing them to values expected for random coils or more
sophisticated conformational ensembles generated by Flexible Meccano (Ozenne et al., 2012).
• The longer and most populated α-helix in CtErbB2 is located in its N-terminus and has the sequence
14DSTFYRSLL22. It is estimated to be populated in about 25% of conformational states according
to the SSP scores, and consistently correlates with a region of slightly positive 1DNH and low 3JHNHα
compared to expected random coil values (see figure 47).
• The extended stretches identified by the SSP scores, that are likely to be PPII helices, indeed corre-
spond to 3JHNHα values close to the random coil value. If they had been β -strands, we would have
expected higher values (around 9 Hz, depending on the amino acid type). Using Flexible Meccano, we
generated constrained conformational ensembles, in which secondary structures propensities were set
to the SSP values. We then slightly adjusted these values to fit the RDC data. Only slight adjustment
was necessary, showing that chemical shifts and RDCs are both consistent with PPII stretches defined
with dihedral angles (-78◦, 149◦)) at propensities of 20% (residues 76-93, 178-191, 216-226 and 238-
261), 30% (residues 111-122, 141-151 and 168-175) and 40% (residues 156-165). These transient
PPII helices are compatible with the major trans conformation of prolines that we have determined.
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Figure 47 – Probing transient secondary structures of CtErbB2. (top) Secondary structure propensities calculated
from combined chemical shifts (SSP score (Marsh et al., 2006)). (middle) Experimental (black) 1HN-1Hα scalar
couplings of CtErbB2 compared with scalar couplings expected from a random coil conformation of this sequence
(Shen et al., 2018) (orange). (bottom) Backbone 1H-15N residual dipolar couplings (RDCs) of CtErbB2 measured
in stretched acrylamide gels. The experimental RDCs (black) are compared with RDCs calculated for the random
coil (orange) and the secondary-structure containing (red) Flexible Meccano ensembles. Corresponding secondary
structures are indicated with a cylinder (α-helix) and with zig-zags (PPII helices), with the associated propensities.
7.5 Dynamics of CtErbB2
15N R1 and R2 rates, as well as {1H}-15N nOes were measured for CtErbB2 at 14.1 and 22.3 T. It is
noteworthy that obtaining reproducible relaxation data, and comparable data at different magnetic fields,
is not an easy thing to do when working with IDPs: even more than for structured proteins, dynamics
greatly depends on the conditions, and in particular very slight changes in pH or temperature can cause
large variations. Great care was therefore taken in the control these parameters, to yield consistent data. The
results are given in figure 48.
The first striking feature is that the relaxation parameters do not exhibit bell-shape profiles as expected
from a random coil, and the dynamic behavior of the chain is highly heterogeneous. Four types of behavior
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Figure 48 – 15N longitudinal (R1) and transverse (R2) relaxation rates and {1H}-15N nOes of CtErbB2, measured at
14.1 T (600 MHz proton resonance frequency, grey) and 22.3 T (950 MHz proton resonance frequency, black). The
positions of glycines are indicated by green vertical bar.
can be distinguished. We analyzed them in the light of the expected relaxation parameters for 1H-15N bonds
in segments exhibiting a single rotational correlation time τC, with small libration of the bond (see figure 39).
• A random-like, very dynamic behavior in the termini of the protein, and in the central, glycine-rich
region (residues 65 to 120). With R1 almost identical at the two magnetic fields, around 1.4 s−1, and
nOes of opposite signs (close to -0.5 at 14.1 T), the corresponding τC can be estimated to be around
0.7 ns.
• A rigid, histidine-rich region (residues 56-61). High R2, R1 higher at 14.1 than at 22.3 T, and nOes
around 0.5 at the two fields point to a τC of about 4 ns, very high for a disordered protein. The histidine
side-chains probably restrain motion in this region.
• A more complex dynamic behavior in the regions 15-49 and 225-244, which do not fit the single-
τC model, indicating a mixture of flexible and restricted motions. The transient α-helix explains
this behavior for region 15-22, but regions 23-49 and 225-244 do not exhibit significant secondary
structure propensities. A possible explanation would be the presence of transient tertiary structure
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(long-range contact).
• A close to random-coil behavior, slightly more restricted than the glycine-rich region, in the rest of
the protein, corresponding to a τC around 1 ns. These regions contain the PPII helices, which do not
exhibit sign of significantly restricted motion. This is consistent with the fact that PPII helices are
more dynamic than "canonical", hydrogen-bonded secondary structures. Furthermore, they are not
really longer than the length of the statistical elements of a random coil determined by Schwalbe et al.
(1997), and are therefore not expected to change the segmental motion of the chain.
7.6 Long-range contact(s) in CtErbB2
A long disordered chain such as CtErbB2 statistically samples a wide conformational space. This is one of
the advantages of IDPs, sometimes called the fly-casting mechanism, and increases encounter probabilities
with partners.
We first used the SAXS data to see if we could detect any global compaction of the protein compared to
a random coil. The radius of gyration determined via the P(r) distribution gave Rg = 49.2 Å. This is very
different from the Rg expected for a globular protein of that size (18.7 Å) but consistent with a random coil
(47.4 Å), both calculated using Flory theory (see section 6.2). However, when we compare the experimental
value with the values calculated from our Flexible Meccano ensembles, we see that Rg should be even
larger taking into account the secondary structures, and especially the PPII helices that extent the protein:
indeed, the random coil ensemble generated by Flexible Meccano yields a Rg of 50.2 Å, while the ensemble
containing secondary structure yields Rg = 57.0 Å. The expected, but not observed, increased Rg compared
to a random coil due to the presence of the transient secondary structures may be compensated by long-range
tertiary interactions.
We then tried to see whether certain regions experience specific contacts during this sampling in CtErbB2.
To probe this at residue resolution, the dedicated technique is paramagnetic relaxation enhancement (PRE).
The principle of this technique is exposed in section 5.6. We first coupled a paramagnetic MTSL probe
at three positions in three distinct experiments to sample the extremities and the central part of CtErbB2
chain: at the two native cysteine positions (45 and 146) and at position 248. After preliminary experiments
showing effects around residue 230, we added position 227. The results are presented in figure 49. A clear
decrease in intensity is observed in the region around residue 230 when the probe is located on residue 45,
and the reciprocal effect is observed when the probe is on residue 248, and even more strongly on residue
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227. A relaxation enhancement is also observed around residue 230 when the probe is on position 146, but
the effect is small and non-reciprocal, and therefore likely artifactual.
SAXS and PRE both indicate the presence of at least one long-range contact, located between the N to the
C-terminus of protein. This contact is likely to be quite transient/lowly populated, since the decrease in Rg
and the PRE are small.
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Figure 49 – Presence of a long-range contact in CtErbB2. Paramagnetic relaxation enhancement (PRE) profiles of
CtErbB2 (black) compared to the profile expected from the Flexible Meccano ensemble including only secondary,
but not tertiary, structures (red). Four experiments, each with MTSL coupled at a different cysteine position marked
by an asterisk (45, 146, 227 and 248) have been performed. The two regions for which we observe significant and
reciprocal effect are shown with grey background.
7.7 Conservation of CtErbB2 features amongst mammals
Usually, sequence conservation in intrinsically disordered proteins is much lower than for globular proteins,
many constraints for structure conservation being released. However, we noticed a very high degree of
conservation of CtErbB2 amongst different species. We therefore tried to look at sequences conservation of
the structural and dynamic features observed here. We chose to focus on mammals, where all four ErbBs are
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present as in humans. Since we do not expect strict sequence conservation for all regions, but for example
region-specific conservation of proline density, we did not perform a global alignment but rather had a look
at node-by-node conservation after building a tree of mammalian sequences with PSI-BLAST. The resulting
alignments of the 21 nodes are presented in the Supplementary figures S2 of the publication submitted to
JBC and given in appendix III, with the corresponding tree (figure S3) and node-by-node alignment (figure
S4). The first striking feature of the alignment is the strict conservation of the 5 autophosphorylation sites
(6 autophosphorylated tyrosines). But surprisingly, the conservation level remains very high even outside of
these regions: compared to the sequence for Homos sapiens, one third of the sequence is strictly conserved
and 15% more has a conservation score given by Clustal Omega higher than 0.5. This high conservation is
also found in EGFR (Kovacs et al., 2015a). This indicates that the role of the other residues in the C-terminal
tail of ErbB receptor is not random, and is not only driven by the conservation of flexibility. Interestingly,
the first 50 residues of CtErbB2 are even more conserved than the rest of the tail: this encompasses the
N-terminal α-helix, as well as the first region shown from PRE experiments to experience a transient long-
range contact. The second region involved in this contact, around residue 230, is the second best conserved,
with the stretch 228PAFDNLYYW236 being strictly conserved. The conservation of the PPII helices is a
little more complicated to analyze, since strict sequence conservation is not expected to be necessary. Yet,
we can notice conservation of the overall proline density, and some mutations of prolines around PxxP
motifs compensate each other thus leading to conservation of the motif (PxxP motifs 6 and 7 in figure S2 of
appendix III).
7.8 Our study reveals new potential mechanisms for the regulation of signal transduction
The goal of our study was to understand the molecular bases for the ability of the C-terminal tail of the
receptor ErbB2 to perform its function in signal transduction, starting from an inactive, non phosphorylated
form. More specifically, we studied CtErbB2 structural and dynamic characteristics to determine its degree
of accessibility and prefolding to interact with partners, both the ErbB kinases in the active dimers for phos-
phorylation, and adaptor proteins triggering signaling. Even though we here used a construct of the isolated
tail, it is a first step towards understanding its crucial role in signal transduction by the full-length receptor.
The secondary and tertiary structure elements that we found in CtErbB2 are recapitulated in figure 50. We
managed to make a complete description of the local and long-range degree of structure of CtErbB2, by
using an approach combining a wide range of NMR data with more global size and shape information given
by SAXS. We also built a model conformational ensemble of 10 000 structures recapitulating the secondary
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structures of the protein. Both its high degree of intrinsic disorder, its local folding into transient α- and
PPII helices that we suspect to be MoRFs, and the presence of long-range contacts are central features de-
termining how such a receptor tail can perform its function.
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Figure 50 – Summary of our structural description of CtErbB2. In the sequence, glycines are in green and prolines
are in blue. The stars indicate the interaction sites, either known (PTP-2c, Grb2, Fyn SH3, Shc, MEMO) (Dankort
et al., 1997; Schulze et al., 2005; Marone et al., 2004) or putative (PxxP motifs potentially binding SH3 domains,
indicated with a question mark). One hundred structures from the 10 000 structure Flexible Meccano ensemble with
secondary structure are shown. The structures were aligned on residues -3 to 20.
Importance of disorder of CtErbB2 for multiple interactions Our study was conducted on a construct
containing only the C-terminal tail of ErbB2. One could wonder whether the disorder observed here is still
relevant in the context of the full-length receptor. Although the distance to the plasma membrane is too high
for significant interaction with CtErbB2, the tail could still interact in an intramolecular fashion with the
kinase domain, and one could argue that it could trigger folding. However, the recent study by Keppel et al.
(2017) showed by HDX/MS that rates of solvent exchange of the C-terminal tail of ErbB2 are significantly
higher than for the globular kinase core in a construct containing the whole ErbB2 cytoplasmic domain, and
are consistent with a high degree of disorder. Therefore, observations made here are very likely to remain
valid in the intact protein.
Additionally, it is expected that great flexibility of CtErbB2 is required for its function, which relies on
accessibility of phosphorylation and interaction sites. The so-called fly-casting mechanism could be a great
advantage of disorder in this instance. In the inactive state studied here, the tail needs to be able to sample
a wide conformational space to encounter both ErbB kinases in the context of kinase-active dimers, and po-
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tential other cytoplasmic partners (cytoplasmic kinases, regulation complexes...). Moreover, if this disorder
is conserved in the phosphorylated, active, states, this feature could enable multiple interactions, high re-
cruitment/dissociation rates to adaptor proteins for fast adaptability, all of these being crucial for an efficient
signal transduction and regulation.
The N-terminal helix might be a prestructured motif for interaction with ErbB2 kinase and regulation
CtErbB2 is likely to make transient contacts with either its own kinase domain, or the kinase of the other
monomer of the dimer (in case of trans-phosphorylation), or both. The first hypothesis is supported by the
two crystal structures of ErbB2 kinase (PDB 3PP0 and 3RCD): in both, the short segment of the C-terminal
tail included in the construct used for crystallization retains long disordered segments but one helix inter-
acts with the kinase core, and is located in our numbering 16TFYRS20. This corresponds to the center of
the α-helix we have identified to be preformed in solution. Therefore, this helix can be considered to be a
MoRF, and its transient folding in the free state could participate in kinase-binding affinity by reducing the
binding entropic cost. This interaction could play a role in the regulation of the kinase activity of ErbB2,
as it was suggested for EGFR (Walton et al., 1990; Sorkin et al., 1992; Alvarez et al., 1995; Cheng and
Koland, 1996; Pines et al., 2010). Besides, it brings the whole C-terminal tail closer to the kinase domain, in
a position where it would also be close to the kinase domain of the dimerization partner. The helix contains
a tyrosine, which is not one of the 5 trans-autophosphorylation sites, but could also be phosphorylated by
other kinases. It is easy to imagine that the introduction of a phosphate group could destabilize the helix
and/or the interaction with the kinase domain.
The N-terminal helix could therefore be important for kinase activity regulation and phosphorylation, creat-
ing feedback mechanisms that are necessary for such important signaling pathways.
PPII helices carry SH3/WW interaction motifs Polyproline motifs, especially those structured in PPII
helices, are known to be involved in protein-protein interactions with two types of folded domains: SH3
an WW domains, which are known to be abundant in receptor tyrosine kinase signaling pathways (Paw-
son, 1992). WW domains are sometimes considered as the phosphorylation-dependent equivalent of SH3
domains (Macias et al., 2002). The PPII helices found in CtErbB2 are short and transient. They are not
especially rigid in the ns timescale, and are populated to a maximum of 40%. They therefore allow to keep
a high degree of flexibility, while reducing the entropic cost of potential folding upon interaction.
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While the consensus motif for interaction with SH3 domains is PxxP, with the two main ligand classes
K/RxxPxxP (class I) and PxxPxR/K (class II), WW ligands include PPxY motifs (group I, with an unphos-
phorylated tyrosine), PPLP (group II), PPR or other proline-rich and K/R containing sequences (group III,
potentially in competition for binding with SH3), and phospho-SP or phospho-TP (group IV) (Macias et al.,
2002).
Three PPII stretches contain PxxP motifs: 81EEAPRSPLAPSEGA94 (2 sequential motifs sharing one pro-
line), 156PDVRPQPPSPREGP169 (two nested motifs, RxxPxxP and PxxPxxR), and 216AAPQPHPPPAFS227.
Two PxxP motifs are found outside of PPII regions: 5EDLGPASPLDST16 and 125YSEDPTVPLPSE136.
Amongst all these PxxP motifs, only one has a sequence recognized as canonical for binding to SH3 do-
mains: the 159RxxPxxP165 motif (class I motif). The 159RPQPPSPRE167 peptide it is embedded in was
shown in a previous study by Bornet et al. (2014) to fold in a PPII helix, and the RxxPxxP motif is respon-
sible for interaction with the Src family kinase Fyn SH3 domain.
No consensus WW-binding PPxY, PPLP or PPR motifs are found in CtErbB2. However, seven SP motifs
(residues 11-12, 86-87, 120-121, 147-148, 164-165, 187-188 and 227-228), and two TP motifs (residues
211-212 ans 253-254) exist, and could constitute, upon S/T phosphorylation, group III binding sites for
WW domains. Although no direct interaction between a WW domain and ErbB2 has been observed,
WW-containing proteins such as Pin1 and WWP1 have been shown to have a role in regulation of ErbB2-
dependent pathways (Wulf et al., 2004; Chen et al., 2008).
In the current model of signal transduction initiation by ErbB receptors, the link between ErbBs and
adaptor proteins is ensured by phosphotyrosines interacting with SH2/PTB/MEMO domains (Yarden and
Sliwkowski, 2001; Schulze et al., 2005; Feracci et al., 2011). However, it is not excluded that other types
of interactions involve ErbB2, for example polyproline/SH3 or polyproline/WW interactions. For example,
Grb2 SH3 domains have been suggested to participate in the ErbB2/Grb2 interaction that is known to hap-
pen via pY/SH2 contacts (Xie et al., 1995). All in all, PPII-structured polyproline motifs expand the number
of possible molecular recognition features of CtErbB2, with potential recognition by SH3 or WW domains.
Probable interplay between proline isomerization and S/T phosphorylation Out of the 44 prolines of
CtErbB2, 7 are preceded by a serine, and 2 by a threonine. It is to be expected that S/T phosphorylation
by proline-directed kinases, and isomerization by the prolyl isomerase Pin1, that recognizes pSP and pTP
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sequences, could play a role in regulation of CtErbB2 conformation. Pin1 has been shown to be involved
in ErbB2 regulation (Khanal et al., 2010; Lam et al., 2008), but the interaction has never been shown to be
direct. A modification of the cis/trans ratio of prolines can have dramatic consequences in terms of overall
conformation, changing the orientation of the chain, and local structure, since increased ratios of cis prolines
can for example disrupt PPII helices, that require an all-trans conformation.
Long-range contacts as a mechanism for regulation of accessibility Our data show absence of a stable
tertiary fold of CtErbB2, with the absence of long-range nOe cross-peaks on nOe-HSQC spectra (data
not shown), moderate PRE effects, and overall shape parameters measured by SAXS compatible with an
extended structure and very far from the behavior of a globular protein. Long-range contacts with long
lifetime should also be detected on the RDC profile, as observed for example on α-synuclein (Bertoncini
et al., 2005; Bernadó et al., 2005). However, the effect is difficult to differentiate from effects of local
structure if the contact is very transient.
Even with no stable tertiary structure, a close comparison of the radius of gyration of the protein to the Rg
expected from a random coil and from the ensemble containing the determined transient secondary structures
reveals a small compaction. From our four PRE experiments, we observe a small but reproducible (also
observed when using with a 3-(2-iodoamido) proxyl probe, data not shown) and reciprocal effect between
the regions around residues 30-45 and 225-242. We have also observed that these two regions undergo
partially restricted dynamics as shown by 15N relaxation data. They are a little more hydrophobic than
the rest of the protein, and contain some aromatic, possibly favoring pi interactions. A small decrease in
intensity is also observed in the region of residue 230 when the probe is on position 146, but the effect is
not reciprocal (no clear effect around residue 146 when the probe is on position 227). It is possible that the
probe "sticks" slightly on the region around residue 230.
The presence of a transient contact between the two ends of the tail of ErbB2 could have two roles:
• Bringing the tyrosine phosphorylation sites closer to the kinase domains in the active dimer. Even very
transient contacts can be enough to trigger a first phosphorylation event and the signaling cascade.
This effect would be added to the intramolecular interaction of the N-terminal α-helix with the kinase
domain that also brings potential phosphorylation sites closer to the kinase.
• Regulating accessibility of the central interaction sites for adaptor protein partners, depending of the
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phosphorylation status of the tail
In both cases, this would require that the long-range contacts be phosphorylation-dependent, which is very
plausible: the main two sites for which contacts are observed encompass the tyrosine auto-transphosphorylation
sites YA (Y36) and YD (Y235/236). We could imagine that additional charges at these positions could mod-
ify the transient contact. The potential functional role of this contact, and its dependence on phosphorylation,
is supported by the study of Dankort et al. (1997) that shows that YA and YD have particular, interdependent
role in ErbB2 signaling. When YA alone is phosphorylated (all other tyrosines being mutated to phenylala-
nines), it suppresses the potential of the V664E "activating" ErbB2 mutant to induce transformation of cells.
But if YA and YD are simultaneously able to be phosphorylated, the transformation potency of the protein
is recovered, contrary to any other combination between YA and another tyrosine phosphorylation site. A
way to investigate individual and combined roles of these tyrosine phosphorylations would be particularly
interesting, and is presented in section 10.2.4.
Perspectives: phosphorylation and interactions Our description of isolated, unphosphorylated CtErbB2
is a great step towards understanding the bases for the central role of this region of ErbB2 in signal trans-
duction. There are three additional steps to complement its mechanistic characterization, in the context of
our work:
• Characterize the effect of tyrosine phosphorylation on the conformational landscape of CtErbB2.
Many of the features that we describe in this section are likely to be affected by phosphorylation.
We therefore developed different approaches to obtain and study tyrosine phosphorylation, in the
particular case of our system. However, this work, presented in section 10, aims at tackling more
generally the problem of structural studies of tyrosine phosphorylation, which is still a challenge.
• Characterize the conformational states and phosphorylation process of CtErbB2 in the context of the
full-length receptor, and eventually in the context of the homo- or heterodimers. This requires to
transfer protein production in eukaryotic cells. Part of this challenge was undertaken, trying to pro-
duce the cytoplasmic portion of the receptor in insects cells for phosphorylation, and is also presented
in section 10.
• Characterize the interactions of the tail with adaptor proteins, a process which is the heart of signal
transduction by ErbB2. This work focuses on Grb2, a partner that is essential for ErbB2-initiated
MAP kinase pathway signaling, and that contains domains able to interact with phosphotyrosines
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and polyproline motifs. It is therefore particularly interesting both from a biological and mechanistic
point of view. Influence of phosphorylation will also be a key aspect of the interaction study. The
characterization of the Grb2 protein itself is presented in section 8, while the study of its interaction
with CtErbB2 is presented in section 9.
Of course part of these questions, and many other questions, go past the aims of this thesis, or even of
this project. S/T phosphorylation probably influences the conformation and interactions of the protein, as
well as prolyl isomerization by isomerases; Many partners other than Grb2 could be studied, as well as the
interdependence of these interactions...
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8 Behavior of Grb2 in solution
Before being able to characterize the interaction between Grb2 and CtErbB2, we had to assign the spectra
of free Grb2. We came across some surprises along the way, highlighting the necessity to study the behavior
of this modular protein alone. From the literature data on Grb2, presented in section 3, two main questions
remain that could affect the interaction with CtErbB2: What is the behavior of each domain relative to one
another in the full-length protein in solution? And what is the oligomeric state of Grb2 in solution?
8.1 NMR backbone assignment of all constructs, instability of the NSH3 domain and effect
of the Histidine tag
Unless otherwise stated (for the NSH3 domain), all assignments were performed and all the spectra shown
were recorded at 308 K, on samples between about 300 and 600 µM in the PIPES buffer at pH 7.2 (40
mM PIPES, 150 mM NaCl, 2 mM TCEP). For the comparison between the His-tagged and tag-free NSH3
domain, the temperature was also 308 K but the buffer was PBS at pH 7.2 with 2 mM TCEP. The reason for
this particular buffer for the NSH3 is that it was done by YingHui Wang, a previous post-doctoral researcher
in the lab, and the experiments were not repeated in PIPES buffer.
8.1.1 Constructs and assignment
Due to difficult removal of the N-terminal purification histidine tag on the constructs containing the NSH3
domain (NSH3, NSH3SH2 and FL Grb2 constructs), assignments were done on both the tagged and non-
tagged constructs. It gave very different spectra:
• For the NSH3: both with and without the tag, two set of peaks can be found and (at least partially)
assigned. One exhibits well-dispersed peaks, and one has peaks gathered in the central region of
the spectrum in the proton dimension. This SH3 domain was already shown by NMR to experience
exchange between a folded and an unfolded form (Goudreau et al., 1994).
• Very surprisingly, an unfolded form of the NSH3 domain is also present in the spectra of the tag-free
NSH3SH2 and FL Grb2 constructs, whereas only the fully folded form is visible in the spectra of the
His-tagged NSH3SH2 and FL constructs. The His-tag, while destabilizing the NSH3 domain when
in isolation, stabilizes it when at least the SH2 domain is present.
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Construct NH assigned Special conditions
His-NSH3* 47/78 PBS buffer
NSH3* 48/56 (Also assigned in PBS buffer)
SH2 80/97 (Also assigned in PBS buffer)
CSH3 53/60 (Also assigned in PBS buffer)
His-NSH3SH2 118/170 (Also assigned in PBS buffer)
NSH3SH2* 123/148
SH2CSH3 130/158
His-Grb2 164/229 (Also assigned in PBS buffer)
Grb2* 173/207
Table 4 – Extent of assignment for each Grb2 construct. Our assignment is compared to the number of NH pairs
that can be assigned, i.e. without counting the prolines and the N-terminal residue. For the constructs containing the
NSH3 for which an unfolded form exists in equilibrium with a folded form (indicated with *), the extent of assign-
ment is given for the folded form.
The spectra are further analyzed in section 8.1.2, but these characteristics had to be taken into account
for assignment. The effect of the His-tag was also investigated for the other constructs to see if it impacted
the fold of the other two domains, but in the SH2, CSH3 and SH2CSH3 constructs the chemical shifts dif-
ferences with and without the tag were restricted to very few N-terminal residues.
The extent of backbone N-H assignment for all the constructs, including the His-tagged ones when the
NSH3 in present, is given in table 4. The 13Cα and 13Cβ were assigned to a large extent, but the complete
assignment is not finished for all constructs and is therefore not detailed here.
Integrity of the domains was verified for all constructs by comparison of the secondary structure cal-
culated by TALOS+ (based on our chemical shifts) with the consensus fold recapitulated in Uniprot (entry
P62993). The verification was done for the folded form of the NSH3 in the NSH3, NSH3SH2 and FL con-
structs. The extent of assignment for the unfolded forms is not sufficient for their complete characterization.
The 1H-15N HSQC spectrum of the assignment of FL Grb2 is shown in figure 51b, 51c, and 51d. Residues
for which peaks were not found, as shown in red in figure 51a, are mainly residues of the linkers between the
NSH3 and SH2 and between the SH2 and CSH3 domains, and the region around C32 in the NSH3 domain.
The linker residues are probably partially flexible, and exchange in the intermediate timescale might results
in line broadening. The C32 region was already described as "poorly defined" by Goudreau et al. (1994). Its
electron density is not defined in the crystal structure of the full-length Grb2 (PDB 1GRI) but is defined in
the N-Src loop in the NMR peptide-bound structures of the isolated NSH3 domain (PDB 1GBR and 1GBQ),
as shown if figure 29a. Once again, partial flexibility is probably at stake. Overall, spectra quality was better
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at lower fields (600 MHz) compared to very higher fields (950 MHz), especially for peaks in the NSH3
domain.
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Figure 51 – Assignment of backbone H-N pairs of FL Grb2 (a) The missing assignments are shown in red along the
sequence. The residues contained in each monodomain are indicated. The bidomains are simply the sum of the mon-
odomains, with the exception of the additional GA residues in the N-terminus of each construct. (b, c, d) HSQC spec-
trum of [U-15N; U-13C; U-80% 2H]-Grb2 with its assignment (308 K, PIPES buffer pH 7.2, 600 MHz). A indicates
the folded form, and B the peaks corresponding to the unfolded form of the NSH3.
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8.1.2 Influence of the His-tag on the stability of the NSH3 and on the interaction between the NSH3
and SH2 domains
Goudreau et al. (1994) showed that the stability of the NSH3 domain depends on pH. The charges in the
His-tag could therefore be the reason for its interaction with the NSH3, which has a theoretical pI of 4.76.
Given that cysteine oxidation was also shown to impact stability of the NSH3 domain via dimerization
(Goudreau et al., 1994), it was verified that the folded/unfolded equilibrium did not depend on the quantity
of the reducing agent in the buffer (TCEP 2 mM, tested up to 5 mM).
The His-tag destabilizes the isolated NSH3 The His-tag in our construct is 24 residues long. The HSQC
spectra of the isolated NSH3 domain with the His-tag and with the His-tag cleaved are shown in figure 52a.
The presence of the tag has two effects: it decreases the proportion of the folded form, and provokes chem-
ical shift differences in the folded form, not only localized near the N-terminus. The combined 1H-15N
chemical shift perturbations (CCSP) between the two constructs are shown in figure 52b. While the C32
region (around the N-Src loop) is missing in both construct, the region around residue 10 is only missing in
the His-tagged constructs, suggesting broadening due to interaction with the tag or exchange between the
folded and unfolded forms. The residues adjacent to the missing stretch around C32 are particularly affected
by the presence of the His-tag, suggesting that this (negatively charged) region interacts with the tag.
The His-tag stabilizes the NSH3 in the NSH3SH2 bidomain and FL Grb2 by interacting with the SH2
domain In the NSH3SH2 domain, and the FL construct, the effect of the His-tag is reversed compared to
the isolated NSH3: the tag stabilizes it. When the His-tag is not cleaved, only one set of peaks is observed.
When the tag is cleaved, too many peaks can be seen on the HSQC spectrum, as shown on figure 53a. While
only one form of the SH2 domain can be found, properly folded, two sets correspond to the NSH3 domain,
one well dispersed and the other one corresponding to an unfolded form. The well-dispersed peak of this
spectrum can be compared to the unique peaks of the His-tag construct (figure 53c). The presence of this
His-tag strongly affects the whole bidomain, but some residues particularly stand out, additionally to the
N-terminus where the tag is attached: the region around the N-Src loop and the residues 129N and 130E
of the SH2 domain. These residues are highlighted in yellow in figure 53c. They are quite far apart when
mapped on the crystal structure of full-length Grb2 (PDB 1GRI). The NSH3 and SH2 domains seem to
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Figure 52 – Effect of the His-tag on the isolated NSH3 domain. (a) HSQC spectra were recorded in the PBS buffer,
at 950 MHz. Cyan: His-NSH3; Dark blue: NSH3. Some example of peak assignments are shown (A: folded form;
B: unfolded form). (b) Chemical shift perturbation caused by the His-tag. Grey: missing data due to lack of assign-
ment in one or both of the constructs; black lines: mean+std (standard deviation), mean and mean-std values after
outliers were removed; yellow: residues with CCSP > mean+std. The result is shown on the structure of the NSH3
domain alone (PDB 1GBQ).
interact, directly or indirectly via the His-tag. Given the nature of the residues involved, the interaction is
probably electrostatic.
The influence of the His-tag is the same for full-length Grb2, and the regions of the protein affected by
the His-tag are identical (data not shown). The CSH3 is not affected at all. The interpretation that the His-tag
mediates an interaction between the NSH3 and SH2 domains is supported by 15N relaxation data recorded
on His-tagged full-length Grb2, presented in figure 54. The data clearly show that the dynamic behavior of
His-Grb2 is separated in two parts: the NSH3SH2 that behaves as one dynamic entity, and the CSH3 that
behaves as another. Mean R1 and R2 (± std) values (after outliers were removed) are very similar for the
NSH3 (0.77±0.05 s−1 and 30.08±2.63 s−1 respectively) and SH2 (0.74±0.06 s−1 and 29.84±3.63 s−1
respectively) domains, and significantly different from the rates for the CSH3 domain (1.13±0.07 s−1 and
21.46± 1.79 s−1 respectively). If each domain was moving freely, the values for the NSH3 and CSH3
domain would be similar, since they have approximately the same size and shape, and would be different
from the SH2. This structural and dynamic behavior of His-Grb2 is to be compared with the behavior of FL
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Figure 53 – Effect of the His-tag on the NSH3SH2 bidomain. (a) HSQC spectra of the His-NSH3SH2 (light pink, 800
MHz) and NSH3SH2 (purple, 950 MHz) constructs, with a zoom in the central region to show additional peaks in
the NSH3SH2 spectrum. (b) Chemical shift perturbation caused by the His-tag in the NSH3SH2 bidomain. Grey:
missing data due to lack of assignment in one or both of the constructs; black lines: mean+std (standard deviation)
and mean values after outliers were removed; yellow: residues with CCSP > mean+std. (c) The result is mapped on
the NSH3SH2 extracted from the crystal structure of FL Grb2 (PDB 1GRI).
Grb2 without the His-tag (sections 8.2 and 8.3).
Histidine tags are relatively small, and rather hydrophilic, and are therefore often considered not to affect
protein structure and function. While that may be true for many proteins, several examples were found were
a histidine tag influenced enzymatic activity (Majorek et al., 2014; Panek et al., 2013; Araújo et al., 2000),
protein dynamics (Thielges et al., 2011), and/or protein stability in a pH and salt-dependent manner (Panek
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Figure 54 – 15N relaxation parameters of His-Grb2 (full-length) measured at 800 MHz. The different colors show the
delimitation of the domains. Blue: NSH3; red: SH2; green: CSH3. Lines indicate mean+std (standard deviation),
mean and mean-std values after outliers were removed for each domain in the full-length protein.
et al., 2013; Booth et al., 2018). Given the large differences in structural and dynamic behavior noted
between the tagged and tag-free forms in our case, the rest of the study was done on tag-cleaved proteins.
8.2 Chemical shifts comparison of domains
Grb2, as an adaptor protein, performs its biological function by binding to different partners. Regulation
of these interactions, their order, and interdependence, are likely to have important consequences in Grb2
signaling, and notably in the Ras-MAPK pathway. This pathway has been shown to be the major pathway
in ErbB2-dependent signaling (Dankort et al., 1997, 2001a,b). To regulate Grb2 interactions, the relative
orientation and dynamics of its three domains, which can bind different partners, is key. While in the crys-
tal structure of Grb2 (PDB 1GRI) an interaction between the two SH3 domains was observed (Maignan
et al., 1995), in solution ligand-bound Grb2 was shown to behaves as three independent domains (Yuzawa
et al., 2001). However, no study so far has investigated the solution structure and dynamics of apo-Grb2.
Comparison with the bound forms of Grb2 with its different partners in the cell will then be a major step in
understanding how they are regulated.
To try and understand what is the organization of each domain relative to one another in the full-length Grb2,
the first approach that we chose was to compare the constructs of individual domains with their behavior in
the full-length protein. In figure 55a are shown the overlaid 1H-15N HSQC spectra of full-length Grb2 and
of the three individual domains (NSH3, SH2 and CSH3). The peaks of the individual domains superimpose
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well with their corresponding peaks in FL Grb2, except for a few peaks corresponding to the edges of the
domains. The additional peaks seen in FL Grb2 correspond to the unfolded form of the NSH3 domain.
This demonstrates the absence of major structural changes or interaction of the domains in the full-length
protein, in sharp contrast with what is seen in the crystal structure where the SH3 domains interact with each
other. No dimer interface can be mapped either. The crystallographic dimer where the SH2 of one monomer
contacts the CSH3 of another monomer is not detected in solution.
Still, some small local chemical shifts changes (mainly CCSP < 0.1 ppm) can be mapped in the sequence
and on the crystal structure of Grb2 (figure 55b). The differences are all located on the sides of the domains
that point to each other in the crystal structure, spatially close to the linkers. The same observations were
made when comparing the individual domains with the bidomain constructs (NSH3SH2 and SH2CSH3),
and the bidomain constructs with the FL protein.
Overall, our data suggest minimal interaction between the domains.
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Figure 55 – Comparison of full-length Grb2 with individual domains (PIPES buffer, 308 K). (a) Overlay of the
HSQC spectra of FL Grb2 (black, 600 MHz), the isolated NSH3 domain (blue, 600 MHz), the isolated SH2 domain
(red, 800 MHz) and the isolated CSH3 domain (green, 950 MHz). (b) Combined 1H-15N chemical shift perturbations
(CCSP) between the peaks of each residue in FL Grb2 and in the individual domains (top). Lines indicate mean+std
(standard deviation), mean and mean-std values after outliers were removed. For the NSH3, the peaks corresponding
to the folded form where chosen for comparison between the isolated domain and the full-length protein. The CCSP
for the assigned peaks of the unfolded form of the NSH3 were lower than for the folded form. The residues for which
CCSP > mean+std are mapped on Grb2 crystal structure (bottom).
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8.3 Dynamics of Grb2
We showed that structurally, the three domains of Grb2 appear independent, with only minor chemical shifts
differences next to the delimitations of the domains. Depending of the length and stiffness of the linkers,
they can still have various dynamics with respect to one another. As seen in figure 54, in the His-tagged
protein, the NSH3 and SH2 domains behave as a single dynamic entity. However, in the tag-free protein, it
is not the case, as shown in figure 56. The NSH3 shows highly heterogenous dynamics both in the sub-ns
(as seen in the heteronuclear nOe values) and ns (as seen in the R1 and R2 rates) timescales, which is con-
sistent with its heterogeneity, with folded and unfolded forms exchanging. The SH2 and CSH3 domains
are more homogeneous along their respective sequences. Contrary to what was observed for the His-tagged
protein, the mean R1 and R2 (± std, after outliers were removed) relaxation rates are similar for the NSH3
(1.15± 0.22 s−1 and 16.20± 3.11 s−1 respectively) and the CSH3 (1.04± 0.10 s−1 and 15.56± 1.41 s−1
respectively) domains, consistently with the fact that they have similar sizes and are smaller than the SH2,
which has significantly different relaxation rate constants (0.80± 0.07 s−1 and 18.90± 2.49 s−1 respec-
tively).
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Figure 56 – 15N relaxation parameters of FL Grb2 measured at 800 MHz. The different colors show the delimita-
tion of the domains. Blue: NSH3; red: SH2; green: CSH3. Lines indicate mean+std (standard deviation), mean and
mean-std values after outliers were removed for each domain in the full-length protein.
From the ratio of the relaxation rates averaged over the whole protein, we can also estimate a mean
rotational correlation time of the NH bonds of Grb2. Details on the method of calculation are given in
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section 5.3. With mean R1 of 0.93± 0.17 s−1 and mean R2 of 17.47± 2.86 s−1 (outliers being removed),
this gives us 10.09± 2.48 ns. If we compare this value with the one expected from the Stokes-Einstein
model (described in section 5.3) at 308 K, which gives 15.58 ns, we can see that Grb2 tumbles more rapidly
than an ideal globular protein of this size, suggesting some degree of flexibility. This is consistent with three
domains that are not docked to one another. This also indicates that the protein is probably monomeric.
Even though the missing peaks in the linkers prevent us from directly getting information of their flexibility,
the data that we have indicate that they are flexible enough to allow partially decorrelated dynamics of the
three domains.
8.4 Domain organization determined by SEC-SAXS
To confirm our interpretation of the NMR data, get more information on the envelop of Grb2, and compare
it with the crystal structure available, we recorded SAXS data on FL Grb2, as well as on the bidomains
(NSH3SH2 and SH2CSH3). To make sure that the samples were homogeneous, which is essential for
SAXS measurements, we used size-exclusion chromatography (SEC) coupled to SAXS (David and Pérez,
2009; Pérez and Vachette, 2017). This was all-the-more necessary since two peaks were observed by SEC
when these constructs were purified, suggesting monomer/dimer equilibria.
8.4.1 The NSH3SH2 bidomain organization corresponds to the organization in the crystal structure
of full-length Grb2
We first ran the SEC-SAXS experiment on the NSH3SH2 bidomain. The SEC elution profile, as well as the
extrapolated intensity at q=0, I0, and radius of gyration Rg along this profile, are shown in figure 57a. Firstly,
we notice that this construct gives two size-exclusion peaks. From the corresponding SAXS data, the peaks
correspond to proteins of respectively 33.1 and 17.8 kDa, while the expected mass of the construct is 17.8
kDa. A reasonable assumption is that the first peak corresponds to a dimeric form of the bidomain, and the
second to the monomer, with about twice as much monomer compared to the dimer from the absorbance
profiles at 280 nm. While the curves corresponding to the dimer have not been analyzed yet, the scattering
intensity, dimensionless Kratky plot and distance distribution P(r) extracted for the monomer are given in
figure 57b, 57c and 57d, respectively. The Kratky plot and P(r) are close from the profile expected for a
globular protein, but with a shoulder in the P(r) distribution consistent with the presence of two distinct
domains. Then, we compared the experimental SAXS curve with the one calculated by Crysol (Svergun
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et al., 1995) for the NSH3SH2 domain structure extracted from the crystal structure of Grb2 (PDB 1GRI).
The fit is very good, with a residual value χ = 1.15 between the two curves. The NSH3SH2 bidomain
therefore has an organization in solution fully compatible with the one seen in the crystal structure, with the
two domains rather far from one another. No variation of the mean inter-domain distance can be detected
by SAXS, with a measured Rg of 19.3 Å.
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Figure 57 – SEC-SAXS data of Grb2 NSH3SH2 bidomain monomer. (a) SEC-SAXS profile. Along the elution pro-
file are plotted the absorbance at 280 nm A280, the radius of gyration Rg and the extrapolated scattered intensity at
q=0 I0. The chosen SAXS curves are taken in a zone of stable Rg (boxed). (b) Experimental scattering curve (black)
and scattering curve from the NSH3SH2 bidomain extracted from the crystal structure (PDB 1GRI), calculated with
crysol (red). χ = 1.15. A zoom at small q is shown. (c) Dimensionless Kratky plot. In grey is the expected maximum
for a globular protein. (d) Distance distribution between atoms, computed from the SAXS curve.
8.4.2 The SH2CSH3 bidomain adopts multiple conformations of different Rg
Then, we applied the same method to the SH2CSH3 bidomain. As shown in figure 58a, the proportion
of dimer for this construct is minor, and no SAXS curve could be extracted from the corresponding peak.
The monomer gave a molecular weight estimated by SAXS of 18.7 kDa, close to the expected value from
the sequence (19.3 kDa). Contrary to the results for the NSH3SH2 bidomain, the Kratky plot given in fig-
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ure 58c has a shifted maximum compared to the expected one for a globular protein, consistent with a more
pronounced shoulder in the P(r) distribution shown in figure 58d. When we calculated the expected SAXS
curve for the SH2CSH3 bidomain from the PDB structure of the full-length protein, the fit with our data was
not as good as previously observed for the NSH3SH2 bidomain. The fit is shown in figure 58b, and gives
χ = 1.42. The domain organization of the SH2CSH3 bidomain is therefore not the same when isolated in
solution than in the crystal structure of the full-length protein.
To have more information on the difference between the organization of our construct in solution and
in the crystal, we used EOM (Tria et al., 2015; Bernadó et al., 2007). We defined as flexible the linker
between the two domains (residues 154-160, slightly longer than the linker defined in Uniprot to make
sure to have the best sampling). EOM generated 10,000 structures of the bidomain sampling the confor-
mational space available with this flexible linker, starting from the crystal structure. The Rg distribution of
the sub-ensembles that were selected by the program to fit the experimental data is shown in figure 58e.
To fit the experimental curve, two populations with very different Rg are needed. They correspond to com-
pact (low Rg) and extended (high Rg) conformers. The sampling of conformers with different Rg is not
directly detected on the NMR spectra of this bidomain, in which we observe only one set of peaks. This
suggests an exchange that is fast on the chemical shift timescale. Even in the most compact conformations
selected by EOM, the domains are not very close and are not expected to interact very tightly with each
other, consistently with the absence of significant chemical shift differences in the spectra of the individual
domains and the bidomain. The presence of a higher degree of dynamics in the SH2CSH3 bidomain than
in the NSH3SH2 bidomain is compatible with the absence of need for deuteration for the acquisition of 3D
spectra of the SH2CSH3, contrary to the NSH3SH2.
8.4.3 FL Grb2 also adopts multiple conformations with different Rg
The analysis of SAXS data for the SH2CSH3 domain was finally repeated for the full-length Grb2 construct,
as shown in figure 59. As for the SH2CSH3 bidomain, the proportion of dimer is small. FL Grb2 monomer
(for which the molecular weight estimated by SAXS is 25.0 kDa, close to the expected value of 25.33 kDa) is
overall more globular than the SH2CSH3 bidomain, as seen on the Kratky plot in figure 59c. This excludes
the possibility of a completely extended form where all three domains are linearly arranged. The crystal
structure, where the two SH3 domains are tightly packed (giving Rg = 21.36 Å), does not fit the solution
data (Rg = 22.9 Å, figure 59b). Once again, in order to get a better idea of the domain organization, we used
117
8. Behavior of Grb2 in solution
 0
 5
 10
 15
 20
 25
 30
 35
 11  12  13  14
 0
 0.002
 0.004
 0.006
 0.008
 0.01
 0.012
A 2
80
/5
0 
(m
Au
)
R
g 
(Å
)
I 0 
(cm
-
1 )
Elution time (min)
(a)
0.000010
0.000100
0.001000
0.010000
 0.05  0.1  0.15  0.2  0.25  0.3
I (a
rb
ira
ry
 u
n
its
)
q (Å-1)
 0.01
 0.02  0.04  0.06  0.08  0.1
(b)
 0
 0.2
 0.4
 0.6
 0.8
 1
 1.2
 1.4
 0  2  4  6  8  10
(qR
g)2
I/I
0
qRg
(c)
 0
 5x10 -6
 1x10 -5
 1.5x10 -5
 2x10 -5
 2.5x10 -5
 3x10 -5
 0  10  20  30  40  50  60  70  80  90
P
r (Å)
(d)
 0
 0.01
 0.02
 0.03
 0.04
 0.05
 0.06
 16  17  18  19  20  21  22  23  24  25
P
Rg (Å)
(e)
Figure 58 – SEC-SAXS data of Grb2 SH2CSH3 bidomain. (a) SEC-SAXS profile. Along the elution profile are plot-
ted the absorbance at 280 nm A280, the radius of gyration Rg and the extrapolated scattered intensity at q=0 I0. The
chosen SAXS curves are taken in a zone of stable Rg (boxed). (b) Experimental scattering curve (black) and scat-
tering curve from the SH2CSH3 bidomain extracted from the crystal structure (PDB 1GRI), calculated with crysol
(red). χ = 1.42. A zoom at small q is shown. (c) Dimensionless Kratky plot. In grey is the expected maximum for a
globular protein (d) Distance distribution between atoms, computed from the SAXS curve. (e) EOM Rg distribution
for the SH2CSH3 bidomain monomer. Black: pool generated by Flexible Meccano; red: ensembles selected by EOM
to fit the experimental SAXS data; grey bar: Rg of the bidomain from the crystal structure; red bar: experimental Rg.
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EOM, defining as flexible the two linkers between the domains (residues 57-65 and 154-160). The results
are shown in figure 59e. As for the SH2CSH3 bidomain, different types of conformations are needed to fit
the experimental data, from a rather compact form, with a radius of gyration compatible with the crystal
structure, to a more extended conformation. Structures of intermediate Rg are also populated. These data
show that Grb2 samples conformations more extended than the crystal structure. From the observation made
on the SH2CSH3 bidomain, the presence of extended conformations could come from extension of the SH2-
CSH3 linker, but it could also indicate "breathing" of the protein, with the NSH3 and CSH3 experiencing
different distance from one another.
Overall, flexibility of Grb2, with variations of the inter-domain distances, is consistent with its role as an
adaptor protein.
8.5 New model for Grb2 domain organization and oligomeric state
Although Grb2 is an essential link between receptor tyrosine kinases and the Ras/MAPK signaling pathway
(Lowenstein et al., 1992; Gale et al., 1993; Buday and Downward, 1993), the study of its solution struc-
ture without peptide ligands had never really been undertaken. Isolated domains had been characterized
(Goudreau et al., 1994; Wittekind et al., 1994, 1997; Thornton et al., 1996; Kohda et al., 1994), as well
as the full-length protein but either in a crystal (Maignan et al., 1995) or in solution with peptide ligands
for all three domains (Yuzawa et al., 2001). Since the biological role of Grb2 relies on the ability of the
different domains to interact with different partners, inter-domain flexibility is key and is not captured by
crystallography. Binding might also change the dynamics, and therefore the description of the bound state
only is not sufficient to understand Grb2 behavior. This is the reason why we characterized the solution state
of apo-Grb2.
8.5.1 Stability of the NSH3 and His-tag
We showed that in our experimental conditions (40 mM PIPES pH 7.2, 150 mM NaCl, 2 mM TCEP, 308
K) the NSH3 domain of Grb2 is unstable and has a folded and unfolded form, in isolation but also in the
NSH3SH2 bidomain and FL Grb2. This was already reported for this domain (Goudreau et al., 1994),
but also for its Drosophila counterpart Drk (Zhang and Forman-Kay, 1995). Interestingly, we found that
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Figure 59 – SEC-SAXS data of full-length Grb2. (a) SEC-SAXS profile. Along the elution profile are plotted the ab-
sorbance at 280 nm A280, the radius of gyration Rg and the extrapolated scattered intensity at q=0 I0. The chosen
SAXS curves are taken in a zone of stable Rg (boxed). (b) Experimental scattering curve (black) and scattering curve
from the crystal structure (PDB 1GRI), calculated with crysol (red). χ = 1.84. A zoom at small q is shown. (c) Di-
mensionless Kratky plot. In grey is the expected maximum for a globular protein (d) Distance distribution between
atoms, computed from the SAXS curve. (e) EOM Rg distributions for FL Grb2 monomer. Black: pool generated by
Flexible Meccano; red: ensembles selected by EOM to fit the experimental SAXS data; grey bar: Rg of the bidomain
from the crystal structure; red bar: experimental Rg
a Histidine tag in the N-terminus destabilizes even more the isolated domain by interacting with acidic
residues, but stabilizes it by favoring an interaction with the SH2 domain in the NSH3SH2 and FL Grb2.
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This tag-mediated inter-domain interaction significantly changes the dynamics of the domains, docking the
NSH3 and SH2 domain together. Besides, only one peak was observed by SEC for His-tagged Grb2 (data
not shown), while two peaks are seen in the tag-free construct, suggesting an influence of the His-tag on
dimerization. One should then be very careful about results obtained on His-tagged Grb2.
8.5.2 Oligomeric state of apo-Grb2 in solution
In the literature, there are very contradictory data about Grb2 oligomerization, ranging from a low-µM
according to Lin et al. (2012) to high mM (Yuzawa et al., 2001; Guilloteau et al., 1996) dissociation constants
of the dimer. The study by Lin et al. (2012) uses a His-tagged construct of the protein, and therefore one
should be careful about the interepretation of the results, since we showed it changed Grb2 conformation
and dynamics. For all constructs, NMR did not show any sign of the presence of a dimer (at concentrations
of a few hundreds of µM), with only one set of peaks (except for the NSH3 folded/unfolded equilibrium),
excluding non-symmetric dimers, and dynamics of the full-length giving estimated rotational correlation
times incompatible with a dimer. The good superimposition between the spectra of the full-length protein
and the mono- and bi-domains excludes formation of a dimeric interface, that would result in chemical shift
differences. Therefore the crystallographic dimer, where the SH2 domain interacts with the CSH3 domain
of the other monomer, is not seen in solution. It is not impossible that a minor dimeric form exists but can
not be seen due to the combination of low quantity and faster transverse relaxation. The SEC-SAXS data
confirm that the highly major form is a monomer for the SH2CSH3 bidomain as well as for the full-length
protein. The NSH3SH2 presents a high proportion of dimer separated by size-exclusion chromatography,
but was also injected at a higher concentration. The dimeric peak could not be analyzed by NMR or SAXS
so far, by lack of time. A problem with SEC-SAXS is that the concentration of the protein which scattering
curve is measured is unknown. A rough estimate of the dilution factor by the SEC column of 5 gives
concentration of the FL Grb2, SH2CSH3 and NSH3SH2 constructs of about 30 µM, 130 µM and 20 µM
respectively. If data showed that at similar concentrations, the NSH3SH2 bidomain does dimerize in a
higher proportion than the other constructs, it would be compatible with a role of the C-terminal part of
the SH2 domain in dimerization, as in the dimer-swapped SH2 dimer (Schiering et al., 2000; Nioche et al.,
2002; Benfield et al., 2007; Papaioannou et al., 2016). This would have to be investigated further. Overall,
our data are not compatible with a dimer dissociation constant below µM for FL Grb2. However, it does not
exclude the possibility sub-mM dimer dissociation constant.
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8.5.3 Domain organization in Grb2 monomer
In the crystal structure of Grb2 (PDB 1GRI), the two SH3 domains are far from the SH2 domain and
interact with one another. In solution, with ligand peptides loaded, Yuzawa et al. (2001) showed that, on the
contrary, the SH3 domains are not interacting. Here, we firstly showed by NMR that the domains in apo-
Grb2 in solution are structurally and dynamically independent from one another, similarly to the peptide-
loaded form. No interaction interface can be seen between the domains, and the three domains tumble with
different rotational correlation times. From the analysis of SAXS data, we propose a model of apo-Grb2 in
solution that has several populations of different radius of gyration, from a Rg similar to the crystal structure
to a more extended population with significantly higher Rg. We used the bidomain constructs, NSH3SH2
and SH2CSH3 to understand the contribution of each inter-domain linker to this observed flexibility. It
showed that while the NSH3SH2 bidomain is compatible with the organization in the crystal structure, the
SH2CSH3 bidomain also has at least two populations of different Rg. The Rg of the compact form of the
SH2CSH3 bodimain is smaller than the Rg of the crystal structure SH2CSH3 bidomain. Conversely, the
Rg of the most compact form of the FL protein fits the Rg of the full-length crystal structure. The compact
form of the SH2CSH3 bidomain is therefore influenced by the presence of the NSH3 domain. In the model
we propose, even though the two interdomain linkers are flexible enough to decorrelate the dynamics of
the three domains, the NSH3 and SH2 domains experience little to no movement compared to one another,
while the CSH3 domain is able to sample a large conformational space between a compact and an extended
form. This is consistent with the definition of the domains and of the linkers shown in figure 34a, where the
NSH3-SH2 linker in shorter than the SH2-CSH3 linker. Moreover, the NSH3-SH2 linker contains a 57PHP59
sequence that is expected to be particularly rigid, whereas the SH2-CSH3 also contains two prolines but in
a 155PQQP158 sequence expected to be less constrained. Variation of the distance between the two SH3
domains can not be excluded either. The resulting model is presented in figure 60.
Several complementary experiments could be run to confirm and complement this model:
• We could run EOM on the FL Grb2 data, with a fixed NSH3SH2 bidomain and a flexible linker
between the SH2 and CSH3 domains, to confirm that the flexibility of the FL protein can arise solely
from movement of the CSH3 relative to the NSH3 and SH2 domains.
• By NMR, we could record RDC and PRE experiments to have more information on the dynamics,
orientations and distances between the domains.
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• By NMR, relaxation dispersion experiments or CEST experiments would detect potential conforma-
tional exchange in the µs to ms timescale, relative to inter-domain movements or possible existence
of a dimer. Analysis of Grb2 dynamics at several magnetic fields could also be informative.
SH2
N C
crystal structure
(PDB 1GRI)
His-Grb2
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Figure 60 – Model of His-Grb2 and Grb2 (monomers) structure and dynamics in solution, compared to the crystallo-
graphic model.
8.5.4 Importance for Grb2 interactions and biological function
As noted by Yuzawa et al. (2001), in a modular adaptor protein such as Grb2, inter-domain dynamics is
expected to be key, which makes the study of dynamics crucial to understand their biological function. In
the case of the interaction with ErbB2, it would be essential to understand if, and how, Grb2 can interact with
both the expected phosphotyrosine site via its SH2 domain and polyproline motifs via its SH3 domain(s).
If the SH3 domains compete for several partners which are known to interact with polyproline motifs with
moderate affinities, flexibility would also be a way to allow rapid binding and dissociation, in a manner
rather similar to the binding modes of IDPs for that matter.
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9 Interaction between CtErbB2 and Grb2
Even though Grb2 is known to interact with ErbB2 via the phosphorylated tyrosine B (YB, Y152 in our
numbering, Y1139 in the full-length ErbB2 numbering) (Dankort et al., 1997), the interaction has never been
characterized at the atomic level. The existing structures of Grb2 complexes only include single domains
of Grb2, with peptides of partners. Besides, no peptide from ErbB2 has ever been studied in complex with
Grb2. In the current model of signal transduction by Grb2, its SH2 domain interacts with RTKs while the
SH3 domains interact with other signaling proteins: Sos, that is part of the Ras/MAPK pathway, interacts
mainly with the NSH3 domain but can also interact with the CSH3 domain (McDonald et al., 2009); Gab1
and Gab2 large multi-site docking (LMD) proteins interact with the CSH3 domain, and are involved in the
MAPK and PI3K pathways (Lewitzky et al., 2001; Harkiolaki et al., 2009).
Given the existence of several polyproline motifs in CtErbB2, as studied in section 7, and the observation
that Grb2 binding to ErbB2 is impaired by deletion of its SH3 domains (Xie et al., 1995), it is likely that a
SH3-polyproline interaction also participates in Grb2 binding to ErbB2. Several questions therefore remain
regarding this interaction:
• Does Grb2 binding to ErbB2 involve SH3-polyproline interactions? Can these interactions interfere
with binding to other partners of Grb2?
• How are the structural and dynamic features of CtErbB2 affected when bound to Grb2? Do the
transiently formed PPII helices observed in free CtErbB2 fold upon binding to Grb2?
• How does the domain organization of Grb2 in solution that we determined, and in particular the
inter-domain flexibility, influence binding?
• How does phosphorylation of ErbB2 tyrosines influence binding to Grb2?
First, we chose to investigate the binding of Grb2 to unphosphorylated CtErbB2. The binding is expected
to be weak, since it was shown to require phosphorylation of YB in vivo (Dankort et al., 1997, 2001a,b).
However, this could already allow detection of a potential SH3-polyproline interaction.
9.1 Grb2 and unphosphorylated CtErbB2
First we titrated 50 µM labeled CtErbB2 with unlabeled Grb2 in the PIPES buffer (pH 7.2, 298 K), follow-
ing binding by NMR at 950 MHz. The effects are, as expected, weak. Some very small chemical shifts
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changes can be observed, associated with some decreasing intensities, suggesting an intermediate exchange
regime between the free and bound forms. Both chemical shifts and intensity effects at the final titration
point (1:10 CtErbB2:Grb2 ratio) are plotted against CtErbB2 sequence in figure 61a.
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Figure 61 – Titration of CtErbB2 by Grb2. (a) 1H-15N HSQC comparison between CtErbB2 alone and with 10
equivalents of Grb2. 1H-15N CCSP (top) and intensity ratio (bottom) along CtErbB2 sequence. In red is YB (Y152)
and in orange is the polyproline segment. Lines indicate mean+std (standard deviation), mean and mean-std values
after outliers were removed. (b) S164 region of the HSQC spectrum of CtErbB2 alone (black) or with 10 equivalents
of Grb2 (blue).
Three main regions are affected by the interaction, both in terms of intensity and chemical shifts: the N-
terminal region around residue 20, the region between residues 150 and 170, and the region between residues
230 and 240. The middle region is the expected interaction site (Y152). Interestingly, it seems to interact
with Grb2 (although weakly) even when not phosphorylated. The amide group of a nearby residue, S164, is
also particularly affected, as shown on the spectra in figure 61b. It is in the center of a proline-rich segment
159RPQPPSPR166. This segment contains a canonical class I interaction motif for SH3 domains, RxxPxxP,
and a PxxPxxR motif that is not canonical but is close to a class II PxxPxR motif (see section 3.2.2). This
proline-rich segment is located in a transiently formed PPII helix of CtErbB2, with an estimated population
of 40% (see section 7.4). These characteristics make it an ideal candidate for interaction with one or both of
the Grb2 SH3 domains. The two other regions where amide groups are affected by the interaction also con-
tain tyrosines: Y18 for the first one, Y234 and Y235 for the second one. None of them has the asparagine in
position +2 that characterizes the interactions motifs for the SH2 domain of Grb2 (Marengere et al., 1994).
The first one is not an autophosphorylation site, while Y234 and Y235 define the YD autophosphorylation
site. Notably, the region of tyrosine 18 is in the transient α-helix, and the tyrosines 234 and 235 are in
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the C-terminal region involved in the long-range contact that we have characterized in free CtErbB2. No
potential SH3-binding polyproline motif can be found in these regions. The origin of the effect of Grb2 on
these regions, direct or conformational, remains to be investigated. Grb2 binding could, for example, disrupt
the long-range contact.
To investigate the binding on the side of Grb2, we did the reverse titration by following the effect
of the addition of unlabeled CtErbB2 to a sample of 100 µM [U-15N; U-13C; U-80% 2H]-Grb2, up to a
Grb2:CtErbB2 ratio of 1:5, at 600 MHz. The conditions (buffer, temperature) were similar than for the first
titration. The chemical shift and intensity perturbations at the final titration point are plotted along Grb2
sequence in figure 62. The main effect of CtErbB2 addition are small chemical shift perturbations in the
N-terminal SH3 domain, indicating a fast exchange regime. The largest CCSP are seen for residues 12,
15, 37, 47, 50 and 51, consistent with the residues previously shown to be involved in binding of polypro-
line peptides (residues F9, A13, D15, W36 and Y52, see figure 27). A few residues experience significant
chemical shift changes in the SH2, residues 72 and 140 in particular, while residues 107 to 109 experience
small chemical shift changes combined with decreased intensity. Residues E72 and V140 are on the ligand
binding face of the SH2 domain but are not known to be directly involved in binding of phosphopeptides.
Lysine 109 is known to interact with both the ring of the ligand phosphotyrosine and with the asparagine
in position +2 relative to the tyrosine. Perturbation of this lysine is consistent with binding of the tyrosine,
even non phosphorylated. Residues of the SH2 domain that are known to interact with the phosphate group
of phosphotyrosine ligands (R67, R86, S88, S90, see figure 25) are not affected by the binding here. The
CSH3 domain is almost not affected by binding, except for a small chemical shift perturbation of residue
200, which is in the distal loop, far from the expected peptide binding site.
Overall, our data show binding of Grb2 via its N-terminal SH3 domain on at least one polyproline motif
C-terminus of the tyrosine B of ErbB2. Additionally, weak but detectable binding of the SH2 domain to
ErbB2 is detected, most probably on the tyrosine YB, which is the known interaction site of Grb2 on ErbB2
and the most perturbed tyrosine region in the reverse titration. Other regions of ErbB2 including tyrosines
are affected by the binding, but do not show the consensus sequence for Grb2 binding. We could not mea-
sure reliable KDs, as saturation was not reached at the concentrations used, but we can estimate it to be
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Figure 62 – 1H-15N HSQC comparison between Grb2 alone and with 5 equivalents of CtErbB2. 1H-15N CCSP (top)
and intensity ratio (bottom) along Grb2 sequence. Different colors delimit the different domains: blue: NSH3; red:
SH2; green: CSH3. Lines indicate mean+std (standard deviation), mean and mean-std values after outliers were
removed.
in the mM range. Further structural characterization of the complex was done with peptides of ErbB2, as
described below.
9.2 Need for tyrosine phosphorylation of CtErbB2
In the titration experiments presented so far, the binding of Grb2 to unphosphorylated CtErbB2 is too weak,
and therefore the proportion of bound proteins is too low, to easily study the bound state. The results of
most experiments would be dominated by the behavior of the free proteins in solution. This weak binding
might not be biologically significant considering the expected range of the protein concentrations in vivo,
which is consistent with the fact that CtErbB2-Grb2 binding has been shown to occur and be signaling-
competent in vivo only when CtErbB2 is phosphorylated (Dankort et al., 1997). It is thus essential, to
go further into the characterization of this interaction, to be able to phosphorylate CtErbB2 tyrosines, and
especially the known interaction site for Grb2, YB. However, controlled phosphorylation of a multisite
protein is not easy, and tyrosine phosphorylation is not as studied as serine/threonine phosphorylation. From
our study with unphosphorylated CtErbB2, the known phosphotyrosine interaction site, YB, is close to
the polyproline motif also interacting with Grb2. Peptides containing both these sites can thus be easily
obtained by chemical synthesis in the unphosphorylated and phosphorylated form. In parallel to setting up
methods to phosphorylate the whole CtErbB2, presented in section 10, we therefore chose to use a peptide
approach to further study the CtErbB2-Grb2 interaction. To compare binding in the unphosphorylated and
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phosphorylated state, we designed two peptides, P1 (unphosphorylated) and P2 (phosphorylated), containing
both YB and the double PxxP/arginine motif RPQPPSPR. Their sequence is given in figure 63.
P1: 141VAPLTCSPQPEYVNQPDVRPQPPSPREGPLPAARPA176
P2: 141VAPLTCSPQPEpYVNQPDVRPQPPSPREGPLPAARPA176
Figure 63 – ErbB2 P1 and P2 peptides designed for interaction with Grb2. The expected interaction sites, the tyro-
sine and the proline-rich segment, are in bold.
9.3 Grb2 and peptides of CtErbB2
Titrations of Grb2 with ErbB2 peptides were done in the same conditions as the titration of Grb2 with the
whole CtErbB2 construct (on a [U-15N; U-13C; U-80% 2H]-Grb2 sample at 100 µM in PIPES buffer at
pH 7.2, at 298 K), and followed at 600 MHz. Titrations were performed up to a large quantity of peptide
(Grb2:peptide ratio of 1:20, yielding a peptide concentration of 2 mM) to try to saturate Grb2.
9.3.1 Unphosphorylated Y-PxxP peptide P1
First we titrated Grb2 with the unphosphorylated P1 peptide, up to a Grb2:P1 ratio of 1:20. The overlaid
HSQC spectra of the initial (1:0 ratio) and final (1:20 ratio) titrations points, with one intermediate titration
point (1:5 ratio), are shown in figure 64a. The CCSP and intensity ratios between the initial and final points
along the sequence are shown in figure 64b, and the largest shifts and intensity decreases are mapped onto
Grb2 crystal structure in figure 64c. The NSH3 binding site exhibits exchange in the fast regime, while the
region around K109 in the SH2 domain seems to experience intermediate exchange, with peaks of the free
form broadening but no visible appearance of peaks corresponding to the bound form. The position of the
affected peaks in the SH2, on top of the central β -sheet perpendicular to which the SH2-binding peptides
are known to be located, is consistent with correct positioning of the peptide in the binding pockets.
The interaction we observe with both the NSH3 and SH2 domains are similar to what was observed with the
whole C-terminal tail of ErbB2, except that the shifts that we observe here for the NSH3 are slightly larger,
due to the higher ratio of peptide added. Still, we do not saturate 100 µM Grb2 with 2 mM peptide P1.
The dissociation constant once again seems to be of the order of mM. This similarity of binding between
the whole CtErbB2 and P1 indicates that the peptide we chose is a good model to study the influence
of phosphorylation. We then performed the titration with the phosphorylated peptide P2, which is more
biologically relevant.
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Figure 64 – Titration of Grb2 with unphosphorylated peptide P1. (a) 1H-15N HSQC of Grb2 alone (dark blue),
with 5 equivalents of peptide P1 (maroon) and with 20 equivalents of P1 (green). A zoom shows peaks in the NSH3
(I48), SH2 (G93) and CSH3 (G196) domains. (b) Mapping of the differences between the initial and final titration
points 1H-15N HSQC. Grey: missing residues; yellow: residues for which the intensity ratio (bottom) is < 0.1; cyan:
residues for which the 1H-15N CCSP (top) is > 0.06 ppm. Yellow bands correspond to disappearing peaks. Lines
indicate mean+std (standard deviation), mean and mean-std values after outliers were removed. (c) Color-coded
mapping of the perturbations onto Grb2 crystal structure (PDB 1GRI). The residues known to be important for lig-
and binding in the NSH3 and SH2 domains are shown as sticks and named.
9.3.2 Phosphorylated Y-PxxP peptide P2
The titration of Grb2 with the phosphorylated peptide P2 was performed in the same conditions as the titra-
tion with the unphosphorylated peptide P1, up to a Grb2:P2 ratio of 1:20. The NSH3 domain is, as for P1,
experiencing fast exchange. However, with this phosphorylated peptide, the SH2 is in slow exchange be-
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tween the free and the bound form: the disappearance of the SH2 peaks are correlated with the appearance
of peaks corresponding to the bound form. The overlaid HSQC spectra of the initial (1:0 ratio), final (1:20
ratio) and one intermediate (1:5 ratio) titration points are shown in figure 65a. The CCSP and intensity ratios
of the free form (peaks that are disappearing) between the free form and the final titration point are shown
in figure 65b. The mapping of the peaks in the fast and slow exchange regimes is shown in figure 65c.
The interaction of the NSH3 is similar to the binding to the unphosphorylated peptide P1: the same residues,
corresponding to the expected binding site, are affected. Regrettably, uncertainties on the quantity of peptide
added prevented reliable comparison of the estimated dissociation constant. We suspect that the quantity of
added peptide P2 is lower than calculated, preventing the analysis of a potential change in KD of the NSH3
between P1 and P2.
Contrary to what is observed for the NSH3, the kinetics of the SH2 binding dramatically changes when
the peptide is phosphorylated. The exchange between the free and bound SH2 domain is slow when the
peptide is phosphorylated, which is probably associated with a lower KD compared to binding with the
unphosphorylated P1 peptide. The binding sites involved in binding to P1 are also involved in binding to
P2, but additional residues are taking part in the interaction, notably in the regions of R67, R86, S88 and
S90, with are known to form the binding pocket for the phosphate group of the phosphorylated tyrosine.
W121 is known to close the specificity pocket for the arginine 2 residues C-terminal of the tyrosine in the
consensus Grb2-binding motif. Even though its peak is assigned, it unfortunately is too weak at our work-
ing concentration of 100 µM for the precise measure of its intensity or chemical shift perturbation, but it
completely disappears upon binding. So far, the assignment of the bound form has not been done, but it will
be a valuable source of information.
The precise analysis of the titration curves has not been done yet, but it will also tell us more about the
simultaneity of the binding of the two domains.
9.4 Possible consequences for Grb2-mediated signal transduction
We obtained a first description at the atomic level of the binding between Grb2 and ErbB2. We showed that
the SH2 domain of Grb2 interacts with the expected autophosphorylation site tyrosine B of ErbB2, even in
the unphosphorylated state, with a high increase in affinity upon phosphorylation of the tyrosine. We also
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Figure 65 – Titration of Grb2 with phosphorylated peptide P2. (a) 1H-15N HSQC of Grb2 alone (dark blue), with
5 equivalents of peptide P2 (maroon) and with 20 equivalents of P2 (green). A zoom shows peaks in the NSH3
(I48), SH2 (G93) and CSH3 (G196) domains. (b) Mapping of the differences between the initial and final titration
points 1H-15N HSQC. Grey: missing residues; yellow: residues for which the intensity ratio (bottom) is < 0.1; cyan:
residues for which the 1H-15N CCSP (top) is > 0.035 ppm. Yellow bands correspond to disappearing peaks. Lines
indicate mean+std (standard deviation), mean and mean-std values after outliers were removed. (c) Color-coded
mapping of the perturbations onto Grb2 crystal structure (PDB 1GRI). The residues known to be important for lig-
and binding in the NSH3 and SH2 domains are shown as sticks and named.
showed that the N-terminal SH3 domain of Grb2 interacts with ErbB2 via a RPxPPxPR segment just C-
terminal after the tyrosine. This secondary interaction could increase the overall affinity of Grb2 for ErbB2.
This is consistent with the observation by Xie et al. (1995) using pull-down assays that the SH2 domain of
Grb2 alone binds ErbB2 more weakly than full-length Grb2. The C-terminal SH3 domain of Grb2 does not
seem to be affected by the interaction.
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9.4.1 Selectivity of CtErbB2 polyproline motif for the NSH3 of Grb2
The RPxPPxPR segment of ErbB2 contains a RxxPxxP class I polyproline motif that has been shown by
Guerlesquin and colleagues to be able to bind the SH3 domain of Fyn (Bornet et al., 2014). Even though
many PxxP motifs are found in CtErbB2 sequence, as shown in figure 50, there is no canonical class II motif
(PxxPxR) or other class I motif. Both NSH3 and CSH3 have been shown to be able to interact with class I
motifs, even though for both domains the class II motifs have been more often characterized (see figure 32)
(Musacchio, 2002).
Bornet et al. (2014) noticed that the RPxPPxPR segment does not bind the isolated CSH3 domain of Grb2,
consistently with our results showing selectivity towards the NSH3 domain in FL Grb2. McDonald et al.
(2009) observed that in Sos, the binding of the CSH3 domain required several arginines adjacent to the PxxP
motif, which is not the case in the motif of CtErbB2 studied here. The only structure of the CSH3 bound
to a class I motif (PDB 1IO6) involves a highly positively charged polyproline motif too (RHYRPLPPLP).
Binding of the CSH3 to RxxK motifs has also been reported (Harkiolaki et al., 2009), and no such RxxK
motif can be found in CtErbB2. The different selectivities of the NSH3 and CSH3 domains of Grb2 there-
fore seem to rely on electrostatic interactions.
9.4.2 Importance of the organization of Grb2 domains for its interactions
The Grb2 interaction sites described here are far from the linkers and from the regions of each domain that
we identified to be affected by each other in FL Grb2 (see figure 55). Binding of each domain to ErbB2 is
therefore not expected to be directly hindered by the presence of the other domains. However, given that the
tyrosine and polyproline sites in CtErbB2 are very close from one another (only 6 residues between the ty-
rosine and the first arginine), the relative position of the NSH3 and SH2 domains is important to understand
how binding occurs. The relative position of the NSH3 and SH2 domains in solution, as we determined by
SAXS (see section 8.4), is compatible with their relative position in the crystal structure. In this structure,
their respective binding pockets are too far from one another (as seen in figure 65c) for simultaneous binding
to the polyproline and tyrosine motifs of the peptide. The domains have to be arranged differently in the
bound form if their binding is simultaneous. Inter-domain dynamics could also be altered by binding.
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9.4.3 Revisiting the model of signal transduction by Grb2
The current model of signal transduction by Grb2 is shown in figure 66: while the SH2 domain interacts
with RTKs, and in particular ErbB2, the SH3 domains interact with downstream partners for signaling. Sos
preferentially binds to the NSH3 (Chardin et al., 1993; McDonald et al., 2009), while Gab1 (Lewitzky et al.,
2001) and Gab2 (Harkiolaki et al., 2009) bind to the CSH3. The interaction that we showed between the
NSH3 of Grb2 and CtErbB2 polyproline motif has a lower affinity (mM range) compared to the NSH3-Sos
interaction (µM range, measured by Ogura and Okamura (2013)). However, it could beneficiate from the
increased local concentration due to the SH2-pY interaction, and compete with binding to the NSH3 in cer-
tain conditions, regulating Sos-dependent signaling.
P
ErbB2
SH
2
N
C
Sos
Gab1/2Grb2
and/or signaling
current model possible model from our data
P SH
2
N
C
Sos
Gab1/2
Grb2
and/or signaling
PxxP
concentration-dependent 
competition?
ErbB2
Figure 66 – Modification of the current model of Grb2 signal transduction. Only the intracellular region of ErbB2 is
represented for clarity.
We did not study how the binding to Grb2 affects ErbB2 peptides conformation. While the PxxP motif is
expected to be stabilized in a PPII helix upon interaction with the SH3 domain, the phosphotyrosine segment
is expected to adopt a turn in its C-terminus. Whether and how these two expected local conformations are
actually formed remains to be investigated. More globally, how the CtErbB2 conformational ensemble
is affected by its binding to Grb2 is completely unknown, but could regulate other interactions, and impact
signaling. Besides, we saw that sites outside of the YB/RPxPPxPR region are affected by the interaction with
Grb2 in unphosphorylated CtErbB2. Whether it still holds when CtErbB2 is phosphorylated remains to be
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investigated. For all these regions, we would need to obtain tyrosine phosphorylated samples of CtErbB2,
and not just peptides. This is the focus of the next section.
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10 Towards the characterization of functional states of CtErbB2: challenges
of structural and functional studies of tyrosine phosphorylation
Post-translation modifications are a major regulation mechanism in the cell, and are particularly important
in signaling. They allow context-dependent expansion of the protein readout beyond the common 20 amino
acid. Amongst them, phosphorylation is the most commonly observed one, and the second one in terms of
predicted sites (after N-glycosylation), from the Swiss-Prot database (Khoury et al., 2011). Phosphorylation
can occur on the side-chains of serines, threonines and tyrosines (and much more rarely on histidines and
aspartates). While serines and threonines share the same kinases, that were discovered in the 50s (Burnett
and Kennedy, 1954), tyrosines are phosphorylated by specific kinases, namely tyrosine kinases, that were
only discovered in 1979 with Src (Eckhart et al., 1979). Over the years, it has been shown that many tyro-
sine kinases are receptors, and to date 90 tyrosine kinases have been identified in the human genome (for a
total of 525 kinases), amongst which 58 receptor tyrosine kinases (RTKs) (Manning, 2002). Most tyrosine
kinases, and especially RTKs, are activated by transphosphorylation (of a tyrosine in their activation loop
or juxtamembrane region) in oligomers (Lemmon and Schlessinger, 2010). In that regard, ErbB receptors
are unique since dimerization-induced activation is not mediated by transphosphorylation of the kinase do-
mains, but by inter-domain interaction (Stamos et al., 2002; Zhang et al., 2006).
Many essential processes, often linked to transmembrane signal transduction, depend on tyrosine phos-
phorylation (Hunter, 2009). Phosphotyrosines (pY) are less abundant than phosphoserines (pS) and phos-
phothreonines (pT): as of July 2019, from Swiss-Prot, there are 46973 predicted serine, 12599 predicted
threonine, and 9282 predicted tyrosine phosphorylation sites in eukaryotic proteins (http://selene.
princeton.edu/PTMCuration/ (Khoury et al., 2011)). Additionally, phosphotyrosines have short life-
times in the cell, due to high turnover of tyrosine phosphatases, leading to a contribution of pY to the total
number of phosphosites in proteins of animal cells lower than 1% (Hunter and Sefton, 1980). All in all,
tyrosine kinases and phosphorylation remain far less characterized than serine and threonine kinases and
phosphorylation.
In CtErbB2, for interaction studies on a single phosphotyrosine motif, without taking into account the ef-
fect of the full-length protein, chemical synthesis of peptides was the way to go. However, to study the effect
of phosphorylation on the conformation, and interactions, of the full-length C-terminal tail, other strategies
had to be designed. This is very challenging due to the nature of the phosphorylation (on tyrosines), the size
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of the protein and multiplicity of phosphosites, and the complexity of the native auto-transphosphorylation
process. In this section, I present the associated specific challenges, and the three methods to overcome
them that we have tried to apply in the lab, in parallel to our study of unphosphorylated CtErbB2.
10.1 Challenges and existing strategies
10.1.1 Site-resolved detection and study of (tyrosine) phosphorylation
One of the great challenges of the structural study of multiple phosphorylation is its detection at a resolution
allowing information on each phosphorylation site. Here I present the most common and relevant methods
for such detection, available in laboratories such as the ICSN, that could be used to study CtErbB2.
• Antibodies. Phosphospecific antibodies are the common technique to detect phosphorylation in cell
biology studies. However, either they detect phosphorylation of an amino acid without sequence
specificity (any pS or pT or pY) and do not give any information on the specific phosphorylation sites,
or we need site-specific antibodies for all positions. This is cumbersome, does not really allow real-
time monitoring, and very close phosphorylation sites (such as YD1 and YD2 in CtErbB2) can usually
not be discriminated.
• Mass spectrometry. This is one of the most used technique to detect phosphorylation, since the addi-
tion of a phosphate group is expected to be easily detectable with an addition of 80 Da to the protein
mass. However, site-resolved information is only accessible (routinely) with a proteolysis step. De-
pending on the protein sequence and structure, and protease(s) available, not all sites information can
be obtained. Several problems combine for the study of CtErbB2 with this technique: proline-rich
proteins are more difficult to proteolyse in enough peptides to cover the sequence; sequence rep-
etitions, found in particular around CtErbB2 tyrosines, make the identification of cleaved peptides
difficult; and adjacent sites such as D1 and D2 are virtually impossible to discriminate. An additional
problem is that ionization of phosphorylated proteins is less efficient than ionization of their unphos-
phorylated counterpart, preventing accurate quantification. Enrichment is often needed (Thingholm
et al., 2009). There is also a problem of isotopic labeling when working on NMR samples of large
proteins, as in our case: isotopic heterogeneity can mask the phosphorylation information. Complex
labeling strategies to identify and quantify phosphorylation exist (Przybylski et al., 2010), but require
very specific expertise and are costly.
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• NMR. It can give residue-specific, quantitative information about phosphorylation. NMR also has the
major advantage to allow phosphorylation monitoring in real-time, in cases where the phosphorylation
is slow enough to be followed by sequential experiments (in the order of 10 min for a "standard"
HSQC, down to the min or even s timescale with fast experiments and concentrated samples). Given
that phosphorylation sites are often located in disordered regions (Iakoucheva et al., 2004), NMR
is all-the-more relevant for these studies. In the last few years, several groups have been studying
phosphorylation by NMR, notably Selenko and colleagues (Selenko et al., 2008; Liokatis et al., 2010;
Theillet et al., 2012; Mylona et al., 2016), Lippens and colleagues (Landrieu et al., 2006), Wolff
and colleagues (Cordier et al., 2012, 2015), and Brutsher and colleagues (Sólyom et al., 2015), all
focusing on serines and threonines. Few NMR studies exist on tyrosine phosphorylation (Deshmukh
et al., 2011; Rosenlöw et al., 2014; Mayzel et al., 2014). Examples of how serine, threonine and
tyrosine phosphorylation can be looked at by NMR is given in figure 67. There as some specific
challenges associated with the NMR study of phosphorylation in our system:
– By 1H-15N NMR: This is a very good way of observing serine or threonine phosphorylation,
because their phosphorylated and unphosphorylated forms have very different backbone 1H and
15N chemical shifts, and the phosphorylated form has a peak outside of the crowded region of
the spectrum (see figure 67 a and b). The case of tyrosine is unfavorable, since the phosphate
group is quite far from the backbone and induces relatively small 1H-15N shifts (see figure 67
c and d). It has made detection of phosphorylation difficult to distinguish from subtle changes
in conditions such as pH or temperature with standard HSQCs. Besides, phosphotyrosine peaks
are located in already crowded regions of the spectrum.
– By 13C NMR: This is a way to get information close (CHε ) to the actual addition of the phos-
phate group on tyrosines and have larger chemical shift changes upon phosphorylation (see
figure 67d). Unluckily, the disordered nature of CtErbB2 causes superimposition of tyrosine
side-chain carbons on 1H-13C HSQC, and requires to record time-consuming 3D spectra to have
site-resolved information.
– 31P NMR: Being more sensitive than 13C NMR, and giving signal only for phosphorylated
residues in a protein sample (plus potential phosphate from the buffer), this leads to quite a
sensitive detection of phosphorylation. However, the assignment of multi-phosphorylated pro-
teins is not straightforward.
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Figure 67 – Serine, threonine (a, b) and tyrosine (c,d) phosphorylation studied by NMR. Figure from Theillet et al.
(2012).
Additionally to the problem of obtaining information on the phosphorylation state of each tyrosine site,
there is also a major problem of heterogeneity of the sample that comes with many multiphosphorylated
protein samples. This heterogeneity complicates the study of the effect of precise phosphorylation patterns.
10.1.2 Production of phosphorylated samples with multiple sites: site-directed synthetic approaches
and biological relevance
We have seen that obtention of site-resolved information on a multiphosphorylated, heterogeneous sample
is not easily done. Yet, biologically relevant samples are likely to be multiphosphorylated and heteroge-
neous. One way around would therefore be to generate samples with controlled phosphorylation patterns,
to understand the role of each site, followed by the description of more complex and biologically relevant
samples.
To produce site-directed phosphorylated proteins, three main approaches exist (Chen and Cole, 2015):
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• The use of natural amino acid phosphomimetics introduced by site-directed mutagenesis. Phospho-
serines and phosphothreonines have been mimicked by aspartates and glutamates since the end of
the 1980s (Thorsness and Koshland, 1987). However, the validity of this approach is restricted by
the structural and chemical difference between the phospho-amino acid and the mimic. For example,
while Glu and Asp only have one possible negatively charged state, phosphate has two. Mimicking
phosphorylation with Glu or Asp has been proven to be inaccurate in several instances, for example
in α-synuclein (Paleologou et al., 2010) and Bcl-2 (Dai et al., 2013). Besides, these phosphomimetic
residues are even more structurally different from pY than from pS and pT. We therefore dismissed this
strategy. The reverse strategy, preventing phosphorylation by incorporation of a non-phosphorylatable
analog, is more interesting for tyrosines: like alanine can be considered a non-phosphorylatable struc-
tural equivalent of serine, phenylalanine would be the non-phosphorylatable tyrosine. This approach
has already been applied to RTKs from the PDGFR (Valius and Kazlauskas, 1993) and ErbB family
(Dankort et al., 1997) in cell biology studies.
• Total chemical synthesis of proteins. It allows site-specific incorporation of any type of phosphory-
lated amino acid, but is generally limited to proteins of less than 60 residues. Ligation can be per-
formed to then obtain longer proteins, but often requires peptides with N-terminal cysteines (Dawson
et al., 1994). Furthermore, for long proteins with multiple phosphorylations, iterative ligations implies
increased complexity, lower yields, and therefore higher costs. NMR studies would also require to
isotopically label the synthesized peptide(s), further increasing the cost. We have thus restricted our
use of this strategy to the small unlabeled peptides for titrations.
• The incorporation of phospho-residues as unnatural amino acids using a STOP codon. This technique
has been tested for pS (Park et al., 2011), and more recently for pT (Zhang et al., 2017) and pY
(Hoppmann et al., 2017). It is still a technique that requires specific expertise, that we do not have in
the lab.
These approaches can be complemented by production of more biologically relevant phosphorylated
form(s) of the protein of interest. When a protein is overexpressed recombinantly in the usual E. coli
system, it is not phosphorylated. When the protein contains its own kinase domain, such as ErbB2, high-
level expression of active proteins in E. coli is challenging, because of lack of solubility, misfolding and/or
aggregation (Caspers et al., 1994; Rosano and Ceccarelli, 2014). Good levels of autophosphorylation are
difficult to obtain (Shrestha et al., 2012; Bhoir et al., 2018). Other systems can be used, amongst which:
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• In vitro phosphorylation of a recombinantly produced non-phosphorylated protein by either a recom-
binant, purified kinase, or by cell extracts. These two phosphorylation methods were monitored and
compared by NMR by Wolff and colleagues (Cordier et al., 2012, 2015).
• For autophosphorylated proteins which contain their own kinase, overexpression in eukaryotic ex-
pression systems. Many kinases are produced this way, and in particular ErbB2 kinase is often over-
expressed in insect cells using the baculovirus expression system (Brignola et al., 2002b; Fan et al.,
2008; Monsey et al., 2010), including the commercial ones by Life technologiesTM and PRECISIOTM.
We are trying in the lab to combine all those approaches and apply them to the study of CtErbB2
phosphorylation.
10.2 Three methods to produce phosphorylated CtErbB2
We designed three methods to phosphorylate CtErbB2. All three have different challenges, advantages,
drawbacks and costs.
10.2.1 CtErbB2 co-expressed with a tyrosine kinase in E. coli
To try and produce large amounts of tyrosine-phosphorylated CtErbB2, we used the Agilent TKB1 Com-
petent Cells (Catalog #200134). This chemically competent strain, derived from the E. coli BL21(DE3)
strain, allows for inducible expression of amounts of an unknown tyrosine kinase protein sufficient to phos-
phorylate a co-expressed tyrosine-containing protein, here our CtErbB2 construct. This method has the
advantages of E. coli protein overexpression: it is fast, and allows for production of large quantities of
proteins. Compared to a common E. coli production, the cost is higher, for a single transformation costs
about 100 euros in bacteria. It also allows for the desired isotopic labeling in a manner overall similar to
usual E. coli protocols, even though the protocol has to be adapted. The major drawback of this production
technique is the total absence of control on the phosphorylation pattern, since no information is given by the
supplier on the kinase nature and specificity. Moreover, the vector carrying this kinase is unknown, making
it difficult to optimize the protocol.
The TKB1 strain allows for IPTG-induced production of a target protein, here CtErbB2, when transformed
with the appropriate plasmid (since the strain carries the gene for T7 RNA polymerase under the control of
the lacUV5 promoter). Not much information is given on the induction mechanism of the tyrosine kinase,
except "The TKB1 strain harbors a plasmid encoded inducible tyrosine kinase gene". The induction medium
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for the kinase being tryptophan-free in the supplier’s protocol, and containing indoleacrylic acid (see fig-
ure 68a), we think its expression is under control of the tryptophan operon. In addition to the antibiotic
that is specific to our plasmid (kanamycin), the transformation and culture have to be done with tetracycline
according to the Agilent protocol, suggesting it selects for bacteria containing the TK plasmid.
The optimization of the protocol has been done with Dr. Nadine Assrir, and I supervised Ndèye Marième
Diouf, who was a bachelor student in the lab between June and August 2018, and Alan Even, a master
student in the lab between March and July 2019, on this part of the project.
Optimization of the expression/purification protocol For expression of unlabeled phosphorylated CtErbB2,
the Agilent manual of the TKB1 Competent Cells was followed. Briefly, the transformation protocol was
similar to the one used for transformation of CtErbB2 in standard BL21 cells (see section 4.1.2), except
β -mercaptoethanol was added to a concentration of 25 mM to the cells before transformation, and selection
was maintained with both tetracycline and kanamycin. For expression of CtErbB2 and the tyrosine kinase,
a single colony was transferred to 2 mL LB with both antibiotics and grown overnight at 37 ◦C with shak-
ing. The next morning, the preculture was transferred to 50 mL LB with antibiotics until OD600nm = 0.6.
Expression of CtErbB2 was induced with 1 mM IPTG for 3 hours. The culture was then centrifuged at 2000
g and the pellet was resuspended in 100 mL TK induction medium (see figure 68a), and further incubated
overnight at 37 ◦C with shaking. The protein was purified following the usual protocol for CtErbB2 (see
section 4.1.3). It was then analyzed using MALDI-TOF mass spectrometry and showed several phospho-
rylation states, from unphosphorylated to phosphorylated 7 times (maybe more in small proportions), as
shown in figure 68b. This number is intermediate between the total number of tyrosines (9) and the number
of known autophosphorylation sites (5).
The production in a labeled medium is more complicated, since it requires to change the medium to a
M9 medium even for the induction of CtErbB2 and not only for the induction of the kinase. This seems
trivial, but not knowing the kinase plasmid makes it difficult to optimize. The M9 medium that we used was
the TK induction medium given in figure 68a with NH4Cl replaced by 15NH4Cl and removal of casamino
acids. Depletion in tryptophan in such medium, if the kinase expression is indeed controlled by a tryptophan
operon, may trigger expression of the kinase even in this absence of indoleacrylic acid. Therefore, we chose
to induced the production of our protein and of the kinase simultaneously, changing the medium to the TK
medium plus IPTG right after the OD600nm reached 0.6. Although we tried a lot of different conditions,
changing the induction OD600nm, temperatures, times, and order of addition of IPTG and indoleacrylic acid,
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Figure 68 – Production of unlabeled phosphorylated CtErbB2 in the TKB1 strain. (a) TK induction medium com-
position for 1L. Reproduced and adapted from the Agilent TKB1 Competent Cells instruction manual (ampicillin
has been changed to kanamycin, our selection antibiotic). (b) MALDI-TOF spectrum of unlabeled phosphorylated
CtErbB2 expressed in the TKB1 strain and purified.
we could not reproduce our results with the unlabeled protocol. In some cases we had high levels of pro-
teolysis (revealed by mass spectrometry, data not shown), and in no case were we able to unambiguously
show presence of phosphorylation.
From the results we had on the unlabeled protein, we should be able to find a protocol to produce a
labeled, phosphorylated protein. This is work in progress in the lab. In the meantime, the production of
unlabeled protein is still interesting for interaction studies.
10.2.2 In vitro phosphorylation followed by NMR
To try and obtain a phosphorylated form of CtErbB2 closer to the native phosphorylation pattern, and be
able to follow the kinetics of phosphorylation, we decided to use the ErbB2 kinase to phosphorylate our
unphosphorylated construct of CtErbB2 expressed in E. coli in a intermolecular fashion. This approach
respects the native phosphorylation specificity. However, since the topology is different from the topology
in the activated dimers that trigger trans-autophosphorylation, we do not expect the pattern to be exactly
similar to the native one.
The commercially available kinase construct (from Life technologiesTM, Catalog #PV3366) is produced in
Sf9 insect cells with a baculovirus expression system, and contains the whole intracellular part of ErbB2,
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including the juxtamembrane segment, kinase domain and C-terminal tail (residues 676-1255). It is quite ex-
pensive (468 euros/10 µg). We observed by mass spectrometry that this kinase is not catalytic: the amounts
needed for significant phosphorylation levels are high (we managed to have significant levels of phosphory-
lation at a kinase:protein ratio of 1:2, with different levels of phosphorylation from 0 to +4, data not shown).
This is consistent with literature reporting a relatively low activity of the ErbB2 kinase (Brignola et al.,
2002b; Monsey et al., 2010). From this observation, we adapted the ratio of kinase compared to CtErbB2
for our NMR study, to have a relatively high kinase:CtErbB2 ratio, while keeping CtErbB2 concentration
high enough for reasonable acquisition time for 2D experiments, and reasonable cost in commercial kinase.
The protocol is given below.
Protocol The phosphorylation was done with 35 µM CtErbB2 in 200 µL of the following buffer: 20 mM
Tris-HCl pH 7.2, 50 mM MgCl2, 1 mM ATP, 2 mM TCEP, 0.01 % CHAPS, 5% D2O and HaltTM Protease
and Phosphatase inhibitor Cocktail (Thermo Scientific). Manganese is usually used in phosphorylation
buffers. However, it had to be replaced by magnesium because manganese is paramagnetic and causes severe
broadening in NMR spectra. The kinase was added in a 1:50 ratio (10 µg in 25 µL of buffer composed of
50 mM Tris pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 0.01% CHAPS, 2 mM DTT, 50 % glycerol). Just after
addition, a series of 1H-15N HSQC (2h) and 1H-13C HSQC (33 min) were recorded for about 24h at 298 K,
at 950 MHz.
The commercial kinase is contaminated with S/T tyrosine kinase(s) The spectra that we obtained in-
deed showed what looks like phosphorylation but only on serines and/or threonines (see figure 69). The
Ser/Thr region of the spectrum shows peaks disappearing and appearing, and in particular one peak appears
in the region of pSer/pThr. This was observed on both experiments that we performed, with two different
batches of the commercial kinase. Even with a relatively pure kinase (>70% according to the manufacturer),
the high quantity that we had to use due to poor activity of the kinase increases the chance that much more
active residual Ser/Thr kinases phosphorylate our protein.
A solution to overcome this problem would be to produce our own ErbB2 kinase, to be able to control
its quality, and reduce cost.
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Figure 69 – First (red) and final (blue) 1H-15N HSQC spectra of the kinetic study of in vitro phosphorylation of wild-
type CtErbB2 by the commercial ErbB2 kinase. Conditions are given in the protocol section.
10.2.3 Intracellular domain of ErbB2 expressed in Sf9 cells using the baculovirus expression system
The two approaches presented in section 10.2.1 and 10.2.2 are both ways to phosphorylate CtErbB2 in a way
that is either non-specific (with the unknown kinase co-expressed in E. coli, section 10.2.1) or only partially
specific (with the ErbB2 kinase lacking the specificity conferred by the topology of the ErbB dimer). It was
shown that tyrosine kinase specificity is less dependent on the sequence of the substrate than Ser/Thr kinases
specificity (Zhu et al., 2005), and is more dependent on the recruitment of the substrate (local concentration,
accessibility). Reproducing ErbB2 autophosphorylation patterns thus necessitates to get as close as possible
to the actual topology in which phosphorylation happens. Production of the whole ErbB dimers would be
very challenging: the whole receptors are big (137.9 kDa for ErbB2) and are membrane proteins, which are
not easy to solubilize for solution studies. They are not expected to be suitable for overexpression in E. coli.
We therefore chose to try and produce the intracellular part of ErbB2, in insect cells using the baculovirus
expression system. The construct (presented in figure 70a) was defined following the construct of the ki-
144
10. Towards the characterization of functional states of CtErbB2: challenges of structural and functional studies of
tyrosine phosphorylation
nase domain by Life technologiesTM, and contains the intracellular juxtamembrane region that is known to
have an important role for dimerization of the kinase domains and activity. According to the tests by Life
TechnologiesTM, it should have an activity of about 0.1 nmol/min for 1 µg of kinase in 30 µL. Even though
membrane anchoring increases ErbB2 kinase activity (by a factor of 3.5), it is not strictly necessary (Monsey
et al., 2010). Being able to produce the intracellular ErbB2 would allow:
• The production of our own active kinase (unlabeled) to perform the in vitro phosphorylation described
in section 10.2.2, but controlling the kinase purity and reducing the costs.
• The study of the behavior of autophosphorylated CtErbB2 in the context of the whole intracellular
domain. This whole domain is big (around 65 kDa) for NMR. However, we hope that since the C-
terminal tail was shown to be disordered even when attached to the kinase (Keppel et al., 2017), its
favorable relaxation properties would yield good signal to noise ratio for this part. This kind of study
of flexible parts of big proteins was already conducted on a viral nucleocapsid (Jensen et al., 2011),
a DNA replication complex (De Biasio et al., 2015), and a nuclear receptor (Belorusova et al., 2016).
This study would require that we isotopically label the protein. A protocol for labeling of protein
produced in insect cells was developed in the lab a few years ago (Meola et al., 2014).
• The study of the kinase domain alone (residues 676-987) or the phosphorylated C-terminal tail alone
(988-1255), made possible by insertion of a TEV cleavage site between the two domains in one of our
constructs (that we call the TK-TEV-Ct construct, see figure 70a). We could compare the activity of
the kinase domain with of without the tail, and compare the behavior of the phosphorylated tail with
or without the kinase domain.
The principle of protein production in insect cells using the baculovirus expression system is given in
section 4.2.1.
Constructs and vectors The intracellular domain (ICD) constructs correspond to the residues 676-1255
of the full-length ErbB2 receptor. We chose to put the purification His6 tag at the C-terminus as it is less
likely to disrupt kinase activity that we want to preserve here.
The ICD insert for the pFastBacTM, shown in figure 70b for the construct without the TEV cleavage site,
and in figure 70c for the TK-TEV-Ct construct, comes from a pcDNA3 vector containing full-length ErbB2
provided by Dr. Ali Badache (CRCM, Marseille). The ribosome binding site was optimized for insect cells.
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It was further modified to add the His6 tag, and to insert the TEV cleavage site for the TK-TEV-Ct con-
struct. Cloning into the pFastBacTM vector was done following guidelines of the Bac-to-bac R© Baculovirus
Expression System protocol (Invitrogen). The detailed protocols for the generation of the viral stock and its
titration are given in sections 4.2.2 and 4.2.3. Viral stocks were generated for both constructs.
ICD (65.009 kDa) 
M His6
His6M
TK-TEV-Ct (65.861 kDa)
=Tev cleavage consensus sequence ENLYFQG
His6M ENLYFQ G+
TK (36.700 kDa)+ CtErbB2 (29.179 kDa)
FL ErbB2 (137.910 kDa)
Expressed in SF9
After TEV cleavage
(a)
(b) (c)
Figure 70 – ErbB2 constructs and pFastBacTM vectors used for generation of Bacmids for expression in Sf9 cells.
(a) The two protein constructs that we want to express in Sf9 cells, compared to the full-length ErbB2 receptor. The
result of TEV cleavage is also given for the second construct (TK-TEV-Ct). (b) For the ICD construct. (c) For the
TK-TEV-Ct construct.
Small-scale expression tests Once one has the viral stock at a known titer, the expression conditions can
be optimized. In particular, two parameters can be tested: the MOI (multiplicity of infection), that is to say
the virus to cell ratio for infection, and the expression time before harvest. The MOI has to be high enough
for as many cells as possible to be infected, but without using too much of the viral stock for each produc-
tion. The expression time, for non secreted proteins, must be long enough for a high quantity of proteins to
be expressed, but with limited lysis so that the protein is not lost in the medium upon cell harvest. So far,
we have done these tests only on the ICD construct.
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3mL of Sf9 cells at 1.106 cells/mL were infected with the P3 viral stock corresponding to the ICD construct
(3.108 PFU/mL). Different MOIs from 1 to 30, as well as different incubation times from 1 to 3 days before
harvesting cells, were tested. The quantity of protein in the pellet was assessed by Western blotting (fig-
ure 71). Tests were not continued after day 3 because cell viability was going down dramatically. Before
blotting, cells were lysed by sonication, the lysate was cleared by centrifugation, and enriched in His-tagged
proteins by retention on Ni-NTA resin. Western blots were done on nitrocellulose membranes, using a pri-
mary anti-His tag mouse monoclonal antibody and a secondary IRDye R© 800 CW Goat anti-mouse (IgG)
antibody.
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Figure 71 – Expression tests for the ICD construct. Different MOIs were tested with harvest at day 2, and for MOI
= 10, harvest at day 1, 2 and 3 was tested. (a) Ponceau staining of the membrane for the estimation of total protein
loading and (b) Western blot revealing His-tagged proteins. In lane 2 is the positive control consisting of purified
His-lipoyl-CtErbB2 (expressed in E. coli and purified as described in section 4.1, without cleavage of the His-lipoyl
tag). Lanes 1 and 3 are molecular weight markers.
The anti-His Western blot shows a band between 75 and 100 kDa. This is consistent with the expected
migration for our construct: its molecular weight is 65 kDa, but since the C-terminal tail is expected to
remain very flexible, it is not surprising that it migrates at a higher apparent molecular weight. From the
relative intensities of the bands (which should be normalized against total protein loading assessed from
Ponceau staining shown in figure 71a), it seems that the amount of protein expressed does not dramatically
increase when MOI is above 5. It also seems that the quantity of protein increases from day 2 to 3 even if
lysis had begun to occur. The chosen conditions for expression of our protein would therefore be MOI = 5,
and three days of expression before harvest.
We could not go further for now due to lack of time, but we have a proof of concept that we are able to
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produce the ICD construct in Sf9 cells. Even though the construct does not recapitulate the native ErbB
dimers, this would allow a leap forward in the understanding of the phosphorylation process by the ErbB
kinase, and in the intramolecular interaction of the C-terminal tail with the kinase domain.
10.2.4 Overcoming the heterogeneity problem: using Tyr to Phe point mutants
We have three ways to produce phosphorylated CtErbB2, although optimization is still necessary for all three
methods. Two problems persist: with our co-expression bacterial system (section 10.2.1), the phosphoryla-
tion pattern will not be specific of the ErbB kinases; and in all systems, heterogeneous phosphorylation on
different sites will prevent easy characterization of the phosphorylated states.
We therefore chose to use tyrosine to phenylalanine mutations to selectively prevent phosphorylation on cer-
tain tyrosine sites, and select the sites that we want to keep accessible for phosphorylation. This approach is
similar to the one that was used for several studies of ErbB2 phosphorylation (Dankort et al., 1997, 2001a,b;
Marone et al., 2004). Our approach so far is to have mutants which can only be phosphorylated on one
tyrosine (out of 6) autophosphorylation sites. These mutants with 8 point mutations (there are 9 tyrosines in
total in CtErbB2) are called YA, YB, YC, YD1, YD2 and YE and are described in section 4.1.1. These mu-
tations are designed to selectively prevent phosphorylation without perturbing the behavior of the protein.
To verify the latter, we assigned the 0Y mutant, where all the tyrosines are mutated to phenylalanines, by
transferring the assignment from the wild-type and with the help of HNCACB, HN(CO)CACB and HNCO
spectra. Then, we recorded 15N T1 and T2 relaxation experiments to compare the dynamics of the mutant
to that of the wild-type protein, at 950 MHz. The results are presented in figure 72. We noticed that the
spectra recorded on the mutant had a small pH difference compared to the spectra recorded, as seen by a
decreased intensity in the histidine-rich regions (around residue 50). These peaks becoming weak, we could
not obtain reliable relaxation data on this region. Overall, the dynamic profile of the mutant is similar to
the behavior of the wild-type protein. The same regions present higher R2 and/or R1 rates, even though the
values are not exactly the same. These relaxation experiments being extremely sensitive to small changes in
pH, temperature or small differences in the experiment parameters, we plan on recording new experiments,
controlling these more closely, and also recording {1H}-15N nOes data. This would confirm the similarity
of behavior of the 0Y mutant and the wild-type protein, validating our approach.
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Figure 72 – 15N R1 and R2 relaxation rates for the 0Y mutant of CtErbB2, measured at 22.3 T (950 MHz proton fre-
quency).
The first mutants that we tried to use in our phosphorylation experiments described above, are the YA,
YB and YD mutants. Although we did not manage to have any usable phosphorylated sample yet, these
three mutants are particularly interesting. The phosphorylation of YA has been shown to inhibit the trans-
formation potency of ErbB2 by Dankort et al. (1997). This could be an indirect effect, via recruitment of
proteins involved in regulation mechanisms of ErbB2, or a more direct, conformational effect for example.
The authors also showed that even though the negative effect of YA phosphorylation could not be rescued by
phosphorylation of YB, YC or YE, simultaneous phosphorylation of YA and YD enabled to recover ErbB2
transformation potency. This suggests interdependence of the effect of phosphorylation on these two sites.
This data, combined with our observation that the regions containing YA and YD experience a long-range
contact, make these two sites particularly interesting. A YAYD mutant, allowing simultaneous phosphory-
lation of the two tyrosines, would also be helpful. Our other mutant of particular interest, YB, would allow
us to study the effect of phosphorylation on the interaction of Grb2 with YB, as done with our titrations
with peptides, but in the context of the full-length protein. Since we showed that sites outside the primary
phosphotyrosine motif are involved in the interaction, this could further improve our understanding of the
interaction.
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In this work, we have characterized the structure and dynamics of the C-terminal tail of the receptor tyrosine
kinase ErbB2 (CtErbB2). We have also undertaken the study of the two main phenomena that regulate its
function: its phosphorylation and its phosphorylation-dependent interactions. We mainly used NMR to get
atomic-resolution information, and we combined it with SAXS to obtain size and shape parameters.
First, we studied the conformational ensemble of isolated, unphosphorylated CtErbB2. No stable sec-
ondary or tertiary structure is present along the 268 residues of this tail, which makes it a particularly long
and highly disordered region. A N-terminal α-helix is transiently formed, and is suspected to interact with
the kinase domain in the full-length receptor. The numerous prolines in the tail participate in the transient
folding of several segments into PPII helices. Two regions near the termini engage in a short-lived contact
that could regulate CtErbB2 interactions.
We have shown that the structural heterogeneity of the tail is accompanied by high dynamic heterogeneity, as
seen in 15N relaxation data. However, we have not investigated the details of these dynamics heterogeneities.
In particular, the regions involved in long-range contacts seem to undergo conformational exchange. Anal-
ysis of the relaxation data at several fields using different models, and complementary relaxation-dispersion
or CEST experiments (depending on the exchange rate) could give some insight into the type of movement
involved. The different dynamic behaviors experienced by glycine-rich and proline-rich regions could also
be investigated in more detail.
Then, we studied a major interaction partner of ErbB2, the modular SH3-SH2-SH3 protein Grb2. Grb2
SH2 domain is known to interact with phosphotyrosine B of ErbB2 and its two SH3 domains link it to
the Ras/MAPK pathway, a pathway critical for ErbB2 function and its role in cancer. Contrary to what is
suggested by the crystal structure of Grb2, we showed by NMR that in its unliganded form, Grb2 domains
do not interact with one another in solution. The NSH3 domain is exchanging between a folded and an
unfolded form, and stays at a fix distance to the SH2 in the NSH3SH2 bidomain. Conversely, the fully
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folded CSH3 domain experiences extension and shortening of its linker relative to the SH2 domain in the
SH2CSH3 bidomain. Extension and compaction is also seen in the full-length protein. This behavior may
influence binding to partners of Grb2.
Complementary RDC experiments and analysis of relaxation data would allow further characterization of
the inter-domain orientations and dynamics. Additionally, Grb2 oligomeric state in controversial. In both
the NMR and SAXS experiments that we performed, Grb2 in mainly monomeric. However, size exclusion
chromatography shows peaks of dimers. We have not investigated the monomer/dimer equilibrium, that
seems to have a dissociation constant higher than the µM KD suggested by some studies. Once again, fur-
ther relaxation-dispersion experiments could help detect the potential dimeric form, and SAXS analysis of
the dimer peaks in SEC could give information about the organization of the dimer.
Having characterized both partners, we investigated the binding of Grb2 to unphosphorylated CtErbB2.
Grb2 SH2 domain binds weakly to unphosphorylated CtErbB2 tyrosine B, and its NSH3 domain interacts
with a proline-rich segment a few residues C-terminus of this tyrosine. Using ErbB2 peptides containing
these two binding motifs, we showed that upon tyrosine phosphorylation the interaction with the SH2 do-
main of Grb2 is tighter, giving very different binding characteristics for the SH2-phosphotyrosine and the
NSH3-polyproline interactions.
Peptides containing only the tyrosine or only the polyproline segment will be tested for interaction with
Grb2 to investigate potential cooperativity between the SH2 and NSH3 binding. Peptides mutating the dif-
ferent prolines in the polyproline segment will also enable to determine if the canonical class I RxxPxxP
motif is indeed the interaction motif, or if the other prolines and arginine are directly involved. Titrations of
the whole CtErbB2 with Grb2 showed effects of binding on regions outside of the tyrosine B-polyproline
segment. We will titrate Grb2 with peptides corresponding to these regions, to see if these effects are due to
direct binding or indirect effects. The goal would eventually be to give up the peptide approach and study the
interaction of Grb2 with the whole phosphorylated CtErbB2. In this context, multisteric effects as defined
by Tompa (2014) as an extension of the concept of allostery could really be investigated.
Finally, an important perspective for this study is the obtention of phosphorylated CtErbB2. The differ-
ent methods that we described would allow the study of the effect of phosphorylation on the structure and
dynamics of CtErbB2 alone, and on its interactions. The study of the phosphorylation process itself, and
more generally of the interaction of the C-terminal tail with the kinase domain of ErbB2 is another reason
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for trying to produce constructs containing the kinase domain, using eukaryotic expression systems. We
showed that we are able the express the intracellular region in insect cells, and the perspectives are therefore
numerous.
All in all, our study is part of the ongoing global effort to understand how intrinsically disordered pro-
teins perform their biological functions. In CtErbB2, the high level of disorder all along the sequence allows
very high accessibility of all the tyrosine phosphorylation/interaction sites. We showed an even higher den-
sity of interaction sites along the tail that what was previously thought, with polyproline motifs adding up
to (phospho)tyrosines. A folded region of this size could probably not fit as many interaction sites. We have
also shown that in terms of transient secondary and tertiary structure, and in terms of dynamics, the tail is
highly heterogeneous. Despite disorder, different sites have different behaviors, which suggests that there
would be different binding modes of different regions of the tail, supporting the hypothesis of potentially
different specificities of the multiple sites. In addition to this multiplicity, another layer of complexity and
adaptability is added by phosphorylation, increasing the possibilities for regulation.
The interaction that we studied here is a model of the possibilities only offered by disorder: two motifs
of very different nature (phosphotyrosine and polyproline), within only twenty residues, bind to different
modules of a single protein, in a phosphorylation-dependent manner. In ErbB2, for which regulation by
ligand-binding to a folded domain (the extracellular domain) is lacking, the regulation by this disordered
region is particularly important. And the outcome of this regulation of interactions, determining the na-
ture and intensity of signaling, is crucial for our understanding of physiological and pathological function,
especially in cancer.
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SUPPLEMENTARY INFORMATION
I M9 medium composition
Component Concentration15N M9 15N13C M9
Na2HPO4 45 mM (6.4 g/L)
KH2PO4 22 mM (3 g/L)
NaCl 8.5 mM (0.5 g/L)
15NH4Cl 18.5 mM (1 g/L)
MgSO4 2 mM
CaCl2 10 µM
Vitamin mix GibcoTM MEM Vitamin Solution
Trace elements see (b)
Glucose 4g/L X
13C Glucose X 3g/L
(a) General M9 composition
Compound Concentration (mM)
EDTA 17.1
CaCl2 40.8
CuSO4 17.6
MnCl2 6
H3BO3 0.323
ZnSO4 2.345
FeSO4 21.6
Ascorbic acid 1.1
(b) 100X stock solution of trace elements
Table S1 – M9 medium composition (for [U-15N] or [U-15N; U-13C] labeling). For deuteration, the same M9 is used
with D2O as solvent instead of H2O.
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Titre: Exploration structurale et fonctionnelle de la partie C-terminale intrinse`quement de´sordonne´e de ErbB2
Mots cle´s: Re´sonance magne´tique nucle´aire (RMN), prote´ine intrinse`quement de´sordonne´e (IDP), re´cepteur
tyrosine kinase ErbB2, prote´ine adaptatrice Grb2, phosphorylation de tyrosines, interaction prote´ine-prote´ine
Re´sume´: ErbB2/HER2 est un re´cepteur tyrosine ki-
nase de la famille d’EGFR (ErbB1) surexprime´ dans
plus de 20% des cancers du sein et associe´ a`
une forme particulie`rement agressive de la maladie.
Les re´cepteurs ErbBs sont actifs seulement sous
forme de dime`res, permettant la phosphorylation de
leur queue C-terminale par leur domaine tyrosine ki-
nase. La phosphorylation entraine l’interaction avec
des prote´ines adaptatrices et l’activation de voies de
signalisation, Ras/MAPK et PI3K/Akt principalement.
Ces voies controˆlent la prolife´ration, la motilite´ cel-
lulaire et la re´sistance a` l’apoptose. Contrairement
a` ErbB1/3/4, ErbB2 dime´rise en l’absence de ligand.
Comprendre les autres me´canismes de re´gulation de
la phosphorylation de ses tyrosines et de ses interac-
tions est donc particulie`rement inte´ressant.
ErbB2 a fait l’objet de nombreuses e´tudes struc-
turales et fonctionnelles. Elles ont permis la mise
au point de traitements cible´s efficaces mais su-
jets a` l’apparition de re´sistance, dont l’anticorps
Trastuzumab, ciblant sa partie extracellulaire. La
queue C-terminale d’ErbB2 (CtErbB2) a e´te´ tre`s sou-
vent ignore´e dans ces e´tudes. Cette partie e´tant in-
trinse`quement de´sordonne´e, il a fallu attendre ces
dernie`res anne´es pour que les concepts et les out-
ils permettant de l’e´tudier e´mergent.
Dans cette the`se, j’ai d’abord effectue´ la car-
acte´risation structurale et dynamique de CtErbB2.
J’ai montre´ que bien qu’e´tant de´pourvue de toute
structure stable, cette re´gion riche en prolines
posse`de plusieurs structures secondaires transitoires
et un contact longue-distance participant tre`s prob-
ablement a` la re´gulation de ses interactions intra-
et inter-mole´culaires. Dans une deuxie`me partie je
me suis inte´resse´e a` la caracte´risation de la prote´ine
adaptatrice Grb2, partenaire essentiel de ErbB2 pour
l’activation de la voie des MAP kinases. L’organisation
en solution des domaines de cette prote´ine modu-
laire dans sa forme libre e´tait jusque la` inconnue.
J’ai ensuite e´tudie´ l’interaction entre Grb2 et CtErbB2,
et montre´ que CtErbB2 interagit non seulement avec
le domaine SH2 de Grb2 (par l’interme´diaire d’une
phosphotyrosine), mais aussi avec son domaine SH3
N-terminal (graˆce a` un motif polyproline). Enfin, j’ai
mis en place plusieurs strate´gies de phosphorylation
des tyrosines de CtErbB2, dans le but d’e´tudier plus
largement l’effet des phosphorylations sur l’ensemble
de cette re´gion.
Title: Structural and functional investigation of the C-terminal intrinsically disordered fragment of ErbB2
Keywords: Nuclear magnetic resonance (NMR), intrinsically disordered protein (IDP), receptor tyrosine ki-
nase ErbB2, adaptor protein Grb2, tyrosine phosphorylation, protein-protein interaction
Abstract: ErbB2/HER2 is a receptor tyrosine kinase
of the EGFR (ErbB1) family overexpressed in 20% of
breast cancers and associated to a particularly ag-
gressive form of the disease. ErbB receptors are
only active upon dimerization that enables phospho-
rylation of their C-terminal tail by their tyrosine ki-
nase domain. Phosphorylation then triggers inter-
action with adaptor proteins and activation of signal-
ing pathways, mainly Ras/MAPK and Akt/PI3K. Those
pathways control cell proliferation, motility and resis-
tance to apoptosis. Contrary to ErbB1/3/4, ErbB2
can dimerize without any ligand. Understanding other
mechanisms of regulation of its tyrosine phosphoryla-
tion and of its interactions is thus particularly interest-
ing.
ErbB2 structure and function have been extensively
studied. This has led to the development of sev-
eral FDA-approved targeted drugs, that are effective
but to which resistance occurs, amongst which the
Trastuzumab antibody that targets ErbB2 extracellular
domain. The C-terminal tail of ErbB2 (CtErbB2) has
been widely ignored in these studies. Since it is intrin-
sically disordered, the concepts and tools to study it
have only emerged in the last few years.
In the present work, I have performed the structural
and dynamic study of CtErbB2. I showed that de-
spite its lack of any stable structure, this proline-rich
region exhibits several transient secondary structures
and a long-range contact that might participate in the
regulation of its intra- and inter-molecular interactions.
Then, I characterized the adaptor protein Grb2, which
is a partner of ErbB2 that is essential for the activa-
tion of the MAPK pathway. The solution organiza-
tion of the domains of this modular protein in its apo-
form was unknown so far. I also studied the interac-
tion between Grb2 and CtErbB2, showing that in addi-
tion to the known SH2-phosphotyrosine interaction, a
polyproline motif of CtErbB2 binds to the N-terminal
SH3 domain of Grb2. Finally, I implemented sev-
eral strategies to phosphorylate CtErbB2 tyrosines, to
study more extensively the effect of phosphorylation
on the whole tail.
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